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Abstract
IVD degeneration is a multifactorial pathological process associated with back pain. While
biomechanical factors are important regulators of IVD homeostasis, mechanical loading also
contribute to the onset of IVD degeneration. Importantly, the mechanotransduction pathways
that mediate cell type-specific responses to mechanical loading are not well understood.
Transient receptor potential vanilloid 4 (TRPV4) is a multimodally activated cell surface cation
channel implicated as a mechanoreceptor regulating the mechano-response in other
musculoskeletal cell types. Using both in vitro and in vivo models, the current study aimed to
characterize the role of TRPV4 in annulus fibrosus (AF) cell mechanotransduction. Using a
mechanically dynamic bioreactor system, AF cells were exposed to cyclic tensile strain (CTS)
to assess mechanically-induced changes in gene expression and mitogen activated protein
kinase (MAPK) pathway activation. Next, a novel transgenic Trpv4-reporter mouse model was
used to determine the expression pattern of Trpv4 during mouse spine development and aging.
TRPV4 function in AF cells was then characterized using live cell calcium imaging and
treatment with pharmacological modulators of TRPV4 during CTS. Lastly, conditional Trpv4
knockout mice (Col2-Cre;Trpv4fl/fl) were used to determine the role of TRPV4 signalling in
IVD health and injury-induced degeneration. These studies demonstrated that the mechanoresponse of AF cells was frequency-dependent, showing increased stress fibre formation,
ERK1/2 pathway activation, and gene expression changes (i.e. Extracellular matrix (ECM)
genes, matrix remodelling genes, mechano-sensitive genes, inflammatory cytokine genes, and
mechanoreceptor genes). Trpv4 expression was first detected during spine development, was
maintained in NP and inner AF tissues and subsequently decreased with age. Activation of
ii

TRPV4 elicited intracellular calcium response in AF cells that was shown to regulate
cytoskeletal remodelling and CTS-induced changes in Acan, Col1a1, and Prg4 expression.
Furthermore, loss of Trpv4 led to decreased proteoglycan staining and the attenuation of
degenerative changes in IVDs experiencing aberrant load following injury. Taken together, our
findings suggest the existence of mechanical threshold that regulates IVD health and
degeneration through TRPV4-mediated mechanotransduction pathways.
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Summary for Lay Audience
Back pain is a major global health challenge and one of the most common causes of disability
worldwide, imposing high socioeconomic burden on individuals and healthcare systems. In
North America, four out of five adults will experience back pain at some point in their lives.
Currently, back pain is treated mostly with pain management strategies and disc surgery, but
the outcomes are disappointing, as the causes of back pain are rarely addressed. Back pain is a
complex condition with multiple causes but is typically associated with intervertebral disc
(IVD) degeneration. The IVD is a joint found between the spinal column that acts as a shock
absorber during movement. Similar to muscles and bones, the force experienced by IVD is
important for maintaining joint health, but abnormal levels can cause damage. This adaptive
response to mechanical load is regulated at the cellular level by a process called
mechanotransduction, in which cells sense and change external mechanical force into
biological chemical signals. However, this cellular mechanism is not well understood. Using
different experimental approaches, we aimed to determine how IVD cells adapt and respond
to mechanical stimulation. Our studies showed that IVD cells respond to mechanical
stimulation by changing their stiffness, activating specific biochemical signals, and regulating
gene expression. Interestingly, the cellular responses differed depending on the frequency of
the mechanical stimulation applied to the cells. These responses were found to be mediated by
a receptor protein found on the cell surface that is activated by normal and abnormal levels of
mechanical loading, serving to regulate IVD health and degeneration. Our findings contribute
to an important biological question in the field of spine and IVD research regarding how
mechanical forces regulate joint health.
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Chapter 1

1

Introduction and Review of the Literature

1.1

Overview

Musculoskeletal disorders are the second most common cause of disability worldwide,
with disability-adjusted life years and prevalence increasing exponentially annually1.
Among them, back pain is the leading cause of years lived with disability in more than half
of the world. The etiology of back pain is not fully understood; it can originate from
different anatomical structures of the spine including, ligaments, paravertebral
musculatures, vertebral bones, spinal nerve roots, facet joints, but is most commonly
associated with intervertebral disc (IVD) degeneration2,3. While pain management
treatments are available, they do not adequately improve clinical outcomes and no disease
modifying treatments exist for IVD degeneration. The current lack of therapeutic
interventions for IVD degeneration is related to our limited understanding of the
mechanisms regulating IVD development, homeostasis, and degeneration.
This chapter provides an overview of the current understanding of IVD biology, discussing
topics ranging from spine development to the structural and molecular characteristics of
normal and degenerative IVDs. Also described are the different experimental models used
to study the molecular, cellular, and tissue-level effects of mechanical loading on the IVD
as well as our knowledge of cellular mechanosensing and mechanotransduction in the
musculoskeletal system.

2

1.2

Spine as a Joint Complex

The term spine describes a collection of vertebral bones (vertebrae) articulated in an
interlocking stacked column4. This structure is found at the posterior midline of the body
acting as the primary structural support for the torso. In taxonomic hierarchy, the vertebral
column defines the subphylum Vertebrata of the phylum Chordata5. Specifically, the
human spine is composed of 33 vertebrae divided into five anatomical regions: 7 cervical,
12 thoracic, 5 lumbar, 5 sacral, and 4 coccygeal6 (Figure 1.1A). The zygapophyseal joints
between the superior and inferior facets of the vertebral articular processes (commonly
referred to as facet joints), as well as the intervertebral discs (IVDs) located between the
vertebral bodies are the two major joints that form the articulations and serve as shockabsorbers for the 24 presacral vertebrae (Figure 1.1B). Functionally, the facet joints
maintain vertebral alignment and allow for flexion-extension of the spine, while partially
limiting axial rotation, lateral bending, as well as translation (glide) motions enabled by
IVDs7.

1.3

The Intervertebral Disc

The IVD is a connective tissue structure located between the vertebral bodies essential for
spine stabilization, load bearing and movement. Anatomically, IVDs are composed of three
distinct yet interdependent tissues: the gelatinous, highly hydrated central nucleus pulposus
(NP), the outer fibrous annulus fibrosus (AF) encapsulating the NP, and the cartilage
endplates (CEP) that anchor the disc to the adjacent vertebrae8 (Figure 1.1C). Accordingly,
IVDs are not uniform in their composition, possessing the components of both fibrous and
cartilaginous connective tissues, and are therefore considered as fibrocartilage tissue9. The
cells of the NP and AF have distinct developmental origins and produce a distinct
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Figure 1.1. Schematic representation of the human spine, joint structure and
intervertebral disc.
A) Illustration of the human spine highlighting the different anatomical regions. The human
spine is made up of 33 vertebrae: 7 cervical (orange), 12 thoracic (yellow), 5 lumbar
(green), 5 sacral (purple; sacral vertebrae are fused and collectively known as sacrum), and
4 coccygeal (brown; vertebrae fused and collectively called coccyx). B) Intervertebral discs
are the joints between the vertebral bodies while the facet joints articulate the vertebral
spinous processes. C) The intervertebral disc is composed of three tissues: the central
nucleus pulposus that is contained radially by the annulus fibrosus and superiorly/inferiorly
by the cartilage endplates. D) The annulus fibrosus is formed by concentric lamellae with
parallel bundles of type I collagen which form an angle-ply structure, allowing for the
annulus fibrosus to resist tensile strain.
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extracellular matrix (ECM) compatible with the mechanical function of each tissue, that
together form the complex microarchitecture required for proper disc function10. The
interdependency of these tissue types requires maintenance of the integrity of all three disc
tissues, as the breakdown of any one will functionally impact the others. Within each tissue,
the cellular activity, including ECM production and the cellular response to mechanical
loading, shapes the physiological and biomechanical functions of the IVD.

1.3.1 The Nucleus Pulposus
The NP is an aneural, avascular gelatinous tissue that forms the innermost core of the IVD.
It is composed of water (70-90%), proteoglycans (50% of dry weight) and type II collagen
(20% of dry weight)11–13. Proteoglycans found in the NP can be divided into two distinct
classes: aggregating and non-aggregating proteoglycans. Large aggregating proteoglycans
(i.e. aggrecan and versican) are monomers that form large aggregates through cross-linking
with hyaluronan14–17. These monomers contain protein cores covalently linked to numerous
sulphated glycosaminoglycans (GAG) side chains (i.e. chondroitin sulphate and keratan
sulphate)18,19. Almost 90% of aggrecan’s mass is attributed to GAG chains, each containing
~100 chondroitin sulphate chains and up to 60 keratan sulphate chains20. These sulphated
side chains confer a strong negative charge which allows them to attract water molecules
and provides viscoelastic properties to the tissue21. Non-aggregating proteoglycans include
members of the small leucine-rich proteoglycans (i.e. biglycan, decorin, and fibromodulin)
and other matrix proteoglycans that are important in the control of collagen fibrillogenesis,
growth factor binding and sequestration, and interact with signalling molecules controlling
proliferation, differentiation and ECM homeostasis22,23. In addition to proteoglycans,
fibrillar proteins, such as type II collagen, are irregularly arranged and distributed
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throughout the NP, providing a three-dimensional mesh-like microarchitecture to support
both the proteoglycans and resident cell populations12,22.
A feature that distinguishes the NP from other IVD tissues is its drastic change in cellular
composition over time. In some species (e.g. rodents, cats and non-chondrodystrophoid
dogs), the NP is formed and populated at birth by large vacuolated notochordal cells (3040 μm in diameter) that persist through most of adulthood. In contrast, in other species (e.g.
horses, and humans), the notochordal cells that initially populate the NP are progressively
lost within the first decade after birth24–28 and the NP becomes instead populated by small
chondrocyte-like NP cells24,25. Historically, there have been two hypotheses regarding the
origin of the cartilage-like cells of the NP. It was originally suggested that these NP cells
were of mesenchymal origin, populating the NP following migration from the surrounding
cartilage endplates29. Notochordal cells were thought to direct mesenchymal cell migration,
stimulate matrix synthesis, and then undergo apoptosis30,31. Alternatively, it was suggested
that notochord cells act as progenitors of the NP cells, and undergo terminal differentiation
to produce cartilage-like cells (notochord cell maturation model)32–34. Previous fate
mapping studies demonstrated that, at least in mice, chondrocyte-like NP cells are derived
from the embryonic notochord35,36. Notably, the loss of notochordal cells is associated with
the initiation of early degenerative changes in the IVD, suggesting that this cell population
is crucial for the maintenance of the NP37–39. Recent studies also reported that hypertrophic
cells detected in the NP during age-associated IVD degeneration are also of notochordal
origin, formed by fusion of chondrocyte-like NP cells to form nested lacunae40.
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1.3.2 The Annulus Fibrosus
The AF is a highly organized tissue that circumferentially surrounds the NP. In contrast to
the NP, the AF is composed of water (60-80%), with a greater proportion of collagen (5070% dry weight) than proteoglycan (10-20% dry weight)12,41. The AF is formed by 15-25
concentric lamellae (in humans), each composed of parallel bundles of collagen fibres in
an angle-ply fibre orientation22,42. Specifically, collagen fibres are oriented at 25-30° from
the transverse plane in alternating orientation with each subsequent lamella42 (Figure
1.1D). Individual lamellae are separated by an interlamellar proteoglycan-rich ECM (i.e.
aggrecan, versican, lubricin, and elastin) produced by its resident cells42,43. It is thought
that the interlamellar network formed by elastin fibres maintains the integrity of the
lamellar structure, enabling the structure to recoil after deformation43,44. The AF is further
divided into inner and outer regions, distinguishable by differences in cell shape and
interlamellar ECM composition. The outer AF lamellae are primarily made up of tightly
arranged bundles of type I collagen with resident cells exhibiting an elongated fibroblastlike morphology and adhering to collagen fibres within the lamellae45,46. The inner AF
serves as a transition between the NP and AF tissues. Its matrix contains decreased levels
of type I collagen compared to the outer AF, with increased concentration of type II
collagen, and increased proteoglycan-rich interlamellar matrix produced by cells that show
more rounded morphology42,45,46. This heterogeneity in the profile of the AF ECM may be
due to different types and magnitudes of load experienced in different regions of AF tissues
in vivo45–48.
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1.3.3 The Cartilage Endplate
IVDs are bordered at the superior and inferior ends by cartilage endplates, thin layers of
hyaline cartilage that cover the vertebral bone creating an interface with the AF and NP12.
The ECM of the CEP is composed of proteoglycans and type II collagen, populated by
chondrocytes with a similar phenotype to those found in articular cartilage49. The
orientation of the collagen fibres varies regionally across the CEP, with fibres running
parallel to the vertebral bodies in the centre of the CEP (NP interfacing region) but are
curved closer to the inner AF region. These curved collagen fibres merge with the collagen
fibres of the AF (along with elastin fibres oriented parallel to collagen fibres) to structurally
anchor the inner AF to the CEPs50,51. The collagen fibres in the outer AF penetrate the
thinner layer of CEP and become interwoven with fibrillar matrix of vertebral bone to form
a stable anchor52.
The CEP serves important structural, load bearing, and barrier functions in the IVD. First,
it acts as a structural barrier to separate the IVD from the adjacent vertebrae and contain
the NP10,49. Secondly, the ECM composition and structure of the CEP allow it to evenly
distribute compressive load originating from the IVD onto the vertebral body 53,54. Lastly,
the CEP functions as a semi-permeable barrier through which small molecules and solutes
diffuse into the primarily avascular IVD. Although a blood supply is present in the outer
AF, the inner AF and NP are avascular. As such, these tissues rely on solute diffusion as
the primary source of nutrients from the capillary beds located in the bony endplate of the
vertebrae

50

. The central zone of the CEP allows for the highest diffusion of small

molecules such as oxygen and glucose, owing to the higher tissue porosity and GAG
content in the central region55–58. With age, the CEP becomes thinner and other defects

8

such as fissures or calcification may prevent adequate nutrient supply, contributing to IVD
degeneration22,54.

1.4

Spine Development

As detailed above, the IVD is a heterogeneous structure formed by different tissues with
distinct cell types, specific ECM composition, and tissue architecture. As such, complex
mechanisms regulate embryonic IVD development. Previous studies have used different
animal models to understand IVD development, including frogs (Xenopus laevis)59,60,
zebrafish61,62, chick63,64, and mice35,36. This section will provide an overview of the current
understanding of murine IVD development since the studies outlined in the current thesis
exclusively use the mouse as a model system.

1.4.1 Node and Notochord Development
In the early mouse embryo, the key event required for subsequent development of the spine
is initiated at embryonic day (E)7.5, when the node is formed near the anterior end of the
primitive streak (Figure 1.2A)65. The node is a transient structure located at the distal tip
of the early embryo, responsible for establishing a left asymmetry of embryo patterning66–
68

. Monocilia that protrude from cells located on the apical surface of the node generate a

rotation (clockwise rotation when viewed from the ventral size) to drive a leftward flow of
extra-embryonic fluid containing morphogens, such as Nodal and Cerl-2, secreted by the
epithelial cells found at the ventral node66,68–70. This unidirectional flow (referred to as
nodal flow) regulates left side patterning via two possible mechanisms: i) through direct
induction of differentiation on the left side of the embryo by morphogens carried through
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the leftward nodal flow (formation of morphogen gradient) (Figure 1.2B)69,71, or ii)

10

Figure 1.2. Schematic illustration of nodal flow models and key stages of murine spine
development.
A) Node cells found within the node at embryonic day (E)7.5 create a nodal flow that is
essential for left/right patterning of the embryo. A, anterior. P, posterior. L, left. R, right.
Node cells contain monocilia that rotate in a clockwise direction, creating a leftward flow
of extra-embryonic fluid, called nodal flow (B, C). In the mouse embryo, two possible
mechanisms have been proposed to explain the contribution of nodal flow to embryo
patterning. B) The nodal flow transports morphogens to the left side of the embryo, creating
a gradient of signals. C) The leftward fluid flow is sensed by crown cells, leading to
activation of mechano-sensitive calcium signalling. D) After node formation, by E9.0,
notochord (NC) is formed flanked by paraxial mesoderm (PM) laterally. The cells of the
notochord migrate, and the notochord elongates. The PM then undergoes segmentation to
form the somites. LPM, lateral plate mesoderm. E) By E12.5, inner regions of the somites
differentiate into sclerotome and aggregate around the NC for form perichordal tube (PT).
F) Mesenchymal cells, found at the inner layer of PT, condense around the NC, acquiring
a metameric pattern of condensed and non-condensed regions, which will form the annulus
fibrosus (AF) and vertebral bone (VB), respectively, leading to NC segmentation.
Metameric patterning is followed by segmentation of the NC. G) Formation of primitive
intervertebral discs is associated with disappearance of NC within the VB regions, after
which immature structures of nucleus pulposus (NP), AF, VB, and cartilage endplate (CEP)
can be detected.
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through fluid flow induction of mechanosensitive calcium signalling in peri-nodal crown
cells that promote cells specification (physical stimulation) (Figure 1.2C)72. Although the
underlying mechanisms remain to be elucidated, nodal flow creates left-right symmetry
during development. By E9.0, mesodermal cells ingress through the primitive streak to
form a solid rod-like structure called the notochord (axial mesoderm), flanked laterally by
the paraxial mesoderm, which will go on to form the somites (Figure 1.2D)67. The cells
that form the notochord migrate from the node and elongate along the central midline of
the embryo to form the notochord52,62. In a developing embryo, the notochord serves two
important functions. First, the notochord acts as a primitive axial support resisting
compression along the primitive longitudinal (anterior/posterior) axis as the embryo
grows52. Second, the notochord serves as a signalling centre, secreting morphogens, such
as sonic hedgehog (Shh) and noggin, responsible for patterning of surrounding tissues35,73.

1.4.2 The Patterning of the Axial Skeleton
Development of axial skeleton is a complex, stepwise process that requires intricate
coordination of cell signalling and differentiation. At E6.0 gastrulation establishes three
germ layers of the embryo: the ectoderm, which forms the skin and nervous system, the
endoderm, which forms the digestive, respiratory, and urinary system, and the mesoderm,
which forms the circulatory system, muscles, bones, and connective tissues74. The
mesoderm is further divided into three compartments: lateral plate mesoderm, intermediate
mesoderm, and paraxial mesoderm74. From E7.5-E11.5, the paraxial mesoderm undergoes
segmentation to form the somites (Figure 1.2D)75. Somites are transient structures that
pattern and segment the embryo along the anterior-posterior axis76. At E12.5 Shh released
from the notochord directs the somites to a sclerotomal fate by inducing paired box 1
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(Pax1) gene expression, facilitating sclerotome cells to aggregate and condense around the
notochord to form a perichordal tube (Figure 1.2E)77,78. These sclerotome gives rise to the
ribs, vertebral bodies, CEP and AF of the IVD76. By E13.5, mesenchymal cells from the
inner layer of perichordal tube accumulate around the notochord and acquire a metameric
pattern of condensed and non-condensed segments that later give rise to the AF and
vertebral bodies, respectively (Figure 1.2F)35,36,77.

Concurrent with mesenchymal

condensation, the notochord regresses in the regions where the vertebral bodies will
develop, but expands within the prospective IVD regions, exhibiting the “moniliform”
shape (Figure 1.2F)76. The processes that control notochord segmentation are unclear. One
possible mechanism is biomechanical force exerted by the developing vertebral bodies,
squeezing the notochord cells toward the prospective IVD regions79,80. In support of
proposed mechanical force model of notochord segmentation, pan-Col2a1 knockout mice
(Col2a1-/-) showed defects in vertebral bone formation and retention of the notochord in
developing spine, leading to either the absence or reduced size of the NP in the IVD79. The
segmented notochord can be detected at E15.5, after which immature structures of NP, AF,
and vertebral bodies begins to form (E16.5-E18.5) (Figure 1.2G)77.

1.5

Back Pain and Intervertebral Disc Degeneration

The most recent Global Burden of Disease Study reports that low back pain is the leading
cause of years lived with disability in 126 of 195 countries and territories studied1. In fact,
low back pain has been one of the top three causes of years lived with disability globally
since 1990, with the over 245 million newly reported cases in 20171. Clinically, low back
pain is one of the most common reasons for doctor visits, with a reported lifetime
prevalence of 84% in North America, making it the most prevalent medical condition
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. On a socioeconomic level, back pain is associated with a substantial economic burden

on the healthcare system, as well as indirect costs decreased productivity and work absence
among affected individuals84,85. In the United States alone, back pain accounts for more
than $100 billion in annual health care costs86,87. Although back pain may manifest and
affect individuals at all ages, the debilitating impact on quality of life is more severe in the
older population88. With the aging population and increased life expectancy, the
socioeconomic burden of back pain is expected to rise globally.
Back pain can originate from a single or combination of different anatomical structures of
the spine, including muscles, ligaments, vertebral bones, spinal nerve roots, facet joints,
and IVDs81,82. However, approximately 30% of cases of chronic back pain are associated
with radiographic findings of IVD degeneration89. Currently, there are no diseasemodifying treatments for IVD degeneration or its associated back pain. Treatment options
are limited to pain management and, in severe cases, surgical approaches such as spinal
fusion or artificial disc replacement that show limited efficacy, stressing the need for the
development of novel therapeutic interventions90–92. Such treatment strategies for IVD
degeneration should not only aim to eliminate painful symptoms, but should target the
restoration of tissue structure and function. Although the etiology and pathophysiology of
IVD degeneration is still unclear, multiple interdependent factors, including altered
mechanical loading22,93,94, reduced nutrient supply38,56, and genetics95,96, have been
implicated in the initiation and progression of this degenerative cascade.
IVD degeneration, has been perhaps best defined as a progressive cell-mediated response
to aberrant mechanical load that activates a non-reversible cascade of changes in the cells
and their microenvironment, ultimately leading to structural and functional failure22. The
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pathogenesis of IVD degeneration is marked by loss of the balance between anabolic and
catabolic processes in the tissue, associated with increased matrix degradation and
abnormal matrix synthesis9. In the IVD, matrix remodelling is mediated by the matrix
metalloproteinase (MMP) and disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS) families of catabolic enzymes that break down major ECM components
such as collagens and proteoglycans97. These enzymes are expressed in healthy IVD
tissues, playing an important role in adaptive tissue matrix remodelling. However, IVD
tissue degeneration initiates when there is an imbalance between ECM degradation and
new matrix synthesis. In the human IVD, proteoglycan fragmentation is first detected
during childhood, and with increasing age, there is a gradual decrease in proteoglycan
content (i.e. aggrecan)97,98. Cleaved aggrecan fragments do not aggregate, making them
less effective in attracting water molecules97,98. In addition to the overall degradation of the
ECM during IVD degeneration, altered matrix synthesis and composition are observed.
Along with decreased aggrecan, the inner AF and the NP show increased biglycan
production, while the outer AF show decreased decorin and increased biglycan and
fibromodulin production99. In addition, the relative proportions of chondroitin sulphate and
keratan sulphate decrease in the NP100. The collagen synthesis pattern is also altered, with
more type II collagen appearing in the outer AF and type I collagen expression increased
in the inner AF and NP97,101. These alterations in ECM composition lead to reduced water
content in the NP98,101,102, reducing its ability to absorb and redistribute compressive forces
during axial loading98,101,102. Due to a loss of intradiscal pressure, the AF deforms by inand out-ward bulging and buckling, leading to structural defects such as rim lesions,
circumferential tears, and radial fissures, which may lead to IVD herniation94,103.
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Furthermore, with age, the CEP undergoes progressive thinning and calcification, leading
to reduced nutrient diffusion, acidic pH, and complete oxygen deprivation56,104–106. This
degenerative cascade is also associated with increased levels of proinflammatory
cytokines, such as interleukin 1 (IL-1) and tumor necrosis factor α (TNF-α) in the IVD that
can upregulate catabolic enzymes, exacerbating the degenerative changes22,97. In advanced
IVD degeneration, such as disc herniation, increased levels of inflammatory cytokines can
stimulate NP cells to produce neurotropic and angiogenic factors, such as nerve growth
factor (NGF), brain derived neurotrophic factor (BDNF), and vascular endothelial growth
factor (VEGF), that can promote neuronal and vascular ingrowth107. Sensory neurons that
are found in degenerated IVDs are often NGF-dependent neurons immunoreactive for
calcitonin gene-related peptide (CGRP), involved in pain perception related to
inflammatory pain, leading to discogenic back pain108.

1.6

Mechanical Load and Intervertebral Disc Degeneration

1.6.1 Mechanical Environment of Intervertebral Disc
The primary function of the IVD is to act as a shock absorber for the spine. The mechanism
by which the IVD accommodates such mechanical demands was first described in the
‘hydrostatic model’ by Schmorl109. When a healthy IVD is under load, the compressive
load is absorbed by the highly hydrated, aggrecan-rich NP. The resulting pressure within
the NP is redistributed radially to the surrounding AF and vertically to the CEP. The
consequent radial pressure exerted by the NP is then balanced by the elastic tension that
develops in the concentric lamellae of the AF8,22,48 (Figure 1.3). Accordingly, during axial
loading, NP cells experience hydrostatic and osmotic pressure, while AF cells experience
tensile and shear stress110. Similar to other musculoskeletal tissues, the IVD is sensitive to
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Figure 1.3. Schematic illustration depicting mechanical forces experienced by the
intervertebral disc (IVD) during axial load.
The interdependent tissues of the IVD work together to absorb mechanical load in the
spine. Upon load, the compressive forces are absorbed by the highly hydrated nucleus
pulposus (NP). The NP contains a high concentration of negatively charged proteoglycans
that imbibe water. The compressive load absorbed by the NP creates an intradiscal pressure
around the surrounding annulus fibrosus (AF). The AF accommodates this pressure by
stretching radially, creating tension along its concentric lamellae.
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its mechanical environment and depends on these mechanical cues for maintenance of its
structural integrity. Cells of the IVD respond to mechanical stimuli by changing gene
expression and other cellular processes that enable the tissue to adapt to their
environment48,110.
Information on mechanical stresses experienced by human IVDs in vivo are limited to a
few studies that reported intradiscal pressure measured by inserting needle pressure
transducers into the lumbar IVDs of healthy subjects performing various activities111–113.
These studies reported a baseline intradiscal pressure of 0.1-0.2 MPa in supine bedrest and
0.5 MPa in a standing posture. High pressure was measured while performing various
activities, peaking at 2.3 MPa during heavy lifting. Furthermore, loading frequencies were
found to rage between 0.1 – 1.0 Hz when performing normal daily activities (bed rest to
walking)53. With recent studies reporting increased risk of IVD degeneration by the use of
needle disc puncture114, more recent studies used ex vivo models to characterize the strain
profile of the human IVDs. These studies demonstrated that the AF experiences tissue
strain ranging from 1-26% during compressive loading that generated physiologically
relevant pressure in the IVD (0.74±0.15 MPa) 53,115,116.

1.6.2 Altered Mechanical Load and Intervertebral Disc Degeneration
Mechanical loading is one of the risk factors that contribute to the onset of IVD
degeneration. Previous studies reported that IVD degeneration is most frequently detected
in the lower lumbar IVDs (i.e. L3/L4 and L4/L5)117,118 – sites experiencing higher
mechanical stress compared to IVDs in other lumbar levels119. In humans, over-loading
either through exposure to occupational hazards120,121 or intense recreational activities such
as weightlifting122 are associated with IVD degeneration. On the other hand, under-loading
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due to extended bedrest123 or exposure to microgravity124,125 also contribute to IVD
degeneration. A number of studies investigating the effects of mechanical stimulation on
IVD cells have proposed that a physiological ‘window’ of loading parameters exists that
elicits anabolic response in the IVD cells. Indeed, studies demonstrate that mechanical
stimulation of physiologically relevant parameters induces anabolic response, such as upregulated matrix gene expression, while aberrant ‘non-physiological’ loading parameters
(i.e. under- and over-load) leads to catabolic response, including increased matrix
degrading enzyme expression and cell death.

1.7

Mechanotransduction in the Intervertebral Disc

Mechanotransduction refers to the process by which cells sense and convert a mechanical
input (i.e. physical force) into intracellular biochemical signalling pathways to elicit
biological responses126. In the context of the IVD, cells not only respond to mechanical
cues through interaction with their ECM, but also to direct mechanical stimulation, causing
cell deformation, cell membrane stretching and cell volume changes110. Importantly,
mechanisms by which IVD cells sense mechanical loads are still poorly understood. The
mechanical environment, and thus, type of strain, experienced is cell type and region
specific127. Given the complex loading environment of the IVD, studies have used different
models to understand the mechano-response and identify candidate mechanotransduction
pathways in the IVD at the cell or tissue level.

1.7.1 In Vitro Models of Mechanobiology in the Intervertebral Disc
In vitro studies using mechanically dynamic bioreactor systems have been extensively used
to study the effects of mechanical stimulation on IVD cells. Although human cells are
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optimal for translation of findings, access to human IVD cells is limited to surgical or postmortem samples where the age, gender, and levels of degeneration influence the results
observed. In particular, access to ‘healthy’ controls is limited in human tissues. In
comparison, animal models are more readily available to study the pathobiology of IVD
degeneration. IVD cells from large (cows, pigs, and sheep) and small (mice, rats, and
rabbits) animals have been used to study the cellular response to different types of
mechanical load, including tensile, compressive, and fluid shear strains. In vitro loading
parameters used are generally based on values reported in human IVDs. For example,
tensile loading at 10% strain and 1.0 Hz is generally used to recapitulate the strain profile
experienced by the human AF during daily activity.
Bioreactor systems have been widely used to characterize the mechano-response of AF
cells to tensile load. Several studies used the commercially available Flexcell® tension
bioreactor that uses a pneumatic system to deliver biaxial cyclic tensile strain (CTS) to
flexible culture surfaces. Using this system, exposure of bovine AF to 10% CTS at 1.0 Hz
for 60 min induced remodelling of F-actin filaments and microtubules, with increased gene
and protein expression of β-actin and β-tubulin. CTS-stimulated bovine AF cells showed
increased type I collagen and type II collagen gene expression compared to the unloaded
control. Interestingly, this CTS protocol increased MMP2, MMP3 and ADAMTS5 gene
expression, but decreased MMP1 and MMP9 gene expression128. Moreover, studies using
these devices stablished that rabbit AF cells respond differently based on the magnitude,
frequency, and duration of the applied load as well as in the presence of interleukin 1 beta
(IL-1β)129. Rabbit AF cells stimulated with IL-1β in static culture showed increased
expression of catabolic genes, including, inducible nitric oxide synthase (iNOS),
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cyclooxygenase 2 (COX-2), MMP3, and MMP1. However, mechanical stimulation at
physiological range (3% - 6% at 0.1 Hz - 1.0 Hz) decreased the expression levels of iNOS,
COX2, and MMP3. Notably, exposure of rabbit AF cells to high mechanical loading (18%
CTS at 0.1 Hz for 24 h) upregulated the expression of all catabolic genes increased by IL1β and downregulated TIMP1, a natural inhibitor of MMP proteins. Complementing
studies using the commercial bioreactor system, previous work by Gawri et al130 used a
bioreactor systems to deliver low-frequency high-magnitude strains131 to IVD cells. These
studies demonstrated that prolonged exposure of human NP and AF cells to 20% CTS at
0.001 Hz promoted the secretion of factors detected in IVD degeneration that promote
neurite outgrowth and cell death, including toll-like receptor 2 and 4, neuronal growth
factor, and tumor necrosis factor α130. Building on these findings, recent studies have
investigated the mechanosensitive signalling pathways mediating the response of AF cells
to tensile load. In human AF cells, α5β1 integrin receptor activation and mitogen-activated
protein kinase (MAPK) signalling (i.e. extracellular signal regulated kinase 1/2 (ERK1/2),
c-Jun N-terminal kinase JNK, and p38) have been shown to mediate CTS-induced
inflammatory cytokine gene expression changes(i.e. COX-2, IL-6, IL-8)132,133.
To date, the study of NP cell mechanotransduction has focused on bioreactor systems that
delivers cyclic compression to NP cells in 3-dimensional (3D) culture. Exposure of rat NP
cells to cyclic compression (10% scaffold deformation at 1.0 Hz; 6 h per day) for 10 days
increased aggrecan and type II collagen gene and protein expression, while maintaining
phenotypic NP markers (i.e. Krt19, Foxf1, and Pax1)134,135. Moreover, human NP cells
exposed to hydrostatic pressure using parameters that model in vivo loading (0.25 MPa at
0.1 Hz) for 30 min showed decreased matrix degrading enzyme gene expression, including
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MMP2 and MMP3. In contrast, increased loading of rat NP cells at 1.3 MPa at 1.0 Hz
induced a catabolic response marked by decreased aggrecan and type II collagen gene
expression, increased reactive oxygen species generation, and the expression of markers of
cell senescence (i.e. p16 and p53)136. Studies by Li et al137 demonstrated that the response
of porcine NP cells to mechanical load was dependent on the magnitude, frequency, and
duration of loading – a cellular behaviour also detected in CTS-induced AF cells.
Specifically, these studies showed increased GAG content and type II collagen staining, as
well as decreased cell death in porcine NP cells exposed to 0.4 MPa compression at 1.0
Hz. The opposite effect was observed in porcine NP cells exposed to 1.3 MPa compression
at 5.0 Hz, with decreased aggrecan and type II collagen gene expression and increased
MMP3 and ADAMTS4 gene expression137. Using a 3D culture system, dynamic
compression induction of Krt19, Foxf1, and Pax1 gene expression was shown to be driven
by N-Cadherin mediated PI3K/Akt pathway activation. Dynamic compression also
increased the expression of N-Cadherin (Cdh2), suggesting potential role for the NCadherin adhesion molecule in NP mechanotransduction135. Moreover, hyperosmotic
stress elicited an intracellular calcium transient in rat NP cells that mediated aquaporin2
(Aqp2) gene expression138. Interestingly, intracellular calcium transients were only
detected in porcine NP cells exposed to hyperosmotic stress after actin cytoskeleton
destabilization139.
Taken together, these studies establish the existence of a range of mechanical loading
parameters that promote an anabolic response in IVD cells, however they also demonstrate
the existence of a threshold beyond which mechanical loading induces tissue catabolism.
However, it is important to acknowledge that in vitro models do not recapitulate the
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complex loading environment experienced in vivo, nor the direct interaction between IVD
cell types that may contribute to the cellular response.

1.7.2 Ex Vivo Models of Mechanobiology in the Intervertebral Disc
Ex vivo organ culture models allow the preservation of tissue architecture and biochemical
components to study IVD mechanotransduction in cells within their innate environment.
Early studies on an IVD explant organ culture system investigated the effects of static
culture in rabbit IVDs within alginate gels, and found that IVDs embedded in alginate gel
maintained higher sulphated GAG, antigenic keratan sulphate, hyaluronan, and collagen
compared to the free swelling controls, suggesting that cellular activity in the explant can
be modulated by tuning culture conditions139. Subsequent studies introduced static
compression (0, 0.2, 0.4, 0.8, and 1.0 MPa) to mouse caudal IVDs, and demonstrated dosedependent increased cell apoptosis140. To improve cell viability in explant, ovine caudal
IVDs were anticoagulated to allow for adequate CEP permeability and cultured in cyclic
uniaxial diurnal loading (0.2 MPa for 8 h and 0.8 MPa for 16 h) for up to 7 days141. These
studies showed increased solute diffusion through the endplate by cyclic loading, leading
to improved cell viability and increased GAG synthesis. Moreover, studies simulating
physiological load (cyclic compression alternating in magnitude ranging from 0.1 - 0.6
MPa at 1 Hz for 16 h per day, followed by 8 h of low cyclic load of 0.1 - 0.2 MPa) on
caprine lumbar IVD showed that after 21-day of culture, increased cell viability and
increased ACAN and COL2A1 gene expression were detected in both NP and AF compared
to static controls142. Among the matrix remodelling genes assessed, TIMP1 and ADAMTS4
were up-regulated in the NP, suggesting simulated physiological load preserved the native
properties of caprine IVDs in culture.
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Another advantage of organ culture system is the ability to investigate drivers of IVD
degeneration in the microenvironment. Previous studies cultured bovine caudal IVDs
under static or dynamic loading with or without exogenous TNFα in culture, simulating an
inflammatory state of surrounding spinal tissues143. In IVDs under dynamic loading,
exogenous TNFα increased the production and secretion of inflammatory cytokines
(TNFα, IL-1β and IL-6) as well as increased tissue stiffness compared to the controls. In
addition, ex vivo organ culture has been used to study IVD mechanical injury. Acute
mechanical injury was induced in healthy human IVDs by rapid compression by 30%,
inducing CEP cracks144. Compared to uninjured controls (received 5% compression), IVD
injury caused significantly increase in cell death. Proteoglycan content within the injured
IVD was reduced, but its content in the matrix was increased. Increased matrix
metalloproteinase and aggrecanase activity were detected in injured tissue, and injured
IVDs secreted elevated levels of inflammatory cytokines and nerve growth factors. Other
injury models such as needle puncture or burst fractures in bony endplate have also been
adopted to study their effects on IVD mechanical properties and degenerative progression
ex vivo145–147.

1.7.3 In Vivo Models to Study Mechanobiology in the Intervertebral Disc
In order to study the effects of mechanical loading in vivo, two general categories of animal
models have been used, with load induced by either exercise or IVD injury.
Exercise-induced models aim to increase joint tissue loading through the introduction of
specific forms of exercise, typically designed to model human activities. Previous work by
our group developed a whole-body vibration platform suitable for small rodents to deliver
high-frequency low-amplitude whole body vibration (WBV), mimicking parameters used

24

in clinical and commercial settings for whole-body vibration148–150. 10-week-old CD1 male
mice were exposed to WBV (45 Hz, 0.3 g, 30 min/day, 5 days/week) for 4 weeks to study
the effects of whole-body vibration on IVD health. Following 4 weeks of vibration, mice
showed signs of IVD degeneration with disrupted AF structure, increased cell death, and
up-regulated Mmp3 gene expression, which correlated with increased staining of MMPcleaved collagen and aggrecan fragments148. With longer exposure to vibration (8 weeks),
IVD tissues showed increased expression of Mmp3, Mmp13, Adamts5 and Il-1β149.
IVD injury models disrupt IVD structure to alter mechanical loading both at the site of
injury as well as at adjacent IVDs and allow for reproducible and inducible IVD
degeneration. In the context of the mouse, three models have been established, all of which
target the caudal (tail) spines: Tail Compression, Tail Looping, and AF Needle Puncture.
First, the tail compression model first developed by Lotz et al151, involves the insertion of
pins into two adjacent caudal vertebrae which are then fixed to external rings connected by
spring-suture system to deliver static compressive load to the IVD between the two
vertebrae. The system can be adjusted to control the magnitude of static compression
delivered. Previous work showed that with increasing compressive stress, the inner and
middle AF became progressively more disorganized with increased cell death and
decreased aggrecan and type II collagen gene expression151. A similar model was
developed in the rat to immobilize or deliver cyclic compression loading to caudal IVDs152.
Rats that underwent 72 h of immobilization and subsequent 1.5 h cyclic compression (1.0
MPa at 2.0 Hz) showed catabolic response, with decreased type I collagen, and type II
collagen gene expression and increased Mmp3 and Adamts4 gene expression152.
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Secondly, the tail looping model developed by Sakai et al153 is a procedure where the tail
is looped and caudal vertebra (Co)5 and Co13 are fixed together using wire, followed by
removal of distal tail from Co14. In this model, the IVDs upstream of Co5 (Co2/Co3 and
Co3/Co4) are used as internal control. The caudal IVDs within the loop are subjected to
chronic compressive load and assume a wedged shape and histological signs of severe
degeneration marked by NP fibrosis and loss of AF lamellar structure are detected within
4 weeks153.
Lastly, AF needle puncture models cause acute mechanical instability following
decompression (i.e. herniation) of the NP. Loss of the NP impairs the ability of the
punctured IVD to withstand compression during normal tail movement, and aberrant loads
are transferred to adjacent IVD tissues proximal and distal to punctured IVD. Yang et al154
first adopted the AF puncture model in mice, showing advanced degeneration in punctured
caudal IVDs. More recently, the IVDs adjacent to the punctured IVD were used to study
tissue response to aberrant load following injury155,156.
Together, in vitro and in vivo models have informed our current understanding of cellular
mechano-response and mechanically induced degeneration in the IVD. Despite the
growing evidence that mechano-regulatory processes regulate IVD health and
degeneration, the mechanisms by which cells respond to normal and aberrant load is
unknown. Accordingly, cellular mechanosensation in the IVD must be considered.
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1.8

Mechanoreceptors: Mechanosensation at the Cell
Membrane

All cells of the body are subjected to external mechanical forces from their environment.
The detailed molecular mechanisms that underlie mechanotransduction processes can be
complex and specific to cell types and their pericellular environments. However, central
aspects of cell mechanotransduction are shared in all cells. First, mechanical force is sensed
by mechanoreceptors. Mechanoreceptors are cell surface molecules that usually undergo
force-induced conformational changes to couple a biochemical event directly or
allosterically157.

Second, activated mechanoreceptors then interact with ‘mechano-

transmitters’ to transduce activation signals, initiated near cell membrane, via specific
cytoplasmic signalling pathways158. Third, these signalling cascades then act on
downstream mechano-targets to regulate cellular processes, including gene expression,
proliferation, and cytoskeletal remodelling159. Importantly, the emergence of these
mechanosensitive “receptorome” allows for studies of mechanosensation and
mechanoadaptation at the cellular level.
Within a biological system, mechanical stimuli can function as a ligand similar to a
biochemical molecule. Types of mechanical load include hydrostatic pressure,
compression, tension, shear stress, osmotic forces, or matrix stiffness, all leading to cellular
deformation160. Moreover, similar to how the effect of a biochemical ligand is regulated by
ligand concentration, receptor concentration and frequency of action, a mechanical force
can vary in magnitude, frequency, and duration. Finally, given the significance of
mechanical input to proper physiological function, receptor-ligand specificity exists, with
specific cell surface receptors capable of receiving different mechanical inputs. These
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mechanical inputs can directly change receptor conformation through distinct mechanisms
depending on the receptor type.

1.8.1 Integrins
Integrins are a class of cell adhesion molecules that regulate interactions between a cell
and its surrounding ECM161. Mechanical activation of integrins occur through a hinge
movement mechanism126 (Figure 1.4A). Structurally, integrin receptors are heterodimers
consisting one alpha (α) and one beta (β) subunit bound non-covalently. Currently, 18 α
and 8 β subunits are known to exist in humans, which are reported to form 24 distinct
heterodimers162. Integrins participate in various signalling events, controlling gene
expression, cell cycle, and apoptosis161,163. Among the known heterodimers, the α5β1 and
α5β3 are used ubiquitously by cells to interact with fibronectin within the ECM161,164.
Under physiological conditions, α5β1 and α5β3 integrins assume a bent conformation,
which represents an inactive state with low to moderate affinities for ligands162. As a
transmembrane mechanical link between the intracellular and extracellular environment,
integrins are often subjected to tensile forces applied externally at the head or internally at
the cytoplasmic tail where the cytoskeleton is attached. During mechanical stimulation,
this tension can cause a conformational change from the bent to the extended state, leading
to receptor activation165–167. Force-induced receptor activation has been shown to
strengthen integrin-mediated adhesion, increase fibronectin production and reinforce
integrin-ligand bond165,168,169.
In the context of the IVD, integrin subunit expression profile studies reported α1, α5, αv,
α6, β1, β3, β4, β5 subunits to be expressed in human and porcine IVDs170. Specifically,
α5β1 integrin signalling has been reported to mediate the mechano-response of human NP
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and AF cells to dynamic compression, resulting in decreased aggrecan (ACAN) and
ADAMTS4 gene expression171. Furthermore, studies using mechanically dynamic organ

Figure 1.4. Schematic illustration depicting the different mechanisms of
mechanosensation by mechanoreceptors.
Mechanosensitive receptor proteins have the ability to change their structure in response
physical forces. Different receptors, potentially due to their physical structure or secondary
mechanism of signal transduction, adopt different force-induced rearrangement for their
activation. A) Hinge activation describes when receptors in a bent position (inactive state)
are extended by mechanical force, resulting in receptor activation. B) The
unfolding/unmasking mechanism is a force-gated process that involves mechanical force
changing the conformation of a receptor to reveal specific activation sites that are otherwise
auto-inhibited (buried). C) Deformation by stretch is a common mechanism adopted by
pore-forming ion channel receptors, in which membrane stretch leads to direct
conformational change leading to receptor activation (channel opening).
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culture system reported that α5β1 integrin signalling mediates mechanically-induced
apoptosis and induces Mmp3, Mmp13 expression in rat IVD cells172.

1.8.2 Cell-Cell Receptors
A specific example of a cell-cell receptor, the Notch receptor, is mechanically activated by
an unfolding/unmasking mechanism157 (Figure 1.4B). Notch receptors are transmembrane
receptors that regulate cell-cell communication. Notch signalling affects diverse cellular
processes, from cell fate decisions during development to the regulation of tissue
homeostasis in mature tissues. Notch receptor activation occurs in a juxtacrine manner by
cell surface ligands from neighbouring cells173. Notch ligands are single-pass
transmembrane proteins that are members of the DSL (Delta/Serrate/LAG-2) family173,174.
Upon activation, the Notch receptor exposes S2 site where ADAM metalloproteasemediated proteolytic cleavage occurs174. Cleavage at this site leads to intracellular cleavage
to release the Notch intracellular domain that localizes to the nucleus and regulates gene
expression175. Interestingly, although ligand binding relieves Notch receptor of its autoinhibited conformation, this conformational change alone is not sufficient for unmasking
the S2 site. A tensile force created by the neighbouring cell through ligand-receptor binding
further unmasks the S2 site for cleavage173,176–179. Hence, Notch activation is mechanically
regulated and requires a pulling force to expose an otherwise buried S2 cleavage site.
In the IVD, activation of Notch signalling induces cell type-specific effects. Activation of
Notch signalling in healthy AF cells from the rat model suppressed Acan and Col1a1 gene
expression while promoted expression of Adamts4 gene. In contrast, Notch activation in
healthy NP cells did not induce any change in ECM gene expression, but suppressed
catabolic gene expression (Mmp3, Mmp13, Adamts4, and Adamts5)180. Furthermore, in
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human IVDs, Notch signalling was increased in AF and NP cells of degenerated human
IVDs compared to healthy controls, with proinflammatory cytokines inducing Notch
signalling in the NP cells 181,182.

1.8.3 Ion Channels
The activation of mechanically gated pore-forming ion channels occur through
deformation due to membrane stretch157 (Figure 1.4C). The transient receptor potential
(TRP) ion channels are a family of cation channels that serve as sensors for a broad
spectrum of stimuli183. TRP ion channels are mechanosensitive, responding to tension, cell
swelling, cell shrinkage, compression, and shear stress184–189. It is important to note that in
all mechanical stimuli reported to activate TRP channels, the force experienced at the site
of ion channel activation, is membrane deformation. Two distinct models of mechanical
gating have been proposed for TRP channels. The membrane tension model states that
tensile force applied to the lipid bilayer generates membrane tension to gate the channel190.
For example, using a strategy based on detergent solubilization of frog oocyte membrane
proteins followed by liposome reconstitution and evaluation by patch-clamp, studies
reported that TRPC1 channel activation was achieved by direct membrane stretch189.
Alternatively, the tether model involves applied force being transmitted through a tether
connecting the channel with cytoskeleton and other periphery proteins to gate the
channel190. Studies demonstrated that the cytosolic domain of TRPN channels acts as a
membrane-microtubule connectors that serve as tethering sites for the channel, microtubule
and cell membrane191. TRPN channels were found to co-localize with the microtubule
cytoskeleton and pharmacological disassembly of the microtubules impaired TRPN
mechano-activation192. Given that TRP channels are diverse in their types and modes of
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activation, they may appropriate different mechanisms of channel activation depending on
type and sensitivity to stimuli. Nevertheless, both models demonstrate force-induced gating
mechanism for TRP ion channels.
Since the first reports of mammalian TRP channels193,194, they have been widely implicated
in the regulation of tissue homeostasis and disease in many organ systems. In recent years,
TRP ion channels have been studied in the context of musculoskeletal health research, as
detailed in the following section.

1.9

Transient Receptor Potential Vanilloid 4 in the
Musculoskeletal System

The TRP channels are a family of membrane bound non-selective cation channel proteins
involved in different homeostatic functions in mammals183. The discovery of TRP channels
revealed a potential mechanisms by which cells are able to sense their environment, as TRP
channels are activated by a diverse array of physical and chemical stimuli, including
osmolarity, heat, cold, pH, metabolites, and mechanical loading195,196. The TRP
superfamily is divided into seven subfamilies by sequence homology: TRPC (canonical),
TRPV (vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML (mucolipin), TRPA
(ankyrin), and TRPN (NOMP-C)197,198. Given their diversity in both activation and
function in cell physiology, TRP channel dysfunction contributes to wide array of diseases,
which were identified through point mutations (channelopathies) or genetic modification
of TRP channels in mouse models195,199. Accordingly, TRP channels have emerged as
novel pharmacological targets for treating disease in major organ systems.

32

Specifically, TRPV4 is a calcium (Ca2+)-permeable, nonselective cation channel that
transduces environmental cues into cellular responses by generating intracellular Ca2+
transients196. TRPV4 contains 6 transmembrane spanning α helix domains with a pore loop
that acts as a selectivity filter allowing for Ca2+ permeability200,201 (Figure 1.5A). TRPV4
was first isolated from rat kidney, reported to be activated by exposure of cells to
hypotonicity202. The hypotonic osmotic stress caused cell swelling, leading to activation of
phospholipase A2 (PLA2)203. PLA2 was found to hydrolyze cell membrane lipids to
produce arachidonic acid, which is metabolized to epoxyeicosatrienoic acids that directly
activate TRPV4 channel through cytochrome P450203,204. Later, TRPV4 was found to be
multi-modally activated, mediating signalling pathways following thermal, chemical,
mechanical stimuli, as well as pain and inflammation197,202,205,206. Recent studies have
shown that TRPV4 is expressed and functionally relevant in musculoskeletal tissues
including cartilage and bone207,208.
In murine chondrogenic cells, pharmacological activation of TRPV4 increased Sox9 gene
expression, which is critical for chondrocyte differentiation207. In the context of
mechanotransduction, TRPV4 was shown to regulate the metabolic response of porcine
chondrocytes to dynamic compressive loading, specifically the induction of Tgf-β3
expression206. Moreover, TRPV4 activation by hypo-osmotic stimulation enhanced
chondrocyte Ca2+ signalling, which was necessary for regulatory cell volume decrease and
prostaglandin E2 production209. Mice with global deletion of Trpv4 (Trpv4-/-) show
accelerated osteoarthritis and increased subchondral bone volume compared to wildtype210. In addition to accelerated age-associated osteoarthritis, Trpv4-/- mice fed high-fat
diet had increased weight gain, adiposity, and more severe osteoarthritis compared to wild-
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Figure 1.5. Transient receptor potential vanilloid 4 structure and function.
A) TRPV4 is a membrane spanning cation channel with 6 transmembrane domains, a pore
loop region, and intracellular C- and N-terminus ends. B) TRPV4 ion channels are multimodally activated calcium (Ca2+)-permeable cation channels that regulate numerous
cellular processes. Specifically, TRPV4 acts as a mechanoreceptor in bone and cartilage
tissues. Mechanically induced TRPV4 signalling regulates cell swelling, differentiation,
gene expression and matrix turnover (i.e. bone formation and resorption). In the
musculoskeletal system, expression and activity of TRPV4 is tightly regulated as
demonstrated by channelopathies associated with alterations in channel activity. TRPV4
gain-of-function mutations cause skeletal dysplasia whereas loss of TRPV4 accelerates
arthropathic changes.
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type mice on the same diet211. Recently, using an inducible, cartilage-specific Trpv4
knockout mouse model (Col2a1-CreERT2; Trpv4lox/lox), O’Conor et. al212 showed that loss
of TRPV4-mediated signalling in chondrocytes at skeletal maturity reduced the severity of
age-associated osteoarthritis.
Mechanical stimulation and Ca2+ signalling are important for bone homeostasis. TRPV4 is
expressed by both osteoblasts and osteoclasts and serves to regulate bone formation and
resorption213. In osteoblastic cells, BMP2-mediated signalling enhances TRPV4
expression, thereby regulating cell differentiation. In differentiated osteoblasts, TRPV4
activation is necessary for fluid flow-induced Ca2+ oscillations214. In Trpv4-/- mice,
osteoclast cell number and bone resorption activity are decreased compared to wild-type
mice, leading to increased bone mass and trabecular bone volume208. The opposite
phenotype was observed in mice carrying osteocyte-specific gain-of-function TRPV4
mutation, which showed increased osteoclast numbers and resorptive activity compared to
wild-type, leading to overall bone loss. Clinically, gain-of-function TRPV4 mutations have
been associated with a range of skeletal dysplasias, such as brachyolmia and metatropic
dwarfism215,216.
Recently, TRP channels have been studied in the context of the IVD. Studies using gene
array analysis to compare healthy and degenerate human IVDs identified 26 out of 28
currently known TRP genes to be expressed irrespective of health status217. Among the 26
TRP genes identified, TRPV4, TRPC6, TRPM2 and TRPML1 expression was increased in
degenerate IVDs compared to the healthy controls217,218. Furthermore, work by Walter et
al219 demonstrated that in an IVD organ culture model, decreased osmolarity induced
TRPV4 expression and activity, leading to increased TRPV4-mediated intracellular Ca2+
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influx, regulating inflammatory cytokine gene expression. While previous studies have
begun exploring the expression and function of TRP channels in degenerative IVDs, the
role of TRPV4 in IVD mechanobiology and tissue homeostasis remains largely
unexplored.

1.10 Rationale, Hypotheses and Objectives
Aim 1: Quantify the Effects of Mechanical Loading on Annulus Fibrosus Cells
Rationale: Previous studies examining the effects of mechanical loading on AF cells were
limited

to

the

analysis

of

extracellular

matrix

and

matrix

remodelling

genes47,128,132,133,220,221. Information characterizing the effects of mechanical load on other
biologically relevant genes (i.e. mechanosensitive genes, inflammatory cytokines,
mechanoreceptor proteins) in AF cells is limited. Furthermore, the characterization of
MAPK signalling in mechanically stimulated human AF cells was limited to cells derived
from degenerative tissue, which has been reported to affect the cellular response to
mechanical loading133. To address these limitations, we used the commercially available
MechanoCulture device to deliver bi-axial cyclic tensile strain (CTS) to primary murine
AF cells. Using this device, we quantified the effects of acute exposure of mechanical
loading on AF cell gene expression and other cellular processes, using parameters of
frequency, magnitude, and duration designed to recapitulate a range of physiological
conditions.
Hypothesis: Exposure of AF cells to physiological loading will induce anabolic changes,
specifically up-regulating the expression of anabolic genes and suppressing the expression
of catabolic genes.
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Objective 1: Validate mechanically-dynamic culture using the MechanoCulture B1
bioreactor
Objective 2: Quantify the effects of acute exposure to CTS on AF cells
Objective 3: Identify mechanosensitive pathway(s) in AF cells following acute exposure
to CTS
Aim 2: Characterize the Expression Pattern and Function of TRPV4 in the Murine
IVD
Rationale: TRPV4 was identified as a potential target to examine how IVD cells sense
external cues since it is known to be activated by many stimuli and mediates a wide range
of physiological responses. For example, previous studies reported the physiological
importance of TRPV4 as a multimodal receptor, osmosensor202,209, puriceptor222,223,
thermosensor224, and mechanosensory206,208,214 in different tissues. Studies examining the
role of TRPV4 in the musculoskeletal system have largely focused on articular cartilage
and bone206–209,213,214. Our analysis of mechanically-induced gene expression in murine
AF cells demonstrated increased Trpv4 expression following acute exposure to CTS
(Aim1). Importantly, the expression pattern and function of TRPV4 in the IVD remains
unknown. Using a novel Trpv4 reporter mouse we sought to examine the spatiotemporal
localization of TRPV4 as well as its functional activation in the murine IVD to assess its
potential role in regulating IVD biology.
Hypothesis: TRPV4 expression and activity is necessary for the development of the IVD
and for mediating mechano-response of AF cells to cyclic tensile strain.
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Objective1: Determine the spatiotemporal expression profile of Trpv4 in the murine spine
Objective 2: Determine the function of TRPV in AF cell mechano-response
Aim 3: Determine the Role of TRPV4 in IVD Health and Injury
Rationale: Studies conducted in Aim 2 demonstrated that TRPV4 is expressed and
functionally active in the murine IVD, mediating mechanically-induced expression of
matrix genes. Previous studies have demonstrated that TRPV4 expression and activity are
sensitive to changes in tissue osmolarity and inflammatory cytokines associated with IVD
degeneration219. Importantly, the role of TRPV4 in regulating IVD health and degeneration
is not well understood. Using Col2-Cre mice225 , we deleted Trpv4 in the IVD and
performed histological analyses on the lumbar spines to characterize changes in IVD health
and vertebral bone length. To study TRPV4 function in the context of IVD degeneration,
we used a percutaneous AF needle puncture model to induce injury in caudal IVDs and
assessed histopathological changes in punctured IVDs, IVDs adjacent to sites of injury,
and control IVDs.
Hypothesis: Deletion of Trpv4 in cells of the IVD will delay and/or prevent injury-induced
IVD degeneration.
Objective 1: Determine the effects of Trpv4 deletion on lumbar IVD health and vertebral
bone growth
Objective 2: Determine the role of Trpv4 in an injury-induced model of IVD degeneration
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Chapter 2

2

The Mechano-Response of Murine Annulus Fibrosus Cells
to Cyclic Tensile Strain is Frequency-Dependent

2.1

Co-Authorship Statement

All data presented in this chapter were collected and analyzed by Kim, M.K.M., Burns,
M.J., and Serjeant, M.E. in the laboratory of Dr. Séguin, C.A. Serjeant, M.E. performed
Western blot analysis and Burns, M.J. performed real-time PCR for inflammatory cytokine
genes. All other experiments were performed by Kim, M.K.M. Manuscript was written by
Kim, M.K.M. with suggestions from Dr. Séguin, C.A.

2.2

Chapter Summary

The intervertebral disc (IVD) is a composite structure essential for spine stabilization, load
bearing, and movement. Biomechanical factors are important contributors to the IVD
microenvironment regulating joint homeostasis; however the cell type-specific effectors of
mechanotransduction in the IVD are not fully understood. The current study aimed to
determine the effects of cyclic tensile strain (CTS) on annulus fibrosus (AF) cells and
identify mechano-sensitive pathways. Using a cell-type specific reporter mouse to
differentiation NP and AF cells from the murine IVD, we characterized AF cells in
dynamic culture exposed to CTS (6% strain) at specific frequencies (0.1 Hz, 1.0 Hz, or 2.0
Hz). We demonstrate that our culture model maintains the phenotype of primary AF cells
and that the bioreactor system delivers uniform biaxial strain across the cell culture surface.
We show that exposure of AF cells to CTS induces cytoskeleton reorganization resulting
in stress fibre formation, with acute exposure to CTS at 2.0 Hz inducing a significant yet
transient increase ERK1/2 pathway activation. Using SYBR-based qPCR to assess the
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expression of extracellular matrix (ECM) genes, ECM-remodeling genes, candidate
mechano-sensitive genes, inflammatory cytokines and cell surface receptors, we
demonstrated that exposure of AF cells to CTS at 0.1 Hz increased Acan, Prg4, Col1a1
and Mmp3 expression. AF cells exposed to CTS at 1.0 Hz showed a significant increase in
the expression of Acan, Myc, and Tnfα. Exposure of AF cells to CTS at 2.0 Hz induced a
significant increase in Acan, Prg4, Cox2, Myc, Fos, and Tnfα expression. Among the cell
surface receptors assessed, AF cells exposed to CTS at 2.0 Hz showed a significant increase
in Itgβ1, Itgα5, and Trpv4 expression. Our findings demonstrate that the response of AF
cells to CTS is frequency-dependent, and suggest that mechanical loading may directly
contribute to matrix remodelling and the onset of local tissue inflammation in the murine
IVD.

2.3

Introduction

According to the most recent Global Burden of Disease Study, back pain is the leading
cause of years lived with disability worldwide1. Although the etiology of chronic back pain
remains largely unknown, persistent back pain has been associated with magnetic
resonance imaging (MRI) findings of lumbar intervertebral disc (IVD) degeneration in
~30% of patients2. The pathophysiology of IVD degeneration involves progressive cellmediated changes to the IVD microenvironment, including extracellular matrix (ECM)
breakdown, altered matrix synthesis, and local tissue inflammation, ultimately resulting in
structural and functional tissue failure3-6. Although the etiology of IVD degeneration is
unclear, initiation and progression of the degenerative cascade involves multiple
interdependent factors including altered mechanical loading7-10, reduced nutrient supply912

, altered cellular composition3, 13, and hereditary factors5, 14-15.
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The IVD is a fibrocartilaginous connective tissue structure essential for spine load bearing
and movement. Anatomically, IVDs consist of three distinct tissues: the central gelatinous
nucleus pulposus (NP), the outer collagenous annulus fibrosus (AF) that circumferentially
encapsulates the NP, and the cartilage endplates that anchor the disc to the adjacent
vertebrae and allow for passive diffusion of nutrients to the IVD8,12,16-17. As such, IVDs are
heterogenous composite structures with each tissue having a unique structure and specific
ECM composition that together form the complex microarchitecture of the IVD required
for joint function17.
Similar to other musculoskeletal tissues, mechanical loading poses an interesting
dichotomy in IVD biology: while physiological levels of mechanical loading during
moderate locomotive activities are essential for IVD health and tissue homeostasis10,18-19,
mechanical stimuli due to high and low degrees of physical activities (overloading and
immobilization) can contribute to tissue degeneration18-20. IVDs are subjected to various
types of mechanical forces, including hydrostatic pressure, compressive, tensile and shear
forces21-24. Within this dynamic microenvironment, NP cells are primarily exposed to
compressive and hydrostatic loading, while AF cells are exposed to multi-directional
deformation resulting in tensile strain21-24. Previous studies investigating the mechanical
forces experienced by human IVDs reported that in performing daily activities, intradiscal
pressures are predicted to range from 0.1 MPa (bedrest) to 2.5 MPa (heavy lifting)25.
Furthermore, studies characterizing the mechanical properties and strain profiling of
human IVDs reported that the AF experiences 1-13% strain during daily activities26, with
tissue strain reaching up to 26% during physiological compressive loading27.
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To better understand how the dynamic environment of the IVD regulates cell function,
studies have examined the effects of cyclic tensile strain (CTS) on AF cells to model their
exposure to tensile loading in vivo. In response to uniaxial CTS (2%, 1.0 Hz), human AF
cells in 3D culture show increased aggrecan gene expression and decreased expression of
matrix degrading enzymes28. Using the same model system, exposure of AF cells to 4%
CTS (1.0 Hz) induced a modest increase in matrix gene expression, dependent on osmotic
potentials29. In contrast, exposure of human AF cells to high levels of bi-axial strain (20%
CTS, 0.001 Hz) induced catabolic responses, including upregulation of inflammatory
cytokine production and cell death30. Studies using the Flexcell tension system reported
that human AF cells exposed to 10% CTS at 1.0 Hz showed increased expression of matrix
genes and decreased expression of matrix degrading enzymes, whereas 10% CTS
frequency at 0.33 Hz shifted the mechano-response toward matrix catabolism31-32. Of note,
application of either loading protocol to human AF cells from degenerate IVDs increased
catabolic gene expression30.
To date, reports on the mechano-sensory mechanism of AF cells have focused on the role
of integrin-ECM interactions in CTS sensing32-33; however, a specific signalling pathway
involved in mechanotransduction remains largely unexplored. Mitogen-activated protein
kinases (MAPKs) are a family of highly conserved protein kinases that serves as
intermediates in signal transduction pathways34. MAPKs are grouped into three
subfamilies – extracellular signal-regulated kinases (ERKs), p38, and c-jun N-terminal or
stress-activated kinases (JNK/SAPK) – based on their sequence, sensitivity to activation
and mechanisms of action35. Functionally, ERKs regulate cell survival and proliferation36,
whereas p38 kinases regulate inflammatory responses, cell cycle control, and
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differentiation37. Interestingly, AF cells isolated from degenerative human IVDs show
activation of all three MAPK subfamilies (ERK1/2, p38, JNK) upon mechanical
stimulation38.
The current study used a transgenic mouse model to genetically label and isolate AF cells
from the murine IVD, and employed an in vitro culture system to deliver acute bi-axial
CTS. Bi-axial multi-directional load was chosen to model complex circumferential tensile
load experienced by the AF cells in vivo when the tissue is subjected to multi-axial load
constrained by the adjacent vertebral bodies (axial and radial load)23, 27. The study aimed
to quantify the mechano-response of healthy murine AF cells to different loading
conditions, focusing on cytoskeletal adaptation, changes in gene expression, and the
identification of CTS-induced signalling pathways.

2.4

Methods

2.4.1 Animals
To differentiate cell types within the IVD, the notochord-specific NotoCre mouse strain
reported by our group39 was mated to the conditional ROSA26 (R26) mT/mG reporter
mouse (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J)40. Genotyping was performed as
previously described39. IVD tissues from NotoCre/WT;RosamTmG/mTmG mice, in which
notochord-derived NP cells are marked by green fluorescent protein (GFP) and AF cells
express tdTomato, were used for all experiments. Mice were housed in standard cages and
maintained on a 12-hour light/dark cycle, with rodent chow and water available ad libitum.
Mice were euthanized by CO2 asphyxiation at 2 months-of-age for tissue isolation. All
animal experiments were performed in accordance with the policies and guidelines set forth
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by the Canadian Council on Animal Care and were approved by the Animal Use
Subcommittee of the University of Western Ontario (protocol 2017-154, Appendix A).

2.4.2 Tissue isolation and culture of AF cells
Lumbar spines from 2-month-old mice were dissected, followed by microdissection of NP
and AF tissues using a fluorescent stereo microscope (Leica M165 FC). Isolated tissues
were immediately fixed for RNA extractions. For primary cell culture (overview in Figure
2.1A), intact IVDs were dissected from 2-month-old mice (cervical to caudal) and the AF
tissues were microdissected (Leica M165 FC). Isolated AF tissues were transferred to a
sterile 3 mm culture dish with 2 mL of Type II collagenase (3 mg/ml; Worthington, NJ,
USA) in Dulbecco’s modified Eagle’s medium/Ham’s F-12 medium (DMEM/F12) and
incubated for 20 minutes at 37oC. AF tissues were then minced and further digested for 1
hour at 37oC. Digested tissues were triturated and filtered using a 70 micron cell strainer
and cells were pelleted by centrifugation (1,100 rpm for 5 min). Cells were plated at an
initial density of ~400,000 cells/cm2 and cultured in DMEM/F12 supplemented with 10%
Fetal Bovine Serum (FBS) and 1% penicillin and streptomycin (Thermo Fisher Scientific,
MA, USA) at 37°C in a humidified atmosphere of 5% CO2. Media was changed every 2
days until cells reached 80% confluency. AF cells isolated from IVD tissues of two mice
were pooled together and used for each experimental replicate.

2.4.3 Mechanical stimulation
The MechanoCulture B1 (MCB1) device (CellScale Biomaterials Testing,
Waterloo, Ontario, Canada) was used to deliver bi-axial multi-directional cyclic tensile
strain to monolayer cultures (Figure 2.1B, C)41. The MCB1 device included an actuator
chamber, housing a programmable circuit board and motor (Figure 2.1B, top), connected
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Figure 2.1. Experimental design and mechanical stimulation of murine annulus
fibrosus cells.
A) Schematic representation of the protocol used for the isolation and culture of primary
murine annulus fibrosus cells. B) Images of the MechanoCulture B1 device inside the cell
culture incubator. C) Schematic depicting the in vitro model used to deliver cyclic tensile
strain. Cells were seeded on a deformable silicone membrane puncture mounted on a 24pin mounting ring designed to generate radial motion from a linear motion input, resulting
in the delivery of biaxial stretch. D, E) Schematic representations of the experimental
procedures used to deliver 6% cyclic tensile strain at frequencies of 0.1, 1.0, or 2.0 Hz to
investigate gene expression (C) and signal transduction (D) in mechanically stimulated
annulus fibrosus cells.
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by a stainless steel arm to a loading chamber containing the deformable construct on which
the cells were grown (Figure 2.1B, bottom). Three deformable polyether ether ketone
plastic layers were assembled in order to transfer the linear motion of the steel arm into a
radial stretch of an inner circle (35 mm diameter) of 24 pins. Clear silicone membranes
(0.005” thickness, ultimate tensile strength 8.62 MPa, McMaster-Carr, Aurora, USA,
#87315K71) were puncture-mounted on the device’s 24-pin mounting ring and the
assembled constructs were sterilized by standard gravity displacement steam autoclave
cycle (30 min sterilization, 20 min cool; temperature during sterilization = 121.1°C –
123.3°C). Sterilized silicone membranes were then coated with 2 mL of 50% FBS
DMEM/F12 overnight. Primary AF cells were seeded at a density of 48,000 cells/cm2 onto
the FBS-coated silicone membrane and cultured for 2 days in culture media supplemented
with 50 ng/μL L-ascorbic acid. Once monolayers reached 80% confluency, the assemblies
were transferred to the loading chamber of the device within the culture incubator. AF cells
were exposed to 6% CTS, at sinusoidal frequencies of either 0.1 Hz, 1.0 Hz, or 2.0 Hz for
30 min. AF cells cultured on FBS-coated silicone membranes without mechanical
stimulation served as time-matched unloaded controls. After 30 min of CTS, cells were
incubated for additional 2, 6, 12, or 24 hours before harvesting for total RNA, with timematched unloaded cells serving as control.

2.4.4 Motion tracking analysis
To quantify the magnitude and uniformity of the strain applied to the silicone membrane
by the MCB1 device, motion tracking analysis was performed. Fine graphite powder was
used to pattern the silicone membrane in order to quantify the motion of specific points
during mechanical stretch. The patterned surface was imaged at 0.5 mm intervals using a
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DMK 41AU02 Monochrome Camera (Imaging Source, Charlotte, NC, USA) until the
programmed displacement (3.5 mm) was reached. Using commercially available image
tracking software, (LabJoy, CellScale), four different regions of the membrane were
tracked and the strains experienced in these regions were calculated based on pixel
displacement.

2.4.5 Immunofluorescence analysis
Immediately following mechanical stimulation, AF cells on the silicone membranes were
fixed with 4% paraformaldehyde for 10 min and then permeabilized with 0.1% Triton X100 (in Phosphate Buffered Saline; PBS) for 10 min at room temperature. After blocking
in 1% Bovine Serum Albumin (in PBS) for 30 min, Alexa Fluor 488 Phalloidin (Life
Technologies, Carlsbad, CA, USA) was used to detect F-actin according to manufacturer’s
protocol and the nuclei detected using Hoechst 33258 stain (Thermo Fisher). Images were
acquired using a Zeiss Axio Observer 7 with AxioVision software (Carl Zeiss, Jena,
Germany). In each of the 4 biological replicates, cells within 3 non-overlapping regions of
interest (ROIs) were imaged for each experimental group (unloaded, 0.1 Hz, 1.0 Hz, and
2.0 Hz) for a total of 12 images for each experimental group. Each image was analyzed by
counting total number of cells (5 – 9 cells per ROI) and categorizing each cell as either
stress fibre-negative (cells with intense F-actin staining localized near cell periphery with
either punctate or weak fibre staining in cytoplasm) or stress fibre-positive (condensed Factin fibre staining). For each experimental group, total of 63 – 84 cells were examined.
Cells staining positive for stress fibres are presented as percentage of total cells counted
for each experimental group.
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2.4.6 Protein isolation and Western blot analysis
AF cells were cultured on the silicone membranes in the MCB1 device as described above
and transferred to serum-free DMEM/F12 media 24 h prior to loading. AF cells were
subjected to 6% CTS at frequencies of either 1.0 Hz, 2.0 Hz, for either 15 or 30 min (n=3).
Immediately following mechanical loading, AF cells were scraped from silicone
membranes and lysed using RIPA buffer containing protease inhibitor (cOmpleteTM Mini,
EDTA-free Protease Inhibitor Cocktail, Sigma-Aldrich Canada). Samples were centrifuged
at 14,000 x g for 15 min at 4oC. The supernatant was collected, and protein concentration
was determined using the BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL,
USA) according to the manufacturer’s protocol. For each sample, 21 μg of protein was
loaded and resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (10%
gels) and proteins were transferred to Immobilon® Polyvinylidene fluoride membranes
(Sigma-Aldrich) using the Trans-Blot® TurboTM Blotting System (Bio-Rad). Membranes
were blocked with 5% w/v non-fat dried milk in Tris-Buffered Saline-Tween (TBST) and
incubated with primary antibody against Phospho-p38 MAPK Thr180/Tyr182 (Cell
Signaling Technology, #4511, 1:1000), p38 MAPK (Cell Signaling Technology, #8690,
1:1000), Phospho-p44/42 MAPK Erk1/2 Thr202/Tyr204 (Cell Signaling Technology,
#4370, 1:1000), or p44/42 MAPK Erk1/2 (Cell Signaling Technology, #4370, 1:1000) in
TBST with 5% milk (Cell Signaling Technology, Danvers, MA, USA). After washing with
TBST, membranes were incubated with anti-rabbit horseradish peroxidase-linked
secondary antibody (Santa Cruz Biotechnology, Dallas, TX, USA, sc-2004; 1:2000).
Protein

bands

were

visualized

by

chemiluminescence

using

the

Enhanced

Chemiluminescence Kit (Bio-Rad, Hercules, CA, USA) and imaged using the ChemiDOC
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XRS+ System (Bio-Rad). Densitometric analysis was performed using ImageLab software
(Bio-Rad). Levels of phospho-proteins were quantified and presented normalized to
corresponding total protein levels.

2.4.7 RNA extraction and gene expression analysis
Total RNA was extracted from IVD tissues, primary AF cells cultured on standard tissue
culture plastic or silicone membrane (passage 1) or CTS-treated and unloaded AF cells 2,
6, 12, or 24 hour post-stimulation (n=4-7) using Trizol reagent (Life Technologies)
according to the manufacturer’s protocol. RNA was quantified using a NanoDrop 2000
spectrophotometer (Thermo Fisher Scientific). Complementary DNA was synthesized
from 150 ng of RNA using the Bio-Rad iScript cDNA synthesis kit. Gene expression was
determined by SYBR-based real-time PCR using the Bio-Rad CFX384 thermocycler. PCR
reactions were run in triplicate using 470 nM forward and reverse primers (primer
sequences in Table 2.1) with 2x SsoFast EvaGreen Supermix (Bio-Rad). The PCR
program consisted of the following: initial 2 min enzyme activation at 95oC, 10 sec
denaturation at 95oC, 30 sec annealing/elongation at 60oC, for total of 40 cycles. For cell
phenotype characterization, transcript levels were determined relative to a six-point
calibration standard curve made from pooled cDNA generated from wild type murine heart,
brain, kidney, muscle, IVD, and mouse embryonic fibroblasts. For CTS experiments, gene
expression values were calculated using ∆∆Ct, normalized for input based on hypoxanthine
quinine phosphoribosyl transferase (Hprt) expression and expressed relative to the timematched unloaded controls within each trial.
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Table 2.1. Sequences of the primers used in the real-time PCR analysis.
Gene
Acan
Acta2
Adamts4
Bgn
Cd24
Cilp
Col1a1
Col2a1
Col10a1
Cox2
Dcn
Fap
Fos
Gdf10
Hprt
Il-1β
Il-6
Itgβ1
Itgα5
Mmp3
P2rx7
Prg4
Timp1
Tlr2
Tlr4
Tnfα
Trpv4

Forward (5’ → 3’)
CCTGCTACTTCATCGACCCC
GTCCCAGACATCAGGGAGTAA
GAGGAGGAGATCGTGTTTCCAG
ACGAATCCATGACAACCGTATC
ACCCACGCAGATTTACTGCAA
ATGGCAGCAATCAAGACTTGG
CTGGCGGTTCAGGTCCAAT
GCACATCTGGTTTGGAGAGACC
GGGACCCCAAGGACCTAAAG
GGCGCAGTTTATGTTGTCTGT
TCTTGGGCTGGACCATTTGAA
GTCACCTGATCGGCAATTTGT
CGGGTTTCAACGCCGACTA
GAAGTACAACCGAAGAGGTGC
CAGGCCAGACTTTGTTGGAT
CCCTGCAGCTGGAGAGTGTGGA
TCTCTGCAAGAGACTTCCATCCAGT
ACTGATTGGCTGGAGGAATGTTAC
CTTCTCCGTGGAGTTTTACCG
TTGTCCCGTTTCCATCTCTCTC
GGCACTGGAGGAAAATTTGA
GGGTGGAAAATACTTCCCGTC
CTTGGTTCCCTGGCGTACTC
CACCACTGCCCGTAGATGAAG
GCCTTTCAGGGAATTAAGCTCC
TCGGGGTGATCGGTCCCCAA
TTCGTAGGGATCGTTGGTCCT

Reverse (5’ → 3’)
AGATGCTGTTGACTCGAACCT
TCGGATACTTCAGCGTCAGGA
CAAACCCTCTACCTGCACCC
GCTCCTGGTTCAAAGCCACT
CCCCTCTGGTGGTAGCGTTA
AGGCTGGACTCTTCTCACTGA
TCCAGGCAATCCAGGAGC
TAGCGGTGTTGGGAGCCA
GCCCAACTAGACCTATCTCACCT
CAAGACAGATCATAAGCGAGGA
CATCGGTAGGGGCACATAGA
CCCCATTCTGAAGGTCGTAGAT
TTGGCACTAGAGACGGACAGA
AGGCTTTTGGTCGATCATTTCC
TTGCGCTCATCTTAGGCTTT
TGTGCTCTGCTTGTGAGGTGCTG
AGTAGGGAAGGCCGTGGTTGTCA
CTGGACAAGGTGAGCAATAGAAGG
GCTGTCAAATTGAATGGTGGTG
TTGGTGATGTCTCAGGTTCCAG
TGAGCAAGTCAATGCACACA
CAGGACAGCACTCCATGTAGT
ACCTGATCCGTCCACAAACAG
AGGGTACAGTCGTCGAACTCT
GATCAACCGATGGACGTGTAAA
GGTGGTTTGCTACGACGTGGGC
TACAGTGGGGCATCGTCCGT
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2.4.8 Statistical analysis
All statistical analyses were performed with GraphPad Prism 6 Software (GraphPad
Software, San Diego, CA, USA). The analysis of data from stress fibre quantification and
gene expression for cell phenotype characterization were analyzed using one-way analysis
of variation (ANOVA) followed by Tukey’s multiple comparison test. Western blot data
were analyzed using Krustkal-Wallis and Dunn’s post-hoc test. For CTS experiments, gene
expression levels in AF cells exposed to CTS at varying frequencies were compared to
unloaded controls at each time point using one-way ANOVA with Dunnett’s post-hoc test.
For each gene, differences in expression values between CTS-treated AF cells harvested at
specific time points post-stimulation were compared using one-way ANOVA with Tukey’s
post-hoc test. In order to test if frequency is a source of variation for a given gene,
differences in gene expression values between different CTS protocols at each time point
were analyzed using two-way ANOVA followed by Tukey’s post-hoc test. P values less
than 0.05 were considered statistically significant.

2.5

Results

2.5.1 MechanoCulture B1 device delivers uniform cyclic tensile loading
To quantify the magnitude and uniformity of the strain applied to the silicone culture
membrane, motion tracking analysis was performed. The device was programmed for a 3.5
mm linear displacement, a load translated into 24 points of radial motion by the device
(Figure 2.1B, C). Regions of interest (ROIs) on the silicone membrane were tracked and
imaged every 0.5 mm during the displacement and the strain calculated based on pixel
displacement (Figure 2.2A). This analysis demonstrated that the average strain
experienced by the ROIs on the silicone membrane at full displacement (3.5 mm) was
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Figure 2.2. Motion tracking analysis of the MechanoCulture B1 device to validate
strain profile.
A) Silicone membrane was textured using graphite powder and the membrane was
stretched and imaged every 0.5 mm until the programmed total displacement (3.5 mm) was
reached. B) Four different regions of interest (ROI) on the membrane were tracked and
strains experienced in these regions were calculated based on pixel displacement (values
indicate within ROIs at each displacement). The analysis demonstrated that a 3.5 mm
displacement produced uniform 6% on the silicone cell culture membrane.
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6.075 ± 0.096%. The small variability in strain measured between ROIs suggests that strain
across the membrane at full displacement is uniform (Figure 2.2B).
Previous studies predicted that the AF experiences compressive tissue strains of 1-26%,
radial tensile strain of 1-19%, and lamellar fibre strain of up to 13% when IVD is
compressed with a load physiologically similar to that of walking26,27,42. Given such data,
CTS of 6% was chosen as it falls within the physiological range of mechanical stimulation
in vivo. Frequency of 1.0 Hz was chosen as being representative of physiologic locomotion,
and frequencies of 0.1 Hz and 2.0 Hz were chosen as being less than and greater than
physiologic locomotion, respectively43. (0.1 Hz = bed rest, 1.0 Hz = walking gait, 2.0 Hz
= steady running gait).

2.5.2 Primary murine annulus fibrosus cells maintain an AF-like
phenotype in culture
To allow cell type-specific isolation from the murine IVD, primary cells were isolated from
the Notocre;ROSAmTmG/mTmG conditional reporter mice in which AF cells express red
fluorescent protein (RFP) whereas notochord-derived NP cells express GFP (Figure 2.3A).
In all AF cell preparations maintained in monolayer culture, only RFP-expressing cells
were observed, confirming the absence of notochord-derived NP cells (Figure 2.3A).
To ensure that primary AF cells maintained their phenotype in our in vitro culture system,
we quantified the expression of previously reported AF- and NP-associated markers44-50 as
well as fibroblast markers, and compared expression levels to those of the intact AF and
NP tissues. Primary AF cells showed robust expression of the AF-associated markers, type
I collagen (Col1a1), growth differentiation factor (Gdf10), paired box 1 (Pax1) and
cartilage intermediate layer protein (Cilp), compared to expression of these genes in the
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Figure 2.3. Analysis of cell phenotype in primary AF cell cultures.
Primary AF cells were isolated from the NotoCre/WT; ROSAmTmG/mTmG conditional reporter
mouse to allow for cell isolation based on fluorescence. A) Fluorescent micrograph of
intact IVD isolated from NotoWT/WT; ROSAmTmG/mTmG and NotoCre/WT; ROSAmTmG/mTmG mice
showing NP-specific CRE activity. AF cells isolated from the conditional reporter show
RFP but not GFP expression, indicating the absence of NP cell contamination. B-D) Gene
expression analysis of primary annulus fibrosus cells compared to intact IVD tissues using
panels of AF- and NP-associated markers and fibroblast markers. The expression of
selected genes was quantified using qRT-PCR in primary AF cells grown on standard tissue
culture plastic or silicone membranes (n=5) and compared to intact AF and NP tissues (n=6
mice; 5-6 IVDs pooled per mouse). Transcript levels were determined relative to a sixpoint calibration curve. B) AF cells cultured on tissue culture plastic and silicone
membranes maintained expression of the AF markers, Col1a1, Gdf10, Pax1, and Cilp at
levels comparable to intact AF tissue, significantly higher compared to NP tissue. C) AF
cells cultured on tissue culture plastic and silicone membranes exhibited significantly lower
expression of the NP markers, Cd24 and Brachyury compared to NP tissues. D) AF cells
cultured on tissue culture plastic and silicone membranes had significantly increased
expression of Acta2 compared to both intact IVD tissues; however, Fap expression was
not significantly altered in AF cell cultures compared to intact AF tissue. Grubb’s outlier
test was used to identify outliers. Data presented as mean ± SEM. Data analyzed using oneway ANOVA followed by Tukey’s post-hoc test. * = P < 0.05; ** = P < 0.01, *** =
P<0.001; **** = P<0.0001. Scale bars = tissue micrograph = 200 μm; cell culture = 100
μm.
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NP tissues (Figure 2.3B). No significant differences were detected in the expression of AF
markers in primary cells cultured on tissue culture plastic or silicone membranes compared
to the intact AF tissues. In contrast, AF cells showed minimal or no detectable expression
of the NP-associated markers, Cd24 and Brachyury, with no differences detected between
AF tissue and primary cells cultured on either tissue culture plastic or silicone membranes
(Figure 2.3C). Moreover, we quantified the expression of the markers of the myofibroblast
/ activated fibroblast phenotype, alpha smooth muscle actin (Acta2)51 and fibroblast
activation protein (Fap)52. Primary AF cells cultured on tissue culture plastic and silicone
membranes showed significantly increased expression of Acta2 compared to intact AF and
NP tissues; however, expression of Fap was not altered in cultured AF cells compared to
intact AF tissues (Figure 2.3D).

2.5.3 Mechanical stimulation induces cytoskeletal rearrangement in
annulus fibrosus cells
To confirm that AF cells sense and respond to the CTS delivered by the MCB1 device,
cytoskeletal rearrangement was examined since cytoskeletal reorganization has been
shown to play a pivotal role in AF mechanotransduction53. In AF cells under static culture
(unloaded control), F-actin was localized near the cell periphery in a predominantly
punctate distribution with weak fibre staining. This pattern of F-actin staining was similar
following 30 min exposure of cells to CTS at 0.1 Hz (Figure 2.4A solid arrow); however
following exposure to CTS at 1.0 and 2.0 Hz, AF cells showed significantly increased stress
fibre formation, which increased with higher frequency of loading (Figure 2.4A hollow
arrow). Upon quantification, 61% of cells and 74% of cells were positive for stress fibres
in AF cells exposed to CTS at 1.0 Hz and 2.0 Hz protocol, respectively (Figure 2.4B). The
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Figure 2.4. Cytoskeletal rearrangement in AF cells exposed to cyclic tensile strain.
A. Representative images of AF cells in which F-actin was visualized with alexa 488
phalloidin (counter stained with Hoechst stain to visualize nuclei) in AF cells grown in
static culture (unloaded control) or following 30 min exposure to 6% cyclic tensile strain
(CTS) at 0.1, 1.0, or 2.0 Hz. In the unloaded control and 0.1 Hz, F-actin was predominantly
localized near the cell periphery with punctate distribution or weak fibre staining in the
cytoplasm (white solid arrow). In contrast, AF cells exposed to CTS at 1.0 Hz and 2.0 Hz
showed distinct stress fibre formations (hollow arrow). B) For each treatment group, the
percentage of stress fibre-positive cells was assessed. Graphs present the average
percentage of stress fibre-positive cells (calculated from 3 independent regions of interest)
for each treatment group, for each of the 4 biological replicate experiments (presented as
matching symbol). Compared to the unloaded control, exposure of AF cells to CTS at 1.0
or 2.0 Hz induced a significant increase in number of stress fibre-positive cells. Data
presented as mean ± SEM from 4 independent experiments. Bars labelled with the same
letter are not significantly different based on p < 0.05; one-way ANOVA followed by
Tukey’s post-hoc test.; Scale bar = 20 μm.
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stress fibres formed in AF cells exposed to CTS at 1.0 and 2.0 Hz showed a random
orientation.

2.5.4 Cyclic tensile strain activates ERK1/2 signalling in AF cells
After validating our model of dynamic cell culture, we first assessed the effects of CTS on
MAPK pathway activation. Exposure of AF cells to 15 or 30 min CTS at 1.0 Hz did not
induce a significant activation of either the ERK1/2 or p38 MAPK pathways, compared to
static (unloaded) control (Figure 2.5A). Exposure of AF cells to CTS at 2.0 Hz induced a
transient increase in ERK1/2 phosphorylation, significantly increased following 15 min of
CTS but not significantly different from static control following 30 min CTS (Figure
2.5B). No statistical difference was detected in p38 activation in AF cells exposed to CTS
at either time point (Figure 2.5B).

2.5.5 Acute exposure of AF cells to CTS induces frequency-dependent
changes in gene expression
Since the effects of CTS on AF cell cytoskeletal rearrangement and MAPK pathway
activation varied based on the frequency of load applied, we aimed to characterize the
corresponding changes in gene expression using real-time PCR, focusing on expression of
ECM

genes,

matrix

degrading

enzymes,

inflammatory

cytokines,

candidate

mechanosensitive genes, and cell surface receptors identified in related musculoskeletal
cell types9,30,32,54-61. Given differences in the dynamic regulation of gene expression, cells
were exposed to a single protocol of CTS (6% strain at 0.1, 1.0, or 2.0 Hz) and RNA was
harvested following 2, 6, 12, or 24 h post stimulation.
AF cells exposed to acute (30 min) 6% CTS at 0.1 Hz showed a significant increase in the
expression of multiple ECM genes, including type I collagen (Col1a1; significant increase
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Figure 2.5. ERK1/2 and p38 pathway activation in annulus fibrosus cells following
cyclic tensile strain.
AF cells were subjected to 6% CTS for 15 or 30 min at frequencies of either 1.0 Hz (A) or
2.0 Hz (B). Cells cultured on silicone membranes in the absence of mechanical loading
served as a control (0 CTS column). Total protein was harvested from AF cells immediately
after loading and MAPK pathway activation was assessed through immunoblotting using
antibodies for the phosphorylated forms (upper panels) or total (lower panels) ERK1/2 and
p38 (bands representative of n=3 cell preparations, 2 animals per cell preparations).
Quantification was performed by measurement of average relative density of bands
corresponding to phosphoproteins, normalized to total protein. Data presented as a mean
SEM; data were analyzed using Kruskal-Wallis test and Dunn’s post-hoc test. * = p <0.05;
** = p < 0.01.
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at 2 h compared to unloaded controls; fold change = 1.6 ± 0.18), lubricin and aggrecan
(Prg4 and Acan respectively; both significantly increased at 2 h and 24 h compared to
unloaded controls; fold change (Prg4) = 1.8 ± 0.16, fold change (Acan) = 1.6 ± 0.13)
(Figure 2.6A); no significant differences were detected in the expression of type X
collagen (Col10a1), biglycan (Bgn), or decorin (Dcn) (Supplementary Figure 2.1). We
next assessed the expression of genes associated with matrix remodelling. Although no
significant differences were detected in the expression of a disintegrin and
metalloproteinase with thrombospondin type 1 motif 4 (Adamts4) or tissue inhibitor of
metallopeptidase 1 (Timp1), mRNA levels of matrix metallopeptidase 3 (Mmp3) were
increased in AF cells following acute exposure to CTS at 0.1 Hz (significantly increased
at 2 h compared to unloaded controls; fold change = 1.6 ± 0.16) (Figure 2.6B). Acute
exposure of AF cells to CTS at 0.1 Hz did not alter inflammatory cytokine gene expression
(tumor necrosis factor alpha, Tnfα; interleukin 1 beta, Il-1β; interleukin 6, Il-6) or candidate
mechanosensitive gene expression (cytochrome c oxidase subunit 2, Cox2; MYC protooncogene, Myc; Fos proto-oncogene AP-1 transcription factor subunit, Fos) compared to
unloaded controls (Figure 2.6C, D).
AF cells were next subjected to acute (30 min) 6% CTS at 1.0 Hz. Compared to CTS at 0.1
Hz, AF cells showed fewer changes in the expression of ECM genes, with significant
increases detected in the expression of Acan (6 h post-loading; fold change = 1.3 ± 0.05;
Figure 2.7A) and no significant changes in the expression of matrix remodelling genes
compared to unloaded controls (Figure 2.7B). No significant differences were detected in
the expression of Col10a1, Bgn, or Dcn (Supplementary Figure 2.1). Interestingly, CTS
at 1.0 Hz induced a significant increase in the expression of Tnfα (12 h post-loading; fold
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Figure 2.6. Real-time PCR analysis of gene expression in AF cells following acute
exposure to CTS at 0.1 Hz.
Primary AF cells were subjected to 6% CTS at 0.1 Hz for 30 min and RNA harvested
following 2, 6, 12 or 24 h to assess the expression of extracellular matrix genes (A), matrix
remodelling genes (B), inflammatory cytokines (C), and candidate mechanosensitive genes
(D). AF cells showed a significant increase in the expression of Col1A1 (2 h post-loading),
Prg4 (2h, 24 h post-loading), Acan (2h, 24 h post-loading) and Mmp3 (2 h post-loading).
Relative gene expression was calculated using ∆∆Ct, normalized for input using the
housekeeping gene Hprt and expressed relative to time-matched unloaded controls within
each trial (control = 1; indicated as grey dotted lines). Data presented in mean ± SEM; n=4
cell preparations. Data were analyzed using one-way ANOVA followed by either
Dunnett;s or Tukey’s post-hoc test. Grubb’s outlier test used to identify outliers. * = P <
0.05 versus unloaded control; Ф = P < 0.05 between fold changes at two time points.
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Figure 2.7. Real-time PCR analysis of gene expression in AF cells following acute
exposure to CTS at 1.0 Hz.
Primary AF cells were subjected to 6% CTS at 1.0 Hz for 30 min and RNA harvested
following 2, 6, 12 or 24 h to assess the expression of extracellular matrix genes (A), matrix
remodelling genes (B), inflammatory cytokines (C), and candidate mechanosensitive genes
(D). AF cells showed a significant increase in the expression of Acan (6 h post-loading),
Tnfα (12 h post-loading) and Myc (6 h post-loading). Relative gene expression was
calculated using ∆∆Ct, normalized for input using the housekeeping gene Hprt and
expressed relative to time-matched unloaded controls within each trial (control = 1;
indicated as grey dotted lines). Data presented in mean ± SEM; n=4 cell preparations. Data
were analyzed using one-way ANOVA followed by either Dunnett;s or Tukey’s post-hoc
test. Grubb’s outlier test used to identify outliers. * = P < 0.05 versus unloaded control; Ф
= P < 0.05 between fold changes at two time points.
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change = 4.36 ± 1.15; Figure 2.7C) in AF cells compared to unloaded controls. Among
the candidate mechanosensitive genes, 30 min CTS at 1.0 Hz induced a significant increase
in Myc expression (6 h post-loading; fold change = 1.6 ± 0.21) in AF cells compared to
unloaded controls (Figure 2.7D).
Lastly, AF cells were exposed to acute (30 min) 6% CTS at 2.0 Hz showed a significant
increase in the expression of the ECM genes Acan and Prg4 (6 h and 2h post-loading,
respectively; fold change (Acan) = 2.4 ± 0.12, fold change (Prg4) = 3.2 ± 0.89) compared
to unloaded controls (Figure 2.8A). No significant differences were detected in the
expression of Col10a1, Bgn, or Dcn (Supplementary Figure 2.1) or genes associated with
matrix remodelling (Figure 2.8B). Acute CTS at 2.0 Hz induced a significant increase in
Tnfα gene expression (2 h post-loading; fold change = 2.2 ± 0.52; Figure 2.8C) in AF cells
compared to unloaded controls. Notably, all candidate mechanosensitive genes assessed
(Cox2, Myc, Fos) were significantly upregulated compared to the unloaded controls at 6 h
following exposure of AF cells to acute CTS at 2.0 Hz (fold change (Cox2) = 2.3 ± 0.45,
fold change (Myc) = 1.5±0.07, fold change (Fos) = 1.6 ± 0.13; Figure 2.8D).
Given that CTS at 2.0 Hz elicited the most robust changes in the expression of ECM, proinflammatory cytokine, and mechanosensitive genes in AF cells compared to other loading
protocols, we assessed if the expression of cell surface receptors would likewise be altered
by these parameters of mechanical load. AF cells exposed to CTS at 2.0 Hz showed a
significant increase in the gene expression of integrin subunits, Itgα5 (12 h post-loading;
fold change = 1.4 ± 0.12) and Itgβ1 (12 h post-loading; fold change = 1.6±0.13) compared
to unloaded controls (Figure 2.9A). Acute (30 min) exposure of AF cells to CTS at 2.0 Hz
did not significantly alter the expression of both toll-like receptor 2 (Tlr2) and toll-like
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Figure 2.8. Real-time PCR analysis of gene expression in AF cells following acute
exposure to CTS at 2.0 Hz.
Primary AF cells were subjected to 6% CTS at 2.0 Hz for 30 min and RNA harvested
following 2, 6, 12 or 24 h to assess the expression of extracellular matrix genes (A), matrix
remodelling genes (B), inflammatory cytokines (C), and candidate mechanosensitive genes
(D). AF cells showed a significant increase in the expression of Acan (6 h post-loading),
Prg4 (2 h post-loading), Tnfα (2 h post-loading), Cox2 (6 h post-loading), Myc (6 h postloading) and Fos (6h post-loading). Relative gene expression was calculated using ∆∆Ct,
normalized for input using the housekeeping gene Hprt and expressed relative to timematched unloaded controls within each trial (control = 1; indicated as grey dotted lines).
Data presented in mean ± SEM; n=4 cell preparations. Data were analyzed using one-way
ANOVA followed by either Dunnett;s or Tukey’s post-hoc test. Grubb’s outlier test used
to identify outliers. * = P < 0.05 versus unloaded control; Ф = P < 0.05 between fold
changes at two time points.
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Figure 2.9. Real-time PCR analysis of candidate cell surface receptor gene expression
in AF cells following acute exposure to CTS at 2.0 Hz.
Primary AF cells were subjected to 6% CTS at 2.0 Hz for 30 min and RNA harvested
following 2, 6, 12 or 24 h to assess the expression of integrin subunits (A), Toll-like
receptors (B), and membrane ion channel receptors (C). AF cells showed a significant
increase in the expression of Itgα5 (12 h post-loading), Itgβ1 (12 h post-loading), and Trpv4
(12 h post-loading). Relative gene expression was calculated using ∆∆Ct, normalized for
input using the housekeeping gene Hprt and expressed relative to time-matched unloaded
controls within each trial (control = 1; indicated as grey dotted lines). Data presented in
mean ± SEM; n=4 cell preparations. Data were analyzed using one-way ANOVA followed
by either Dunnett;s or Tukey’s post-hoc test. Grubb’s outlier test used to identify outliers.
* = P < 0.05 versus unloaded control; ** = P < 0.01 versus unloaded control; Ф = P < 0.05
between fold changes at two time points.
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receptor 4 (Tlr4) genes (Figure 2.9B). In contrast, acute exposure of AF cells to CTS at
2.0 Hz significantly upregulated the expression of the transient receptor potential vanilloid
4 (Trpv4) gene at 12 h post-loading (fold change = 1.9 ± 0.34), with a trend towards
increased purinoreceptor x subtype 7 (P2rx7) gene expression 2 h post-loading (fold
change = 1.3 ± 0.14), compared to unloaded controls (Figure 2.9C).
All of the gene expression data from three different CTS protocols were compared at each
time points to test if changes in gene expression are frequency-dependent. The analysis
identified frequency as a significant source of variation in the expression of Acan, Myc,
and Tnfα genes (Supplementary Figure 2.2).

2.6

Discussion

At the cellular level, mechanical loading in the IVD regulates a variety of biological
processes in both cell type- and stimulus-dependent manner. Considering the dynamic
nature of the loading environment in the IVD, previous studies examined the effects of
CTS on AF cells, focusing on changes in the expression of genes related to ECM anabolism
and catabolism28-32. Loading frequency, among other parameters of CTS, has been shown
to be an important factor in determining cellular response to mechanical load56. Building
upon these findings, the present study aimed to characterize the mechano-response of
primary murine AF cells grown in a dynamic culture system that delivers bi-axial CTS.
Using this model, we showed that AF cells adapted to different load frequencies by
remodelling their cytoskeletal microarchitecture and activating intracellular signalling
pathways dependent on the frequency of the applied load. Furthermore, we demonstrated
that varying loading frequencies altered the mechano-response of AF cells at the level of
gene expression, with notable changes in the expression of extracellular matrix, pro-
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inflammatory cytokines, mechano-sensitive genes, and cell surface receptors. Taken
together, these data provide further evidence for the existence of a “window” of loading
parameters that may be beneficial to the IVD health.
The design of the present study incorporated two essential validation steps. First, we
incorporated both IVD-specific genetic labeling strategies and gene expression analysis to
assess and validate the AF cell phenotypes in our in vitro culture system. This analysis
enabled us to confirm that primary cell preparations did not contain NP cells, and also
enabled us to assess the effects of the culture substrate on cell phenotype, since fibroblasts
have been shown to exhibit matrix stiffness adaptation57. Gene expression analysis
demonstrated that on both tissue culture plastic and deformable silicone membranes,
primary AF cells maintained robust expression of the AF-associated markers Col1a144,
Gdf1045, the marker of sclerotome development, Pax148, and Cilp49 a gene recently
reported by our group as enriched in the murine AF compared to the NP50. In addition, we
assessed the expression of Acta2 and Fap, two markers of the fibroblast phenotype51,52.
Primary AF cells showed increased expression of Acta2 and similar expression of Fap
compared to intact AF tissues. Alpha smooth muscle actin (α-SMA), protein encoded by
Acta2, is a contractile actin isoform found in myofibroblast51. In the context of the IVD,
previous studies showed α-SMA expression in AF cells in both the canine and human
IVD62-63 as well as primary AF cells in 2D culture62. Buckley et al63 and Desmouliere et
al64 independently showed that α-SMA plays a role in cell attachment, maintenance of cell
shape, and may contribute to production and accumulation of ECM. Fap is a specific
marker of the activated fibroblast phenotype and implicated in pathological tissue
fibrosis52; no differences were detected in the current study between the expression of Fap
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in primary AF cells compared to intact AF tissues. These data confirm that AF cells
maintain their phenotype with increased expression of microarchitecture proteins for
attachment and matrix production. Second, we confirmed the peak strain and strain
uniformity of the MCB1 device by motion tracking analysis and showed that the CTS was
being sensed by the AF cells by assessing stress fibre formation. Bioreactor systems
described in previous studies were associated with limitations, including non-uniform
strain patterns and heterogeneity in type of loading delivered (i.e. biaxial at central area,
but approached pure uniaxial strain towards the edge)66-68. Our validation demonstrated
that the MCB1 device overcame these limitations by incorporating a design mechanism
that transfers linear motion into 24 points of radial stretch, which resulted in delivery of
uniform biaxial strain on the silicone membrane.
One of the earliest responses we detected in AF cells exposed to CTS was transient
activation of ERK1/2, but this was only observed at our highest frequency loading (6%
CTS at 2.0 Hz). MAPKs are part of a phospho-relay signalling pathway known to mediate
stress responses in different cell types, including IVD cells33-38, making them potential
mediators of mechanotransduction. Previous study by Pratsinis et al showed that in human
AF cells derived from degenerate IVDs, 4% uniaxial CTS at 1.0 Hz induced the activation
of all three MAPK pathways (ERK. P38, JNK) immediately after CTS, independent of
strain magnitude of the applied load38. In contrast, the present study detected only
significant activation of ERK1/2 in healthy murine AF cells. These differences may be due
to the different species of origin of the AF cells used, differences in loading parameters, or
differences associated with isolating cells from healthy or degenerate tissues. Functionally,
integrin-dependent activation of ERK1/2, Src and RhoA has been found to regulate stress
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fibre formation in other cell types, including endothelial cells and osteocytes71-73. Given
that increased stress fibre formation in AF cells was induced by increasing frequency of
CTS in our study, early activation of ERK1/2 may be required for cytoskeletal
rearrangement in AF cells. Of note, a study by Hirata et al showed that phosphorylated
ERK1/2 proteins localize to the stress fibres upon mechanical stretch, suggesting that stress
fibres

serve

as

a

platform

for

tension-induced

activation

of

biochemical

mechanotransduction pathways74. As such, the link between cytoskeletal tension, stress
fibre formation and the role of ERK1/2 activation should be further explored in AF cells.
Our findings are similar to previous studies reporting an anabolic response of matrix gene
expression in AF cells subjected to CTS28,29,31,32,58. Interestingly, our study demonstrated
that exposure of AF cells to CTS at low (0.1 Hz) and high (2.0 Hz) frequencies induced a
significant increase in the gene expression of Prg4. Lubricin, the protein encoded by Prg4,
is a large mucinous glycoprotein that serves as the primary boundary lubricant for articular
cartilage75 and its expression has been found to be protective against the development of
osteoarthritis76. Previous studies reported lubricin expression in the interlamellar space of
the annular lamellae in caprine IVDs77. Our data suggests that similar to chondrocytes in
which Prg4 expression is regulated by shear force78, Prg4 is mechanically regulated in the
AF.
We also assessed the effects of CTS-exposure on AF cell expression of candidate mechanosensitive genes identified in related musculoskeletal cell types. Previous studies reported
that in osteoblasts, expression of Cox2, Myc, and Fos genes are induced by various modes
of mechanical stimulation (vibration, fluid shear) and muscle cells also increase Fos gene
expression following exposure to 20% cyclic tensile strain53-55. The most robust and
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consistent changes were observed in AF cells exposed to CTS 2.0 Hz, which induced a
significant upregulation of Cox2, Myc, and Fos gene expression. Given that expression of
all three of these genes is required for transition from G1 to S phase of the cell cycle55,56,57,
these findings suggest that AF cells exposure to higher frequency CTS may promote cell
proliferation. A previous study demonstrated that expression of a dominant negative form
of Rho GTPase in osteoblasts blocked fluid shear stress-induced stress fibre formation and
the expression of the immediate early genes Cox2 and Fos57. Future studies using this
model system will build on the characterization of the acute effects of CTS, and specifically
assess the role of Rho GTPase and the changes in cell proliferation in AF cells following
chronic exposure to CTS.
The pathophysiology of IVD degeneration is associated with alterations to the ECM due to
imbalances between synthesis and degradation of ECM proteins. It has been hypothesized
that ECM degradation fragments induce local inflammation driven by cells of the IVD80.
However, the role of mechanical stimulation in either the initiation or propagation of local
inflammation is largely unknown. Previous studies report that IVD cells exposed to high
mechanical strain at low frequency (20% at 0.001 Hz) show increased gene expression of
inflammatory receptors and cytokines30. In keeping with these findings, the present study
showed that exposure of AF cells to CTS at 1.0 Hz and 2.0 Hz induced a significant
upregulation of Tnfα gene expression, suggesting that mechanical stimulation alone can
directly contribute to the initiation of local inflammation. We acknowledge, however, that
these findings are limited to quantification of changes at the level of gene expression; more
long-term experiments should explore how alterations in gene expression alter levels of
secreted inflammatory cytokines. Although traditionally inflammation was viewed as
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detrimental response involved in disease progression, recent reports suggest that a balanced
inflammatory response may be required for matrix repair and maintaining tissue
homeostasis in different cell types, including IVD cells80,81. Given that the loading
parameters used in this study fall within the range of those experienced in a physiological
context, the increased expression of Tnfα may be contributing to matrix homeostasis.
Nonetheless, the data suggest a direct link between mechanical stimulation and
inflammatory cytokine gene expression in AF cells.
At the cellular level, mechanical signals are transduced via cell surface receptors acting in
concert to translate physical force into biologically relevant signals32,72. Previous studies
using dynamic organ culture showed that expression of integrin subunits α5 and β1 genes
was induced in both rat NP and AF tissues by cyclic compressive stress (1.3 MPa, 1.0 Hz)
for 6 days82. Le Maitre et al
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showed that compression-induced changes in matrix gene

expression in human NP cells were mediated by α5β1 integrin signalling. Our findings of
mechanically- induced Itgα5 and Itgβ1 expression suggest that α5β1 integrin signalling
may likewise contribute to AF mechanotransduction in response to CTS, in keeping with
the downstream activation of the ERK1/2 pathway we report. Gawri et al30 showed
increased expression of both the toll-like receptor 2 and 4 genes in human IVD cells
exposed to high mechanical strain at low frequency (20% cyclical stretch at 0.001 Hz). The
observed difference from the current study which showed no change in TLR expression in
murine AF cells may be due to differences in loading parameters, such as strain percentage,
frequency, and duration. Lastly, Trpv4 and P2rx7, candidate mechano-sensitive channels
studied in other musculoskeletal cell types58-60 were upregulated in AF cells following
exposure to CTS. Previous studies reported that the expression of both genes was regulated
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by cyclic compression in chondrocytes58,59. Functionally, both TRPV4 and P2X7 have
been shown to elicit intracellular calcium transient upon mechanical compression58,59. In
the context of the IVD, TRPV4 is activated by changes in osmolarity84, and a related
purinoreceptor, P2X4, has been shown to mediate ATP-induced membrane potential
response85. Taken together, the current study demonstrates that AF cells adapt to
mechanical stimulation by regulating cell surface receptor gene expression, thereby
potentially modulating the activation of intracellular signalling pathways.
A limitation of the current study is the examination of cellular responses to CTS in a cell
culture system where cells were seeded onto silicone membranes; consequently,
endogenous cell-matrix interactions present in the IVD microenvironment were not
recapitulated. In order to minimize these issues, AF cells were pre-cultured on membranes
in media supplemented with ascorbic acid to enable collagen production and secretion. To
fully explore the effect of ECM in mediating mechanical strain, future studies could
incorporate specific ECM protein coatings in the MCB1 device. We also acknowledge that
our protocols for primary murine cell isolation may have introduced heterogeneity in the
AF cell population studied. To maximize the yield of our primary cell isolation from the
murine IVDs, we pooled AF tissues from all anatomical regions (cervical through caudal)
and included cells from both inner and outer AF. Subtle differences in the phenotype of
AF cells in each of these regions, or in the mechanical loading environment from which
they were isolated may impact their response to mechanical stimulation in vitro.

2.7

Conclusions

Overall, our findings suggest that effects of CTS on healthy murine AF cells are frequencydependent. The most anabolic effect marked by increased expression of extracellular
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matrix genes was observed following exposure to 6% CTS at 0.1 Hz. At higher frequency
(2.0 Hz), CTS induced mechanically sensitive genes (associated with the regulation of cell
cycle progression) as well as proinflammatory cytokine gene expression in healthy AF
cells. Taken together, these finding further suggests the existence of a range of loading
parameters that are beneficial to IVD health, which may help to understand the
pathophysiology of IVD degeneration in the context of mechanobiology. Moreover, the
differences in MAPK activation we report in AF cells derived from healthy IVDs compared
to previous findings from degenerate tissues suggest differences in the cellular signalling
pathways activated by CTS in AF cells associated with tissue health. Further studies are
needed to elucidate other mechanotransduction pathways and their involvement in
regulating cellular function in the IVD.
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2.8

Supplementary Figure

Supplementary Figure 2.1. Effects of CTS on the expression of additional candidate
ECM genes in AF cells.
Biglycan (Bgn), type X collagen (Col10a1), and decorin (Dcn) gene expression was
quantified in AF cells exposed to acute CTS at 0.1 Hz (A), 1.0 Hz (B), and 2.0 Hz (C). The
expression levels of the three matrix genes did not change upon mechanical stimulation.
Relative gene expression was calculated using the ∆∆Ct method, normalized for input
using the housekeeping gene Hprt and expressed relative to time-matched unloaded
controls within each trial (control = 1; indicated as grey dotted lines). Data presented in
mean ± SEM; n=4 cell preparations. Data were analyzed using one-way ANOVA followed
by either Dunnett;s or Tukey’s post-hoc test. Grubb’s outlier test used to identify outliers.
Ф = P < 0.05 between fold changes at two time points.
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Gene
Acan
Adamts4
Col1a1
Cox2
Fos
Il-1β
Il-6
Mmp3
Myc
Prg4
Timp1
Tnfα

Source of
Variation
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency
Time
Frequency

F

p value

Significant?

8.505
4.189
1.392
1.425
2.982
0.5803
4.237
0.3675
4.017
0.2096
0.4179
0.2114
0.3325
0.03311
1.147
1.017
4.409
3.506
2.456
2.622
0.7253
0.9733
3.137
3.811

<0.0001
0.0215
0.2519
0.2511
0.0288
0.5639
0.0054
0.6946
0.0072
0.8117
0.7948
0.8102
0.8546
0.9675
0.3469
0.3697
0.0043
0.0385
0.0592
0.0838
0.5793
0.3856
0.0233
0.0296

Yes
Yes
No
No
Yes
No
Yes
No
Yes
No
No
No
No
No
No
No
Yes
Yes
No
No
No
No
Yes
Yes

Supplementary Figure 2.2. Two way ANOVA table with P and F value for each gene.
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Chapter 3

3

Spatiotemporal and Functional Characterization of
TRPV4 in the Murine Intervertebral Disc

3.1

Co-Authorship Statement

All data presented in this chapter were collected and analyzed by Kim, M.K.M. in the
laboratory of Dr. Séguin, C.A. Drs. Ramachandran, R. provided the Trpv4LacZ/LacZ mouse
strain. Dr. Pest, M. and Ryan Beach provided technical assistance with embryo imaging
and live cell calcium imaging, respectively. Drs. Ramachandran, R. and Séguin, C.A.
contributed to study design.

3.2

Chapter Summary

The process of mechanotransduction in intervertebral disc cells are not well understood.
The aim of this study was to determine the expression pattern and function of TRPV4 in
the IVD. A novel transgenic reporter mouse, in which the endogenous Trpv4 locus drives
expression of the lacZ reporter, was used to localize Trpv4 expression in the spine. We
characterized Trpv4 expression during embryonic spine development (embryonic day (E)
8.5, 12.5, 17.5, postnatal day (PN)1) and at time points following skeletal maturity (2.5, 6,
9 months of age). The response of AF cells to the TRPV4-specific agonist GSK1016790A
and antagonist GSK2193874 was assessed using epifluorescence imaging with Ca2+sensitive Fura-2-AM dye and cytoskeletal morphology was assessed using F-actin staining.
The effect of TRPV4 agonism and antagonism in mechanically stimulated AF cells were
quantified at the level of gene expression. We showed that Trpv4 expression in the spine
was specific to developing notochord and intervertebral mesenchyme at E12.5. In contrast,
in mice at 2.5, 6, and 9 months of age, Trpv4 expression was detected in cells of nucleus
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pulposus, inner annulus fibrosus, cartilage endplate, and vertebral growth plate. AF cells
treated with the TRPV4-specific agonist demonstrated heterogeneous Ca2+ responses: no
response, calcium oscillation, or a sustained response. TRPV4-induced Ca2+ signalling was
associated with actin cytoskeleton remodeling and stress fibre formation, dependent on
Rho/ROCK signalling. In AF cells, mechanically induced changes in Acan and Prg4 gene
expression were mediated by TRPV4 activity. These studies show that Trpv4 is expressed
in the cells of developing notochord and intervertebral mesenchyme, then subsequently
detected within multiple cell types of the mature IVD. The functional activity of TRPV4
was validated in murine AF cells, where it was found to regulate cytoskeletal remodelling
and the expression of matrix genes.

3.3

Introduction

Low back pain, recently reported to be one of the leading causes of disability worldwide1,
is typically associated with intervertebral disc (IVD) degeneration2. The lack of diseasemodifying treatments for IVD degeneration is linked to our incomplete understanding of
cellular pathways that contribute to disc development, function, and degeneration. The IVD
is a fibrocartilaginous connective tissue structure located between the vertebral bodies
responsible for spine load bearing and movement. IVDs are composite structure consisting
of distinct tissue types that work in concert to absorb and dissipate mechanical load
throughout the spine. During axial load, the central nucleus pulposus (NP), due to its high
water content, experiences compressive and hydrostatic loading, creating an intradiscal
pressure that deforms the outer annulus fibrosus (AF) which in turn experiences multidirectional tensile strain3–6. Similar to other musculoskeletal tissues, biomechanical factors
are important contributors to the IVD microenvironment and play a role in both tissue

109

homeostasis and the initiation of disc degeneration7–10. Specifically, physiological levels
of mechanical load produce an anabolic response in the IVD marked by increased
expression of extracellular matrix (ECM) genes, such as aggrecan and collagen, and
decreased expression of catabolic enzymes, such as matrix metalloproteinases (MMPs) 11–
15

. In contrast, aberrant mechanical loading (either under- or over-loading) can contribute

to altered ECM homeostasis through the initiation of tissue degeneration7,10,16. Despite
numerous studies characterizing on the effects of mechanical stimulation on IVD tissues,
information regarding the mediators of IVD mechanotransduction – i.e. how cells sense
mechanical forces and convert them into biochemical signals – remains limited.
Previous reports on the mechano-sensing mechanism in AF cells have focused on the role
of integrins as mechanoreceptors. Expression profiling of integrin subunits in the human
IVD showed tissue-type and regional variance in their expression pattern. Notably, the
RGD-integrin, α5β1, was highly expressed in cells of human NP and inner AF compared
to the outer AF17, and was shown to mediate the cellular response to mechanical loading18–
20

. Exposure of non-degenerate human NP cells to compressive load (0.35 – 0.95 MPa, 1

Hz for 2 h) decreased aggrecan gene expression, which was inhibited by pre-treatment of
cells with an RGD peptide that competitively blocked integrin ligand binding. This effect,
however, was not detected in NP cells derived from degenerative human IVDs19. In nondegenerate human AF cells exposed to cyclic tensile strain (CTS) (10%, 1.0 Hz for 20 min)
pre-treatment with RGD peptide prevented the mechanically induced decrease in
aggrecanase-1 (ADAMTS4) gene expression and increased focal adhesion kinase
phosphorylation. Similar to NP cells, the RGD pre-treatment failed to inhibit the
mechanoresponse in degenerative AF cells20. These findings suggest that IVD

110

mechanotransduction pathways and effectors of mechano-response vary depending on the
cell type and degenerative state. To date, however, the role and expression pattern of other
mechanoreceptors in the IVD have not been fully elucidated.
The transient receptor potential vanilloid 4 (TRPV4) channel is a multi-modally activated
Ca2+-permeable non-selective cation channel involved in transducing various external
environmental cues into specific cellular responses by generating intracellular Ca2+
transients21,22. In mammals, TRPV4 was first reported to regulate cellular functions in
response to changes in osmolarity in murine heart, liver, and kidney21,23,24, but was recently
demonstrated to mediate mechano-response in musculoskeletal tissues. In porcine
chondrocytes, chemical and mechanical activation of TRPV4 was shown to regulate the
expression of the type II collagen and transforming growth factor β 3 genes25. Furthermore,
studies using mice with global deletion of Trpv4 showed that mechanically regulated bone
formation and resorption26, as well as mechanically induced intracellular Ca2+ oscillation
in osteoblasts, were TRPV4-dependent27. In the context of the IVD, studies using a bovine
ex vivo IVD organ culture model showed that reduced tissue osmolarity increased TRPV4
protein expression and channel activation, which correlated with increased interleukin-1β
and interleukin-6 gene expression in cells of the IVD28. Furthermore, previous work by our
group showed increased Trpv4 gene expression in murine AF cells following acute
exposure to CTS (6% CTS, 2.0 Hz for 30 min). However, the in situ expression pattern of
TRPV4 and its role in transducing and regulating the IVD mechano-response is unclear.
The goal of this study was to characterize the expression and function of TRPV4 in murine
IVD. Using a novel Trpv4 reporter mouse model, the current study resolved the
spatiotemporal expression profile of Trpv4 during murine embryonic spine development
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and aging. Using both pharmacological and mechanical assays, the role of TRPV4 in AF
cells was interrogated, focusing on intracellular calcium response, cytoskeletal adaptation,
and changes in gene expression.

3.4

Methods

3.4.1 Mice
All animal experiments were performed in accordance with the policies and guidelines set
forth by the Canadian Council on Animal Care and were approved by the Animal Use
Subcommittee of the University of Western Ontario (protocol 2017-154, Appendix A).
The EUCOMM “knockout-first” gene trap strategy was used to generate Trpv4tm1a(KOMP)Wtsi
mice. Embryonic stem cells with the Trpv4tm1a(KOMP)Wtsi allele from Wellcome Trust Sanger
Institute (produced for the Knockout Mouse Project; MGI:4460277) were injected to
C57BL/6NCrl host blastocysts. The resultant chimeric offspring contained the
L1L2_Bact_P cassette inserted upstream of exon 6 in the Trpv4 locus. The cassette
includes 2 FRT sites flanking an IRES:lacZ trapping cassette and a floxed human beta actin
promoter-driven neo cassette inserted upstream, with an additional loxP site downstream
of exon 6, the critical exon (Figure 3.1A). Sperm from Trpv4tm1a(KOMP)Wtsi mice were used
for in vitro fertilization with oocytes from C57BL/6N mice. The resulting embryos were
incubated with TATCre to remove the neomycin resistance cassette and exon 6, to generate
the Trpv4tm1b(KOMP)Wtsi reporter mice where the Trpv4 gene was rendered null, and the gene
locus drives the expression of lacZ (Trpv4LacZ/LacZ; Figure 3.1A). Wild-type C57BL/6N
mice (Charles River: Wilmington, MA, USA) were used for gene expression analysis and
cell culture experiments. Mice were housed in standard cages and maintained on a 12-hour
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Figure 3.1. Generation of Trpv4tm1b reporter mouse and schematic overview of
experimental workflow.
A) EUCOMM “knock-out first” gene trap strategy used to generate the Trpv4 reporter
mouse. The L1L2_Bact_P cassette was inserted upstream of the critical exon (exon 6) in
the Trpv4 locus. The cassette includes FRT site, lacZ sequence and a loxP site. This first
loxP site is followed by a neomycin resistance gene, a second FRT site and a second loxP
site. A third loxP site is inserted downstream of the targeted exon 6. The resulting construct
has exon 6 of Trpv4 gene flanked by loxP sites (tm1a). The tm1a mice were then Creexcised to remove neomycin resistance cassette and exon 6, to generate reporter mice
(tm1b) where the Trpv4 locus drives expression of the lacZ gene (Trpv4LacZ/LacZ). B)
Calcium traces of AF cells isolated from 2.5 month-old WT and Trpv4LacZ/LacZ mice treated
with to the TRPV4 agonist GSK101 (100 nM). After incubation with Fura 2-AM, AF cells
were imaged during 5 min of calibration, 10 min following administration of vehicle (0.1%
v/v DMSO), and then 20 min following administration of GKS101 (100 nM). Calcium
response induced by GSK101, indicative of TRPV4 activation, was detected in WT AF
cells, but was absent in Trpv4LacZ/LacZ AF cells (n=3 per genotype). C) Trpv4LacZ/WT embryos
at E8.5, E12.5, E17.5 and postnatal day 1 were harvested for fate mapping experiments.
Mice at 2.5, 6, 9, 12 months-of-age were used to characterize Trpv4 expression in the
murine IVD over time.
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light/dark cycle, with rodent chow and water available ad libitum. Mice were euthanized
by CO2 asphyxiation or by lethal injection of sodium pentobarbital.
Trpv4LacZ/LacZ mice were mated with wild-type C57BL/6N mice to generate Trpv4LacZ/WT
mice. For fate mapping experiments, Trpv4LacZ/LacZ male mice were bred with wild-type
C57BL/6N females. For timed matings, insemination was confirmed by the presence of
vaginal sperm plug, which was counted as embryonic day (E) 0.5. Pregnant female mice
were sacrificed at E8.5, E12.5 and E17.5 to harvest embryos. Thoracic, lumbar, and caudal
spines were isolated by dissection from mice at 2.5-, 6-, 9-, 12-months-of-age.
NP and AF tissues were isolated by microdissection from the lumbar and caudal spines of
C57BL/6N mice at 2.5-, 6-, 9-, 12-months-of-age and immediately placed in TRIzol
reagent (Life Technologies, Carlsbad, CA, USA) for subsequent RNA extraction.

3.4.2 β-Galactosidase Staining
Embryos were fixed for 40 min (E<10.5) or 1 h (E>10.5) in 2% paraformaldehyde, 0.2%
glutaraldehyde, 0.02% IGEPAL® CA-630 in Phosphate Buffered Saline (PBS) on ice.
Embryos were washed in detergent rinse buffer (0.01% sodium deoxycholate, 2 mM
MgCl2, 0.02% IGEPAL® CA-630) for 3 times 10 min each prior to overnight incubation
in X-gal staining solution (1 mg/mL X-Gal, 2 mM MgCl2, 5 mM EGTA, 0.02% IGEPAL®
CA-630, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6) at 37°C with agitation. Embryos were then
washed 3 times with PBS (10 min each) and stored in PBS overnight to allow stain to
develop. Embryos were imaged using a Leica M165FC stereo microscope (Leica
Microsystems Inc. Canada, Richmond Hill, ON, Canada) and the staining reaction was

115

stopped by placing embryos in 4% paraformaldehyde overnight at room temperature (postfixed).
To visualize β-galactosidase staining in embryos >E10.5 (including postnatal day 1; PN1),
a clearing step was performed as previously described29,30. Briefly, embryos were cleared
using a series of solutions containing decreasing KOH and increasing glycerol
concentrations (100:0, 80:20, 50:50, 20:80, and 0:100%, respectively, for 3 days each)
following post fixation. β-galactosidase staining of isolated thoracic, lumbar and caudal
spinal segments was conducted as outlined above for mice >2.5 months-of-age. Following
staining, tissues were decalcified using Shandon’s TBD-2 (Thermo Fisher Scientific,
Waltham, MA, USA) for 5 days at room temperature with continuous agitation.

3.4.3 Histology
For histological analysis, tissues were dehydrated in a graded series of ethanol, cleared in
xylene, and embedded in paraffin as previously described30. Paraffin-embedded samples
were sectioned sagittally at a thickness of 5 μm. Mid-sagittal sections of whole embryos
and spinal regions of skeletally mature mice (thoracic, lumbar, and caudal) were
counterstained with Eosin-Y (Sigma-Aldrich, St. Louis, MO, USA) and mounted with
DAKO Faramount aqueous mounting medium (DAKO/Agilent, Santa Clara, CA, USA).
Embryo sections were imaged using BioTek Cytation 5 Cell Imaging Multi-Mode Reader
and BioTek Gen5 Microplate Reader and Imaging Software (BioTek, Winooski, VT,
USA). Spine sections were imaged using a Leica DM1000 Microscope with Leica
Application Suite Software.
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3.4.4 Immunohistochemistry
Heat-induced antigen retrieval was performed in sodium citrate buffer (10 mM sodium
citrate, 0.05% Tween-20, pH 6.0) at 95°C for 12 min and tissue sections were blocked for
1 h with 5% goat serum in PBS containing 0.1% Triton X-100 (PBS-T; Sigma Aldrich).
Tissue sections were incubated with a primary antibody directed against β-galactosidase
(1:500 in blocking solution; Abcam, Cambridge, MA, USA) in a humidified chamber
overnight at 4°C. The next day, slides were washed with PBS-T, and tissue sections were
incubated with goat anti-rabbit Alexa Fluor 488 secondary antibody (1:500 in PBS;
Thermo Fisher Scientific) for 1 h, washed three times in PBS, and coverslipped with
Fluoroshield Mounting Medium with DAPI (Abcam), and imaged using the BioTek
Cytation 5.

3.4.5 Primary cell isolation and culture
AF tissues were isolated by microdissection from 2.5-month-old C57BL/6N mice (cervical
to caudal spines) using Leica M165 FC stereo microscope (Leica). Isolated tissues were
digested with Type II collagenase (3 mg/mL; Worthington, NJ, USA) in Dulbecco’s
modified Eagle’s medium/Ham’s F-12 medium (DMEM/F12) for 20 min at 37oC. AF
tissues were then minced and further digested for 1 h at 37°C. Tissue digests were filtered
using a 70 micron cell strainer and cells were pelleted by centrifugation (1,100 rpm for 5
min). Cells were plated at an initial density of ~400,000 cells/cm2 in DMEM/F12
supplemented with 10% Fetal Bovine Serum (FBS) and 1% penicillin and streptomycin
(Thermo Fisher Scientific) at 37°C in a humidified atmosphere of 5% CO2. Media was
changed every 2 days until cells reached 80% confluency.
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All cell culture experiments were conducted with primary AF cells at passage 1. Cells were
treated with the following compounds: TRPV4 antagonist GSK2193874 (Sigma Aldrich),
TRPV4 agonist GSK1016790A (Sigma Aldrich), the pan ROCK inhibitor Y-27632
(Stemcell Technologies, Vancouver, BC, Canada).

3.4.6 Live cell calcium imaging
Primary AF cells were passaged onto 14 mm glass bottom microwell dishes (Thermo
Fisher Scientific; Cat. # NC9069930) at a density of ~5,000 cells/cm2 and allowed to adhere
for 2 h, and cultured in DMEM/F12 containing 10% FBS and 1% Penstrep for 24 hr. On
the day of the experiment, cells were loaded with calcium sensitive Fura-2 by incubation
with 2.5 μM Fura-2-acetoxymethyl ester (Fura-2 AM, Thermo Fisher Scientific, MA,
USA; Cat. # F1221) in culture media for 40 min at 37°C in 5% CO2. After loading, cells
were rinsed once and medium was replaced with warmed (37°C) HEPES buffer containing
135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM D(+)-glucose, and 20 mM
HEPES (buffer adjusted to 290 ± 5 mOsm/L and pH 7.30 ± 0.02). Dishes were placed on
a stage warmer (35°C) mounted on a Nikon inverted microscope (Nikon Eclipse TE2000U, Tokyo, Japan) and imaged using a Plan Fluor 40x/1.3 NA oil/water immersion objective
for fluorescence. Cells were excited with alternating wavelengths of 345/380 nm using a
DeltaRAM™ X Illuminator (Horiba Photon Technology International (PTI) Inc., NJ, USA)
and the emission was acquired using a bandpass filter (510 ± 20 nm)31. Ratio images were
acquired every 5 s with a pco.edge 4.2 LTsCMOS camera (PCO AG, Kelheim, Germany)
and EasyRatioPro 2.3 Software (Horiba PTI). For all of the calcium imaging experiments,
the following protocol was used: 5 min incubation for baseline measurement, 10 min
incubation following addition of either TRPV4 antagonist GSK2193874 (GSK219; 250
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nM) or vehicle control (0.1% v/v DMSO diluted in HEPES buffer), 20 min of TRPV4
agonist GSK1016790A (GSK 101; 100 nM). The ratiometric calcium measurements (345
nm / 380 nm ratio) were determined using a manually defined regions of interest (ROIs)
corresponding to individual cells in the field of view (approximately 14-22 cells per
experiment) and each experimental condition was repeated three times from different cell
preparations established from different mice (3 biological replicates). In the vehicle +
GSK101 treated group, the proportions of cells eliciting intracellular calcium response was
quantified by categorizing each cell (n=67) into one of three groups according to changes
in 345/380 nm ratio upon TRPV4 activation: no response (ratio at 0.76-0.92), oscillation
(ratio fluctuating above and below 1.0), sustained (ratio above 1.0).

3.4.7 Cytoskeleton Staining
Primary AF cells were seeded at a density of 48,000 cells/cm2 onto a standard 35 mm dish
and cultured for 2 days. Following expansion, AF cells were treated with GSK 101 (10 nM
or 100 nM) in culture media to activate TRPV4 for 30 min. AF cells treated with vehicle
(0.1% DMSO v/v diluted in culture media) for 30 min served as a control. Following acute
TRPV4 activation, cells were fixed with 4% paraformaldehyde for 10 min, permeabilized
with 0.1% Triton X-100 (PBS-T) for 10 min at room temperature, and blocked with Bovine
Serum Albumin (in PBS) for 30 min. Alexa Fluor 488 Phalloidin (Life Technologies) was
used to detect F-actin according to manufacturer’s protocol and Hoeschst stain (Thermo
Fisher) was used to visualize the nuclei. Images were acquired using a Leica DMI6000
inverted microscope and Leica Application Suite Software (Leica). For each of the 3
biological replicates, 3 non-overlapping ROIs were imaged for each treatment group.
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To determine the role of Rho-kinase/ROCK signalling, AF cells were pretreated with the
pan ROCK inhibitor Y-27632 (10 μM; Stemcell Technologies, Vancouver, BC, Canada)
or vehicle (equal volume of sterile water) in culture media for 24 h prior to 30 min
incubation with 100 nM of GSK 101. Following acute exposure of TRPV4 agonist, cells
were processed, stained for F-actin, and imaged as described above.

3.4.8 Mechanical stimulation
The MechanoCulture B1 (MCB1) device (CellScale Biomaterials Testing, Waterloo,
Ontario, Canada) was used to deliver bi-axial multi-directional cyclic tensile strain (CTS)
to AF cell cultures, as previously described32. Briefly, primary AF cells were seeded at a
density of 48,000 cells/cm2 onto FBS-coated silicone membranes and cultured for 2 days
in culture media. AF cells were exposed to 10% CTS, at a sinusoidal frequency of 1.0 Hz,
for 30 min in the presence or absence of the TRPV4 antagonist GSK219 (250 nM). To
measure the direct effects of TRPV4 channel activation on AF cell gene expression, AF
cells were treated with 100 nM GSK101 for 30 min in the absence of CTS. AF cells
cultured on FBS-coated silicone membranes treated with vehicle (0.1% DMSO) in static
culture served as time-matched unloaded vehicle controls. After 30 min of treatment (CTS,
CTS + GSK219, or GSK101 only), cells were incubated for additional 6 hours before
harvesting for total RNA. To limit the exposure of cells to the pharmacological TRPV4
modulators, following 30 min treatment, cells were rinsed, media was replaced, and cells
were incubated for additional 6 hours before harvest.

3.4.9 RNA extraction and gene expression analysis
Total RNA was extracted from NP and AF tissues harvested at 2.5-, 6-, 9-, and 12-monthsof-age (n=3), and CTS-treated AF cells (n=3) using Trizol reagent (Life Technologies),
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according to the manufacturer’s protocol. RNA was quantified using a NanoDrop 2000
spectrophotometer (Thermo Fisher Scientific). Complementary DNA was synthesized
from 150 ng of RNA using the Bio-Rad iScript cDNA synthesis kit (Bio-Rad, Hercules,
CA, USA). Gene expression was determined by SYBR-based real-time PCR using the BioRad CFX384 thermocycler. PCR reactions were run in triplicate using 470 nM forward
and reverse primers (primer sequences in Table 3.1) with 2x SsoFast EvaGreen Supermix
(Bio-Rad). The PCR program consisted of the following: initial 2 min enzyme activation
at 95oC, 10 sec denaturation at 95oC, 30 sec annealing/elongation at 60oC, for a total of 40
cycles. Trpv4 transcript levels in NP and AF tissues were quantified relative to a six-point
standard curve made from pooled cDNA generated from wild-type murine heart, brain,
kidney, and IVDs. For CTS experiments, gene expression was quantified using ∆∆Ct,
normalized for input based on hypoxanthine quinine phosphoribosyl transferase (Hprt)
expression and expressed relative to time-matched unloaded controls.

3.4.10 Statistical analyses
Statistical analyses were performed using GraphPad Prism 8. qPCR analyses comparing
IVD gene expression over time or in mechanically stimulated AF cells were assessed using
two-way ANOVA with Tukey’s multiple comparison test. qPCR analyses comparing
GSK101 treated AF cells and vehicle control were assessed by two-tailed, unpaired t-test.
P < 0.05 was considered statistically significant. Biological replicates (n) correspond to
experiments performed in different animals or cell preparations from different animals.
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3.5

Results

3.5.1 Trpv4LacZ/LacZ mice have non-functional TRPV4 channel
The EUCOMM gene trap strategy used to generate Trpv4tm1b(KOMP)Wtsi reporter mice
involved targeting the endogenous Trpv4 gene locus with a LacZ reporter gene (Figure
3.1A). To validate this mouse model, calcium response was examined in primary AF cells
from mice homozygous for the transgene insertion (Trpv4LacZ/LacZ) treated with the TRPV4
agonist GSK101. Acute stimulation of AF cells with GSK101 (100 nM) elicited a rise in
Table 3.1. Sequences of the primers used in the real-time PCR analysis.
Gene
Acan
Col1a1
Col2a1
Prg4
Trpv4

Forward (5’ → 3’)
CCTGCTACTTCATCGACCCC
CTGGCGGTTCAGGTCCAAT
GCACATCTGGTTTGGAGAGACC
GGGTGGAAAATACTTCCCGTC
TTCGTAGGGATCGTTGGTCCT

Reverse (5’ → 3’)
AGATGCTGTTGACTCGAACCT
TCCAGGCAATCCAGGAGC
TAGCGGTGTTGGGAGCCA
CAGGACAGCACTCCATGTAGT
TACAGTGGGGCATCGTCCGT
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intracellular calcium in WT AF cells, but not in Trpv4LacZ/LacZ AF cells, confirming the
absence of functional TRPV4 channel in the homozygous reporter mouse (Figure 3.1B).
Previous studies reported that mice with global knockout of Trpv4 showed accelerated
osteoarthritis detectable at 9 months-of-age, and increased bone mass due to impaired
osteoclast activity33,34. To avoid detrimental effects due to complete loss of TRPV4
function, all subsequent studies were conducted using Trpv4LacZ/WT reporter mice.

3.5.2 Trpv4 is expressed in the notochord and primitive annulus fibrosus
Using heterozygous reporter mice (Trpv4LacZ/WT), experiments were conducted to localize
Trpv4 expression during IVD development. At E8.5 no β-galactosidase staining was
detected in embryos, suggesting that Trpv4 is not expressed during early stages of
notochord formation and elongation (Figure 3.2A; E8.5). At E12.5, β-galactosidase
expression indicative of Trpv4 expression was detected in the developing limb buds,
regions of alar plate of myelencephalon, primitive axial skeleton, and notochord (Figure
3.2A; E12.5). To better resolve β-galactosidase expression within the developing spine,
stained embryos were sectioned for histological analysis. Consistent with the whole mount
examination, patchy β-galactosidase staining was detected in the notochord at E12.5. In
addition to notochord, immunofluorescence staining for β-galactosidase demonstrated
expression in regions of intervertebral mesenchyme, highlighting the metameric patterning
between the developing IVD and prevertebral structure (Figure 3.2B). At E17.5 and PN1,
the cartilage primordium of mandible, limbs, ribs, and spine showed β-galactosidase
expression indicative of Trpv4 expression (Figure 3.2A). At both E17.5 and PN1, βgalactosidase expression was detected in cells of NP and AF, as well as the developing
bone (Figure 3.2C, D).
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Figure 3.2. Localization of Trpv4 expressing cells during mouse spinal development.
A) Representative images of Trpv4lacZ/WT mice at embryonic day (E) 8.5, E12.5, E17.5, and
Postnatal day (PN)1. Embryos were cleared and X-Gal stain was used to detect βgalactosidase activity. Trpv4 expression, indicated by blue β-galactosidase staining
(arrows), is not detected in embryos at E8.5, but was detected in the developing limb buds,
structure of medulla oblongata, and notochord at E12.5. At E17.5 and PN1, the cartilage
primordium of mandible, limbs, ribs, and spine were positive for β-galactosidase. B)
Midsagittal section of the Trpv4lacZ/WT embryos at E12.5 either counterstained with Eosin
or assessed by immunofluorescence using β-galactosidase antibody (1:500). βGalactosidase activity was patchy in the notochord (asterisk) at E12,5; however,
immunofluorescence-based detection showed localization to the notochord (NC) as well as
the intervertebral mesenchyme (IM), but not at the prevertebral (PV) region of the
developing spine. β-galactosidase was detected in primitive AF, NP, and pre-vertebrae
(PV) at both E17.5 and PN1 using both staining methods (C, D). Scale bar = 1 mm, n = 35 embryos/ timepoint derived from at least 2 different litters.
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3.5.3 Trpv4 expression in the IVD differs based on anatomical region,
tissue type and age
In skeletally mature mice, Trpv4 expression was examined in midsagittal sections from the
thoracic, lumbar and caudal spine. At 2.5 months-of-age, β-galactosidase expression
indicative of Trpv4 expression was detected in the lumbar spine in cells of NP and inner
AF (IAF), using both β-galactosidase colorimetric detection and immunofluorescence
staining (Figure 3.3A, B). In keeping with previous reports, staining was also detected in
chondrocytes throughout the vertebral growth plates35–37. Interestingly, β-galactosidase
staining was more intense in the tail IVDs compared to thoracic and lumbar IVDs. In
addition, β-galactosidase staining decreased with increasing age. At 6 months-of-age, less
β-galactosidase staining was detected in the NP and IAF compared to 2.5 months-of-age.
β-galactosidase staining was further reduced at 9 months-of-age, and by 12 months-of-age,
few cells were positive for β-galactosidase staining (Figure 3.3B).
To further quantify age-related changes in Trpv4 expression, we performed gene
expression analysis using NP and AF tissues isolated from lumbar and caudal IVDs of
wild-type mice. Although no significant difference in Trpv4 expression levels was detected
with age in the lumbar IVDs, a significant decrease in Trpv4 gene expression levels was
detected with age in both the NP and AF of the caudal IVDs. In the lumbar IVDs,
expression levels of Trpv4 gene was more robust in the AF compared to the NP, with
significant differences detected in tissues isolated at 6 months-of-age (Figure 3.3C).

3.5.4 TRPV4 is functionally active in AF cells
To correlate Trpv4 expression to functional receptor activation, intracellular calcium
measurements were performed in primary AF cells isolated from mice at 2.5 months-of-
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Figure 3.3. Characterization of Trpv4 expression in the IVD over time.
Midsagittal histological sections of different spinal regions (thoracic, lumbar, or tail) from
Trpv4lacZ/WT mice at 2.5, 6, 9, and 12-months-of-age. A) Representative images of
immunofluorescence-based detection of β-galactosidase in lumbar IVDs of Trpv4lacZ/WT
mice at 2.5-months-of-age. The cells of nucleus pulposus and inner AF were positive for
β-galactosidase, indicative of Trpv4 expression (white arrows). B). Representative
midsagittal sections of IVDs of thoracic, lumbar, or tail regions isolated from the
Trpv4lacZ/WT reporter mice at 2.5, 6, 9, and 12-months of age. X-Gal stain was used to detect
β-galactosidase activity, indicative of Trpv4 expression. β-galactosidase staining was
detected in the nucleus pulposus and inner annulus fibrosus of the IVD (black arrows).
Hypertrophic chondrocytes of the vertebral growth plate served as an internal positive
control for each spine segments. Scale bar = 100 μm, n = 3-4 mice/timepoint. C) SYBRbased real time qPCR quantifying the expression of Trpv4 in AF and NP tissues isolated
from lumbar and tail IVDs at each time point. Transcript levels were expressed relative to
the six-point standard curve. No significant changes in Trpv4 expression were detected in
lumbar IVDs, except at 6 mos where Trpv4 expression was increased in the AF compared
to the NP. A significant decrease in Trpv4 gene expression was detected with advancing
age in both NP and AF tissues of tail IVDs. Data were analyzed using two-way ANOVA
with Tukey’s multiple comparisons. * = p < 0.05; ** = p < 0.01; *** = p < 0.001; **** =
p < 0.0001. Data presented in mean ± SEM. n = 3.

128

age. Activation of TRPV4 channels in AF cells using the TRPV4 agonist GSK1016790A
(GSK101; 100 nM) elicited an increase in intra-cellular calcium (Figure 3.4A), confirming
functional receptor expression. The GSK101-induced calcium response in AF cells was
inhibited when cells were pre-treated with TRPV4 antagonist GSK2193874 (GSK219; 250
nM; Figure 3.4B). Interestingly, AF cells treated with GSK101 demonstrated
heterogeneity in the TRPV4-dependent calcium responses detected, with cells showing a
mixture of sustained, oscillatory, or no calcium responses (Figure 3.4C). To quantify the
proportion of cells exhibiting each of the distinct calcium responses, fluorescence was
assessed in regions of interest corresponding to individual cells and thresholds were set to
represent each calcium response: no response (340/380 ratio 0.76-0.92), oscillation
(340/380 ratio fluctuating above and below 1.0), sustained (340/380 ratio above 1.0). When
all the cells were assessed over 3 biological replicates (n=67), 27% of cells showed no
response, 54% of cells showed an oscillation response, and 19% of cells showed a sustained
response to TRPV4 agonism (Figure 3.4D).

3.5.5 TRPV4 activation is associated with cytoskeletal remodelling in AF
cells
Having confirmed functional activation of TRPV4 in murine AF cell cultures, the
downstream effects of TRPV4-mediated calcium signalling were assayed. TRPV4mediated calcium signalling regulates cytoskeletal rearrangement in other cell types,
including chondrocytes and trabecular meshwork cells38,39. Moreover, in many cell types,
including chondrocyte and cancer cells, Rho-kinase/ROCK signalling regulates
cytoskeletal remodelling in both physiological and pathological states

40–42

. AF cells

showed increased stress fibre formation compared to untreated controls following acute
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Figure 3.4. TRPV4 activity in primary AF cells.
A) Calcium traces of AF cells isolated from 2.5- month-old WT mice in response to the
TRPV4 agonist GSK101 (100 nM), confirming the expression and functionality of TRPV4.
Following incubation with Fura 2-AM, AF cells were imaged for: 5 min of calibration, 10
min following administration of vehicle (0.1% v/v DMSO), and then 20 min following
administration of GKS101 (100 nM). Graph represents the average calcium response of all
cells in the field of view from 3 biological replicates (n = 67). B) The calcium response
induced by GSK101 was inhibited by pre-treatment of AF cells with the TRPV4 antagonist
GSK219 (250 nM). C) Representative images of fluorescence signals at distinct stages of
treatment. TRPV4 activation by GSK101 yielded one of three calcium responses in AF
cells: sustained, oscillation, and no response. D) Stacked histogram showing the
proportions of AF cells showing the distinct calcium responses following TRPV4
activation. Cells were categorized based on their response to the TRPV4 agonist as defined
by their specific fluorescence ratio: 27% of cells showed no response (340/380 ratio 0.760.92), 54% of cells showed oscillation (340/380 ratio fluctuating above and below 1.0),
and 19% of cells showed a sustained response (340/380 ratio above 1.0). Scale bar = 100
μm; n = 67 cells assessed from a total of 3 independent cell preparations.
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treatment with increasing concentrations of the TRPV4 agonist GSK101 (Figure 3.5A).
Moreover, pre-treatment of AF cells with the ROCK inhibitor Y-27632 inhibited GSK101induced stress fibre formation (Figure 3.5B).

3.5.6 TRPV4 activation mediates the response of AF cells to cyclic tensile
loading
To assess the contribution of TRPV4 activation in mediating the mechano-response
of AF cells, cells were exposed to 10% CTS at 1.0 Hz for 30 min in the presence or absence
of the TRPV4 antagonist, GSK219. Cells were harvested 6 h post CTS and gene expression
analysis was performed to detect changes in the expression of aggrecan (Acan), type I
collagen (Col1a1), type II collagen (Col2a1), and lubricin (Prg4). The expression of
Col1a1 and Col2a1 by AF cells were not affected by CTS (Figure 3.6). Interestingly, AF
cells exposed to CTS in the presence of GSK219 showed significantly reduced Col1a1
gene expression compared to unloaded control and CTS only group. In keeping with our
previous findings32, CTS significantly increased Acan (1.5 ± 0.1 fold) and Prg4 (1.7 ± 0.2)
expression compared to unloaded vehicle control. CTS-induced increases in both Acan and
Prg4 expression were inhibited by the presence of GSK219 during mechanical stimulation
(Figure 3.6). These findings suggest that TRPV4 mediates, at least in part, the response of
AF cells to CTS.
To measure the direct effects of TRPV4 activation on AF cell gene expression, cells
were exposed to the TRPV4 agonist GSK101 using a protocol designed to mimic that used
for CTS. AF cells were treated with GSK101 for 30 min in static culture, cells were rinsed,
media was replaced, and cells were incubated for 6 h post-stimulation prior to harvest.
Similar to the effects of CTS, treatment of AF cells with GSK101 induced a significant
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Figure 3.5. Effect of TRPV4 activation on cytoskeleton remodelling in annulus
fibrosus cells.
A) AF cells were incubated with increasing concentrations of GSK101 for 30 minutes,
fixed, and stained with Alexa 488 Phalloidin to visualize the actin cytoskeleton. Increased
stress fibre formation was detected with increasing concentrations of GSK101, suggesting
the cytoskeletal network of the AF cells are changing following acute activation of TRPV4.
B) GSK101-induced stress fibre formation was inhibited when cells were pretreated with
Y-27632 (ROCK inhibitor). Scale bar = 50 μm; n = 3 independent cell preparations derived
from 3 different mice at 2.5 months-of-age.
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Figure 3.6. TRPV4-dependent gene expression in mechanically stimulated AF cells.
AF cells were subjected to 10% cyclic tensile strain (CTS) at 1.0 Hz for 30 min in the
presence or absence of TRPV4-specific antagonist, GSK219. 6 h post CTS, cells were
harvested for gene expression analysis to detect changes in the expression of candidate
ECM genes. Mechanical loading induced an upregulation of Acan and Prg4 expression,
which was blocked by treatment of cells with the TRPV4 antagonist GSK219. Relative
gene expression was calculated using ∆∆Ct, normalized for input using the housekeeping
gene Hprt and expressed relative to time-matched unloaded vehicle control. Data presented
as mean ± SEM; n = 3 cell preparations. Data were analyzed using two-way ANOVA with
Tukey’s multiple comparisons. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P <
0.0001
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increase in the expression of Acan (1.8 ± 0.3 fold) and Prg4 (2.1 ± 0.1 fold) compared to
vehicle control (Figure 3.7). TRPV4 agonism did not alter the expression of Col1a1 or
Col2a1.

3.6

Discussion

The IVD represents a mechanically dynamic environment, in which the cells receive
mechanical cues from their surrounding microenvironment and transduce this information
into intracellular biochemical signals that regulate cellular processes. Although there is
growing evidence of the effects of different types of mechanical stimulation on IVD
biology, information on mechanoreceptor molecules that sense and transduce the
mechanical signals remains limited. In this study, we utilized a novel transgenic reporter
mouse model to characterize the spatiotemporal pattern of TRPV4 expression in the murine
IVD during development and in skeletally mature IVD tissues. We demonstrated that
TRPV4 activation in AF cells elicits intracellular calcium response and regulates
cytoskeleton remodelling. Using a mechanically dynamic bioreactor system and
pharmacological modulation of TRPV4 activation, we showed that TRPV4-dependent
response of AF cells to CTS alters extracellular matrix gene expression. The
characterization of the TRPV4 ion channel provide evidence for the role of TRPV4 as a
mechanoreceptor regulating IVD mechanobiology.
Our findings in the mouse are consistent with previous studies describing Trpv4 expression
during zebrafish embryogenesis35. In the zebrafish, Trpv4 was first detected during
notochord elongation and subsequently in other chondrogenic tissues in later
developmental stages. Similarly, in our reporter mouse, Trpv4 expression was detected in
the notochord as well as the condensed segments of intervertebral mesenchyme,
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Figure 3.7. TRPV4-mediated changes in AF cell gene expression.
Primary AF cells were treated with the TRPV4 agonist GSK101 (100 nM) for 30 min and
after 6 h, cells were harvested for gene expression analysis to detect changes in the
expression of candidate ECM genes. Treatment of AF cells with the TRPV4 agonist
induced a significantly increase in the expression of Acan and Prg4. Relative gene
expression was calculated using ∆∆Ct, normalized for input using the housekeeping gene
Hprt and expressed relative to time-matched vehicle control. Data presented as mean ±
SEM; n = 3 cell preparations. Data were analyzed using unpaired t-tests. * = P < 0.05; **
= P < 0.01.
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highlighting the metameric patterning at E12.5. Anatomically, the notochord is a
continuous rod-like structure that creates the primitive longitudinal and bilateral axes of
the embryo. Functionally, the notochord provides both mechanical and morphogenic
signals to the developing embryo. During development, elongation of the notochord is
thought to happen through two complementary mechanisms: i) through convergent
extension guided along the tension generated by expanding amniotic cavity along the
anterior/posterior axis43–45, and ii) through vacuole expansion within the notochord cells
distributed along the embryonic axis by the rigid ECM of the notochordal sheath restricting
bilateral cell volume expansion46–50. TRPV4 has been shown to regulate cell volume
during cellular osmoregulation51,52 and respond to both compressive and tensile load in
multiple cell types25,53–56. Importantly, TRPV4 expression was detected in the notochord
of zebrafish at the time of vacuole inflation35,57. As such, Trpv4 expression in the notochord
may be evidence for TRPV4 mediating notochord development as mechanoreceptor and
osmosensor, transducing the directionality of mechanical signals and regulating the
notochord cell volume expansion, respectively. Furthermore, intracellular calcium
signalling has been shown to regulate embryogenesis in other animal models. Previous
studies investigating calcium signalling in the developing zebrafish showed high
intracellular calcium transients in the trunk region during early and late segmentation58.
Additionally, intracellular calcium signals were found to regulate cell proliferation,
migration, and shape during zebrafish embryogenesis59–63. Trpv4 expression detected in
the condensed mesenchymal segments at E12.5 in the mouse suggests that TRPV4mediated calcium signalling may contribute to the regulation of cell proliferation and
migration required for metameric patterning along the longitudinal axis.
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In skeletally mature mice, Trpv4 expression was preserved in the cells of NP and inner AF,
with differential expression detected based on anatomical region and age. The differences
in Trpv4 expression in spinal regions may result from differences in mechanical load
experienced in these tissues. Previous studies by our group showed that Trpv4 expression
was upregulated in AF cells following mechanical stimulation32. Accordingly, increased
Trpv4 expression detected in lumbar and tail IVDs compared to thoracic IVDs may be due
to greater mechanical load experienced at these sites. Moreover, the current study
demonstrated decreased Trpv4 expression with increasing age. Tissue osmolarity and pH
within the IVD decrease as aggrecan and other glycosaminoglycans are degraded with
advancing age or degeneration. Previous studies investigating the role of TRPV4 in human
IVDs reported that culturing IVD explants in hypotonic conditions, thereby increasing the
osmotic pressure, leads to increased TRPV4 protein expression28. Notably, the studies used
mechanically dynamic organ culture system delivering cyclic compression to IVD explants
(0.0-0.8 MPa at 0.1 Hz for 8h; 0.2 MPa for 16 h), which may also influence TRPV4
expression. In keeping with these studies, the decrease observed in Trpv4 expression with
increasing age may be due to age-associated changes in tissue osmolarity. Our work
suggests cell type, anatomical region, and age as factors that regulate Trpv4 expression in
the murine IVD.
Our studies show that pharmacological activation of TRPV4 elicited one of three calcium
responses in AF cells: sustained, oscillation, and no response. These findings may relate to
the heterogeneity of the primary cell culture system used which contained cells of both
inner and outer AF. The cells that did not respond to TRPV4 agonism may be outer AF
cells, in which Trpv4 expression was not detected in our reporter mouse. Our results are
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consistent with previous findings reporting sustained intracellular calcium response in AF
and NP tissues upon direct activation of TRPV4 ion channel28. Interestingly, we observed
intracellular calcium oscillation. Calcium oscillation following TRPV4 activation has been
reported to drive matrix production in chondrocytes and regulate cell-matrix adhesion and
alignment in mesenchymal stem cells25,64. The presence of both sustained and oscillatory
calcium response in our cell culture system may be due to agonist concentration and
differences in receptor density on cell subpopulations. Previous studies on receptor
activation in glial cells concluded that lower agonist concentration elicits calcium
oscillation, while high concentration lead to sustained responses65,66. In mesenchymal stem
cells, TRPV4 activation with lower agonist concentration (1 or 10 nM) led to short
oscillatory calcium transients, while high agonist concentration (100 nM) induced
sustained calcium response64. Furthermore, studies investigating the relationship between
intracellular calcium and receptor density showed that changes in receptor density
influences intracellular calcium response following receptor activation67,68. Given the
differences between cells of the inner and outer AF in terms of ECM components, cell
shape, and mechanical environment69, we postulate that differential expression of the
TRPV4 receptor in these cells may account for the different cellular responses we detected.
Differences in TRPV4 expression in AF cells based on anatomical location from which the
IVDs were isolated may likewise contribute to cell heterogeneity in our model and
influence the cellular responses detected.
One of the earliest cellular adaptations to mechanical stimulation is the formation of stress
fibres70–72, and TRPV4-mediated calcium signalling has been shown to regulate
cytoskeletal rearrangement in other cell types, including chondrocytes and trabecular
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meshwork cells38,39. In primary AF cells, pharmacological activation of TRPV4 increased
stress fibre formation, which was blocked with Rho/ROCK inhibition. In many cell types,
including chondrocyte and cancer cells, Rho /ROCK signalling regulate cytoskeletal
remodelling in both physiological and pathological states
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. The crosstalk between

TRPV4 and Rho-kinase/ROCK has been studied in endothelial cells. In normal endothelial
cells, TRPV4 senses mechanical force and induces RhoA/ROCK activation necessary for
migration, stiffening, and contraction73. However, in the pathological state, Rho/ROCK
activation and cell stiffening caused decreased TRPV4 expression, and pharmacological
activation of TRPV4 supressed Rho/ROCK mediated signalling74, suggesting that
Rho/ROCK can act as both an effector and target of TRPV4. Our findings likewise suggest
the involvement of both TRPV4 and Rho/ROCK signalling in cytoskeleton remodelling
and AF cell mechanotransduction.
In other musculoskeletal cell types, intracellular calcium signalling is believed to be one of
the earliest mechano-response events75–78. Specifically in chondrocytes, TRPV4 mediates
the mechano-response, including gene expression and proteoglycan synthesis25. Using a
previously characterized culture system, we assessed the role of TRPV4 in the response of
AF cells to cyclic tensile loading. TRPV4 activation was both necessary and sufficient for
the induction of Col1a1, Acan, and Prg4 expression in response to CTS. Previous studies
investigating the effects of both extracellular osmolarity and mechanical stimulation
showed that in human and bovine AF cells, type I collagen gene expression decreased with
increasing osmolarity, while aggrecan gene expression increased79. Mechanical stimulation
to AF cells inhibited osmotically induced increase in these gene expression, with the
exception of increased aggrecan gene expression in hypertonic environment79. Given that
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TRPV4 is well-established osmosensor, future studies should investigate the role of
TRPV4 in regulating mechano-response of AF cells in different osmotic conditions.

3.7

Conclusions

Our findings show that Trpv4 is first expressed in primitive IVD structures during
development and persists in cells of the mature NP and inner AF. Specifically, in AF cells,
we demonstrated that TRPV4 activation is a key mechanism of mechanical signal
transduction. In addition to previous evidence of TRPV4 as an osmosensor in the IVD, our
data highlights TRPV4 as a mechanoreceptor regulating cytoskeletal architecture and ECM
gene expression. These findings highlight the role of ion channel receptors in modulating
cellular function via intracellular calcium transients. Understanding the mechanism of
mechanoreception and mechanotransduction in IVD cells will help delineate cell-type
specific mediators of mechano-response that regulate IVD health and degeneration.
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3.8

Supplementary Figure

Supplementary Figure 3.1. β-Galactosidase immunofluorescence staining of the
lumbar region at the notochord at E12.5.
The lumbar region within midsagittal sections of Trpv4LacZ/WT embryos at E12.5 were
assessed by immunofluorescence using a β-galactosidase antibody (1:500). βgalactosidase, indicative of Trpv4 expression, was detected at the notochord (B), but not at
the intervertebral mesenchyme (pattern less pronounced in the lumbar region as shown in
brightfield images of A, D). E) No primary antibody negative control. (C, F) DAPI staining
of the nuclei. Scale bar = 100 μm; n = 2 embryos from 2 different litters.
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Supplementary Figure 3.2. Negative control immunofluorescence images of mouse
spine sections at different time points.
Midsagittal sections of the Trpv4lacZ/WT embryos at (A) E12.5, (B) E17.5, (C) PN1, and (D)
2 mos treated with no primary antibody as negative control parallel to immunofluorescence
using β-galactosidase antibody (1:500). DAPI was used to stain the nuclei. Scale bar = 100
μm; n = 3 embryos/ timepoint derived from at least 2 different litters.
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Chapter 4

4

Transient Receptor Potential Vanilloid 4 Mediates LoadInduced Intervertebral Disc Degeneration in a
Percutaneous Tail Disc Puncture Model

4.1

Co-Authorship Statement

All data presented in this chapter were collected and analyzed by Kim, M.K.M. in the
laboratory of Dr. Séguin, C.A. Drs. Ramachandran, R. and Beier, F. provided Trpv4fl/fl and
Col2-Cre mouse strains, respectively. Heather Cadieux-Pitre and Diana Quinonez
provided technical assistance with tail puncture procedures. Drs. Ramachandran, R. and
Séguin, C.A. contributed to study design.

4.2

Chapter Summary

Transient receptor potential vanilloid 4 (TRPV4) is a multi-modally activated cation
channel that mediates mechanotransduction pathways by which musculoskeletal tissues
respond to mechanical load and regulate tissue health. Using Col2Cre;Trpv4fl/fl (Trpv4 KO)
mice, we investigated the role of Trpv4 in an injury-induced model of IVD degeneration.
While loss of Trpv4 did not significantly alter vertebral bone length or histopathological
IVD health compared to age-matched wild-type mice at 4 or 8 months-of-age, Trpv4 KO
mice showed decreased proteoglycan staining in the inner AF compared to IVDs of agematched wild-type mice. Following AF puncture, both Trpv4 KO and wild-type mice
showed similar signs of degeneration at the site of injury. Interestingly, loss of Trpv4
prevented mechanically-induced degeneration in IVDs adjacent to sites of injury. These
studies suggest a role for Trpv4 in regulating extracellular matrix synthesis and mediating
the response of IVD tissues to mechanical stress.
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4.3

Introduction

Low back pain is one of the most disabling conditions worldwide, identified as the leading
cause of years lived with disability in 65% of the world (126 out of 195 countries)1.
Although multifaceted in its cause, in at least 30% of patients low back pain is associated
with radiographic signs of intervertebral disc (IVD) degeneration2,3. IVDs are complex
connective tissue structures located between the vertebrae of the spine that serve as load
bearing joints. The induction of IVD degeneration is thought to be associated with
decreased cellularity and proteoglycan content in the central nucleus pulposus (NP)4,5.
These changes lead to decreased water content, reducing the ability of the tissue to absorb
load. Reduced load absorption in the NP introduces aberrant levels of mechanical load on
the surrounding annulus fibrosus (AF), leading to altered AF cellular processes and
disruption of the lamellar structure3,5. This cascade of degenerative changes ultimately
impairs IVD biomechanical function, leading to structural failures that can precipitate disc
herniation, spondylosis, and spinal stenosis6,7. Although the etiology of IVD degeneration
is unclear, multiple factors are thought to contribute to its onset and progression, including
mechanical loading6,8,9, genetics10,11, nutrient supply12–14, and trauma15,16.
In addition to age-associated IVD degeneration, injury models have been widely used to
study IVD degeneration in both large (bovine17, porcine18, and dog19) and small (rabbit20,
rat21, and mouse22,23) animals. The acute injury induced to the IVD in these models
produces mechanical instability and altered load distribution within the injured IVD and
consequently also within adjacent IVDs. Previous studies in mice adopted an AF puncture
procedure, where a needle inserted through the AF penetrates into the central NP, causing
NP depressurization22. In both lumbar and caudal IVDs, AF puncture induced immediate
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NP herniation followed by progressive degeneration of adjacent tissues, exhibiting
histomorphological signs of mild to advanced degeneration depending on the size of the
needle used and subsequent extent of NP depressurization22–26. Most often, AF injury is
conducted using a surgical approach where an incision and soft tissue dissections are used
to expose the disc space for puncture. More recently, methods have been developed to
allow for percutaneous AF puncture in the caudal spine, an approach that minimizes
inflammation and injury to surrounding tissues, decreases morbidity, and increases
reproducibility of the induced injury27,28.
Although altered mechanical loading is a well-established risk factor for IVD
degeneration29–33, the cell-type specific mediators of mechanotransduction in the IVD are
not fully understood. Transient receptor potential vanilloid 4 (TRPV4) is a cation channel
responsive to multiple extracellular signals, including osmolarity34,35, temperature36–38,
pH39, and mechanical loading (i.e. membrane stretch activation)37,40,41. TRPV4 is expressed
and functionally relevant in musculoskeletal tissues, mediating mechano-response of
chondrocytes and osteoblasts to dynamic compressive load and fluid flow, respectively42,43.
In chondrocytes, mechanical and pharmacological activation of TRPV4 elicits intracellular
calcium transients that serve to regulate matrix synthesis and chondrogenic
differentiation42,44. In bone, mechanically induced TRPV4-mediated calcium signalling
regulates the terminal differentiation of osteoclasts as well as osteoblastic differentiation,
eliciting oscillatory calcium response43,45,46. In the context of the IVD, TRPV4 expression
and activation has been shown to be regulated by changes in extracellular osmolarity in
human NP and AF cells47. In the mouse, we recently demonstrated that TRPV4 is expressed
in the NP and inner AF, and serves to regulate cytoskeletal remodelling and mechano-
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sensitive gene expression in AF cells. Nonetheless, the role of TRPV4 as a regulator of
IVD mechanobiology requires further investigation.
Previous studies demonstrated that TRPV4 function is critical to the maintenance of
musculoskeletal tissues. Whole-body deletion of Trpv4 in mice accelerates age-associated
osteoarthritis and impairs bone turnover, owing to altered mechanotransduction pathways
in chondrocytes, osteoblasts, and osteoclasts48,49. In contrast, conditional deletion of Trpv4
in cartilaginous tissues of skeletally mature mice was shown to attenuate age-associated
but not injury-induced osteoarthritis50. Together, these findings suggest a regulatory role
of TRPV4-mediated signalling in joint health.
The goal of this study was to assess the role of TRPV4-mediated mechanotransduction in
the maintenance of IVD health. Using a newly established ‘knockout ready’ mouse strain,
we targeted Trpv4 expression in the majority of the IVD using Col2-Cre to generate a
knockout mouse model, which was then used to investigate the role of TRPV4 in IVD
health, vertebral bone length, and in an injury-induced model of IVD degeneration.

4.4

Methods

4.4.1 Mice
The EUCOMM “knockout-first” strategy was used to generate Trpv4tm1a(KOMP)Wtsi mice,
containing the L1L2_Bact_P cassette inserted upstream of exon 6 in the Trpv4 locus.
Conditional knockout-ready mice were generated by breeding the Trpv4tm1a(KOMP)Wtsi mice
with Gt(ROSA)26Sortm2(CAG-flpo,- EYFP)Ics mice to excise the selection cassette, generating
Trpv4tm1c(KOMP)Wtsi mice (Figure 4.1A). Homozygous Trpv4tm1c(KOMP)Wtsi mice (Trpv4fl/fl)
were bred to mice carrying Cre recombinase under control of the type IIα1 collagen
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Figure 4.1. Transgenic mouse models.
A) Gene trap strategy used to generate Trpv4 floxed mice. The EUCOMM “knockout-first”
strategy was used to generate Trpv4tm1a(KOMP)Wtsi mouse. The L1L2_Bact_P cassette was
inserted upstream of the critical exon (exon 6) in the Trpv4 locus. The cassette includes
FRT site followed by lacZ sequence and a loxP site. The first loxP site is followed by a
neomycin resistance gene, a second FRT site and a second loxP site. A third loxP site is
inserted downstream of exon 6. The resulting construct has exon 6 of Trpv4 gene flanked
by loxP sites (tm1a). A "conditional ready" (floxed) allele was generated by breeding the
Trpv4tm1a(KOMP)Wtsi mice with Gt(ROSA)26Sortm2(CAG-flpo,- EYFP)Ics mice to excise the selection
cassette, generating Trpv4tm1c(KOMP)Wtsi (Trpv4fl/fl) mice. Subsequent Cre excision leads to
Trpv4tm1d(KOMP)Wtsi (Trpv4 KO) mice B) Fluorescent images of midsagittal sections of Col2Cre;ROSAmTmG/mTmG mice at postnatal day1 (B) and transverse sections of IVDs from mice
at 2.5-moths-of-age (C) to localize Cre activity within the IVD. Expression of GFP
indicates Cre activity. The images demonstrate that Col2Cre targets all cells within the
nucleus pulposus (white label and dotted lines) as well as the inner and middle regions of
the annulus fibrosus (yellow label and dotted lines). Tomato expressing cells (Crenegative) were detected in the outer region of the annulus fibrosus (yellow solid arrow at
C) Scale bar = 100 μm. n = 3 mice per time point.
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promoter and its 3-kb chondrocyte-specific enhancer region (Col2-Cre mice)51–54. Mice
without Cre-recombinase were used as controls (Col2Cre-;Trpv4fl/fl, hereinafter referred to
as WT) for comparison to Cre-positive mice (Col2Cre+;Trpv4fl/fl, hereinafter referred to as
Trpv4 KO).
To localize Col2-Cre activity within the IVD, Col2-Cre mice were mated with the
conditional ROSA26 (R26) mT/mG reporter mouse (Gt(ROSA)26Sortm4(ACTB-tdTomato,EGFP)Luo

/J)55 to generate Col2Cre+;ROSAmTmG/mTmG mice (Figure 4.1B).

All mice were housed in conventional cages and maintained on a 12-hour light/dark cycle,
with rodent chow and water available ad libitum. Mice were euthanized by intraperitoneal
injection of a lethal dose of sodium pentobarbital. All procedures were conducted in
accordance with the policies and guidelines set by the Canadian Council on Animal Care
and approved by the Animal use Subcommittee of Western University, London, ON
(protocol 2017-154, Appendix A).

4.4.2 Percutaneous AF Needle Puncture
To induce IVD degeneration, 2.5-month-old and 6.5-month-old WT and Trpv4 KO mice
(n=5 at 2.5 months-of-age and n=3 for 6.5 months-of-age per genotype) were anesthetized
using 1.75% isofluorane gas and dorsoventral X-ray images were used to locate caudal
IVDs in reference to a custom-made electron-dense landmarking guide (Figure 4.2A).
Using the landmarking tool, caudal IVDs 7/8 (Co7/Co8) and 8/9 (Co8/Co9) were marked
on the dorsal side of the tail. Using aseptic technique, the Co7/Co8 and Co8/Co9 IVDs
were sequentially punctured with a 30-guage needle inserted through the skin into the
centre of the disc (Figure 4.2C). The depth of needle puncture was standardized using a

157

158

Figure 4.2. Injury-induced model of IVD degeneration using percutaneous tail IVD
puncture.
Dorsoventral (A) and lateral (B) view of a 2.5-month-old wild-type mouse undergoing
percutaneous IVD puncture. A) Dorsoventral X-rays with an electron dense measuring tool
are used to locate and mark caudal IVDs 7/8 and 8/9. D) Guided by a 22-gauge sleeve
(asterisk) to standardize depth of puncture, a 30-gauge needle is used to puncture and
depressurize the IVDs, confirmed using lateral X-ray (B). E) Mid-sagittal sections of
internal control (Co5/Co6) and punctured IVDs (Co7/Co8) harvested 48 hours following
needle puncture stained with safranin-O/fast green demonstrating depressurization of the
NP and evidence of fibrous tissue formation in the punctured IVD. F) Experimental
workflow. To induce IVD degeneration, 2.5-month-old and 6.5-month-old WT and Trpv4
KO mice (n=5 per genotype for 2.5 mos; n=3 per genotype for 6.5 mos) were subjected to
tail puncture. Six weeks post-disc puncture (mice 4-months-of-age and 8-months-of-age at
sacrifice) IVD health was assessed using histopathological scoring. Scale bar = 100 μm.
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22-guage needle sleeve designed to expose 1.4 mm of the 30-guage needle for puncture
(Figure 4.2D). Once the IVD was punctured, the needle was held in position for 45 s to
standardize NP depressurization. The puncture location and depth were confirmed by
lateral X-ray images (Figure 4.2B). Uninjured IVDs adjacent to the punctured IVDs
(Co6/Co7 and Co9/Co10) were assayed to look for changes in response to aberrant loading.
Uninjured IVDs two levels above or below the punctured IVDs (Co5/Co6 and Co10/Co11)
served as internal controls. Following the procedure, mice were returned to normal cage
activity and were euthanized 48 h or 6 weeks following disc puncture (Figure 4.2F).

4.4.3 Histological Analyses
Col2Cre+;ROSAmTmG/mTmG pups at postnatal day 1 (PN1) and microdissected lumbar and
caudal IVDs from mice at 2.5 months-of-age were fixed and embedded in optimal cutting
temperature (OCT) compound (VWR International, Mississauga, ON, Canada) for
cryosectioning. Tissues sections were coverslipped with Fluoroshield Mounting Medium
with DAPI (Abcam) and imaged using the BioTek Cytation 5 Cell Imaging Multi-Mode
Reader and BioTek5 Microplate Reader and Imaging Software (BioTek, Winooski, VT,
USA).
Lumbar and caudal spines of WT and Trpv4 KO mice were harvested and fixed overnight
with 4% (w/v) paraformaldehyde in phosphate buffered saline (PBS). Fixed tissues were
decalcified using Shandon’s TBD-2 (Thermo Fisher Scientific, Waltham, MA, USA) for 5
days at room temperature with continuous agitation. Following standard histological
processing, tissues were embedded in paraffin and sectioned sagittally at a thickness of 5
μm. Midsagittal sections of lumbar and caudal spines were deparaffinized and rehydrated
as previously described56,57, and stained with 0.05% Safranin-O/0.05% fast green. Stained
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sections were imaged using a Leica DM1000 Microscope with Leica Application Suite
Software (Leica Microsystems).
Stained sections of the lumbar spine were assessed for both proteoglycan staining and
vertebral bone length using ImageJ software. Briefly, for each lumbar IVD, a region of
interest (ROI) was manually defined to include the entire anterior AF and the area of
corresponding to red pixels within the ROI was normalized to the total ROI area. To assess
vertebral bone length, the distance between the superior and inferior growth plates of each
lumbar vertebrate was measured at the anterior edge, mid-line, and posterior edge and
values were averaged out to generate overall length measurements.
Caudal spine sections stained with Safranin-O/fast green were assessed for IVD
degeneration using an established mouse IVD histopathological scoring system58. For the
purposes of this study, the scoring system included Part (I), Part B(I), and Part C of the
reported criteria, with modifications made in Part (I) (“score 4: mineralized matrix in NP”
omitted). For each caudal IVD, degeneration was scored by two individuals blinded to both
genotype and age of mice in the NP, AF, and NP/AF boundary. Scores from these 3 regions
were summed to provide the overall degeneration score, where the maximum score of 9
reflects the highest degree of degeneration.

4.4.4 Statistical Analyses
All statistical analyses were performed using GraphPad Prism version 8.0.1. Proteoglycan
staining and vertebral bone length measurements were analyzed using two-way ANOVA
followed by Bonferroni multiple comparisons. Grubb’s outlier test was used to identify
outliers in proteoglycan staining quantification. Histopathological scores were compared
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between strains of mice at each time point using a Mann-Whitney U nonparametric test. P
< 0.05 were considered statistically significant.

4.5

Results

4.5.1 Col2-Cre targets the NP and most of the AF
Conditional knockout-ready Trpv4fl/fl mice were generated to examine the role of Trpv4 in
the IVD. The Col2-Cre transgenic strain allows constitutive Cre-recombinase expression
under the control of the type IIα1 collagen promoter and its 3-kb chondrocyte-specific
enhancer51. Type II collagen (Col2a1) has been shown to be expressed in cells of the NP
and AF in mice and other species59–61. Other Col2-Cre strains have been previously
characterized with differences in the genomic location of and regulatory elements driving
Cre recombinase expression62,63. The Col2a1-Cre transgene developed by Ovchinnikov et
al consisted of 3-kb of the Col2a1 promoter region, exon 1 with a mutated initiation codon,
and 3.02-kb fragment of intron 1, followed by an internal ribosome-entry site, and Cre
recombinase coding region62. In this mouse strain, Cre activity was detected in the entire
NP, AF and cartilage endplate (CEP) at 6 weeks-of-age59. Long et al subsequently
modified the Col2a1-Cre construct, adding the G.S.S.-Cre-polyA cassette inserted between
the promoter and enhancer region of Col2a1 gene63. In this Col2a1-Cre mouse line, Cremediated recombination was detected in 75% of NP, 73% in inner AF, 10.6% of outer AF,
and the entire CEP at 2 months-of-age64. To characterize the spatial distribution of Col2Cre
expression in the IVD, Col2-Cre mice were bred with the ROSAmTmG/mTmG double reporter
mice. In Col2-Cre;ROSAmTmG/mTmG mice at PN1, GFP expression indicative of Cre activity
was detected in the NP and AF of both lumbar and caudal IVDs (Figure 4.1B). Transverse
sections of IVD tissues from mice at 2.5 months-of-age demonstrated robust expression of
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GFP in the NP, in all the cells of the inner and middle regions of the AF, and a mixture of
GFP and Tomato expression in the outer 1-3 AF lamellar layers of both lumbar and tail
IVDs (Figure 4.1C). The spatial distribution of Col2-Cre matches our previous work on
the expression profile of Trpv4 in the murine IVD, showing Trpv4 expression in the cells
of the NP and inner half of the AF. As such, Col2-Cre;Trpv4fl/fl mice were generated to
target all Trpv4-expressing cells in the IVD.

4.5.2 Trpv4 deletion leads to decreased proteoglycan staining in the
lumbar IVDs
Using the conditional knockout Col2-Cre;Trpv4fl/fl mice (Trpv4 KO), we investigated the
role of TRPV4 in the IVD. Lumbar spines were harvested for histological analysis from
WT and Trpv4 KO mice at 4 and 8 months-of-age. No gross morphological changes or
overt signs of degeneration were detected in the IVDs of Trpv4 KO mice compared to agematched WT mice (Figure 4.3A). Interestingly, decreased proteoglycan staining was
detected in the inner AF of IVDs from Trpv4 KO mice compared to WT at both timepoints
(Figure 4.3A). Safranin-O staining was therefore quantified within the anterior AF of
lumbar IVDs. No significant difference was detected in the percent area of Safranin-O
staining averaged over all lumbar IVDs between WT and Trpv4 KO mice (Figure 4.3B) at
either time point. However, when assessed at each individual lumbar IVD level, a
significant decrease in proteoglycan staining was detected at L5/L6 in Trpv4 KO mice
compared to WT at 4 months-of-age (Figure 4.3C). At 8 months-of-age, a similar trend
was observed at L5/L6. Decreased proteoglycan staining in Trpv4 KO mice suggests
potential role of TRPV4 as a regulator of matrix synthesis in AF cells.
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Figure 4.3. Loss of Trpv4 does not alter gross IVD morphology.
A) Representative midsagittal sections of lumbar IVDs stained with Safranin-O/fast green
from wild-type and Trpv4 KO mice at 4 and 8 months-of-age. No overt differences were
detected in overall IVD morphology following deletion of Trpv4. To quantify sulphated
proteoglycan levels in the AF, Safranin-O staining was quantified within a region of
interest (ROI) capturing the entire anterior AF and expressed as a percentage of the total
ROI. B) Average percentage of AF area stained by Safranin-O for all lumbar IVDs in WT
and Trpv4 KO. C) Percentage of AF area stained by Safranin-O for each lumbar IVD based
on anatomical location. At 4 months-of-age, Trpv4 KO mice showed decreased SafraninO staining in the AF of L5/L6 compared to wild-type mice. Data presented as mean ± SEM,
analyzed by two-way ANOVA with Bonferroni multiple comparisons test. No outliers
were detected using Grubb’s outlier test. ** = P < 0.01. Scale bar = 100 μm. 4 mos n=5 per
genotype; 8 mos n=3 per genotype.
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4.5.3 Loss of Trpv4 does not affect vertebral bone growth
Since the cartilaginous and bony elements of the spine were likewise targeted by Col2-Cre
(Figure 4.1B), we investigated the effects of Trpv4 deletion on vertebral bone length.
Midsagittal sections of the lumbar spine were used to measure the vertebral bone length,
defined as length of bone between the superior and inferior growth plates of the vertebral
body along the craniocaudal axis (Figure 4.4A). No differences in vertebral bone length
were detected in any lumbar vertebrae between Trpv4 KO and age-matched WT mice at
either 4 or 8 months-of-age.

4.5.4 Percutaneous AF needle puncture induces degeneration of caudal
IVDs
Using a minimally invasive percutaneous AF needle puncture protocol previously
optimized by our group65, we targeted the Co7/Co8 and Co8/Co9 IVDs to induce acute
IVD injury via NP depressurization. In this model, caudal IVDs adjacent to the punctured
IVDs (Co6/Co7 and Co9/Co10) were investigated to assess the tissue response to the
injury-induced aberrant load, and uninjured IVDs two levels above or below punctured
IVDs (Co5/Co6 and Co10/Co11) served as the internal control. To validate this model,
wild-type mice at 2.5 months-of-age underwent percutaneous AF puncture and IVD tissues
were assessed following 48 h. At the site of puncture, IVDs showed histomorphological
changes consistent with the loss of NP tissue volume (due to puncture) and signs of NP
tissue fibrosis compared to adjacent uninjured IVDs (Figure 4.2E).
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Figure 4.4. Vertebral bone length is not altered in Trpv4 KO mice.
A) Representative midsagittal sections of L4 vertebra of WT mice annotated with location
of vertebral bone length measurements. Vertebral bone length was measured at three
different points across the vertebrae (black lines) and averaged for each lumbar vertebrae.
B, C) Average bone lengths for each lumbar vertebral level in wild-type and Trpv4 KO
mice at 4 (B) and 8 months-of-age (C). Vertebral bone length was not altered by loss of
Trpv4. Data presented as mean ± SEM analyzed by two-way anova with Bonferroni
multiple comparisons test. Scale bar = 100 μm. 4 mos n=5 per genotype; 8 mos n=3 per
genotype.
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4.5.5 Loss of Trpv4 protects from degeneration induced in IVDs adjacent
to sites of injury
We then investigated the role of TRPV4 in regulating the response to injury induced IVD
degeneration. Trpv4 KO and age-matched WT mice at 2.5 and 6.5 months-of-age were
subject to percutaneous AF puncture and sacrificed 6 weeks post puncture (at 4 and 8
months-of-age) for histopathological analysis. At both 4 and 8 months-of-age Trpv4 KO
and wild-type mice showed similar degenerative changes at the sites of puncture, including
loss of NP tissue structure and cellularity, NP tissue fibrosis, and disorganization and
reversal of AF lamellae (Figures 4.5 & 4.6 - Co7/Co8; Co8/Co9). Although degenerative
changes induced by puncture were not different between Trpv4 KO and WT mice, loss of
TRPV4 altered the response of adjacent IVDs to the aberrant mechanical load induced by
IVD puncture. In wild-type mice, the Co6/Co7 IVDs adjacent to the sites of puncture
showed signs of advanced degeneration marked by decreased NP cellularity, and NP
fibrosis, and disorganization and reversal of the AF lamellar structure. In contrast, IVDs at
the same level in Trpv4 KO mice showed minimal histopathological signs of degeneration.
Similarly, in wild-type mice Co9/Co10 IVDs (distal to punctured Co8/Co9 IVDs) showed
signs of accelerated NP degeneration, including cell cluster formation, reduced cellularity,
and increased matrix density localized specifically to the side of the needle insertion in the
adjacent punctured IVDs. These degenerative changes were not observed at the same IVD
level in Trpv4 KO mice. The differences observed in both Co6/Co7 and Co9/Co10 were
associated with histopathological scores that were significantly higher in wild-type mice
compared to Trpv4 KO mice at 4 months-of-age (Figure 4.5), but not at 8 months-of-age
(Figure 4.6).
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Figure 4.5. Loss of Trpv4 protects from IVD degeneration adjacent to sites of injury
at 2.5-months-of-age.
Representative mid-sagittal sections of caudal IVDs from wild-type and Trpv4 KO mice
harvested 6 weeks following AF puncture at 2.5-months-of-age (site of puncture indicated
by *). Caudal IVDs Co6/Co5 and Co10/Co11 served as controls while IVDs immediately
adjacent to punctured IVDs were assessed as sites experiencing aberrant load (Co6/Co7
and Co9/Co10). Sections were stained with safranin-o/fast green. IVDs from both wildtype and Trpv4 KO mice showed signs of advanced degeneration following puncture.
Caudal IVDs experiencing aberrant load (Co6/Co7 and Co9/Co10) showed significantly
increased degeneration in wild-type mice compared to Trpv4 KO mice, as reflected by
increased histopathological scores. Data presented as mean ± SD, analyzed by MannWhitney test. * = P < 0.05. Scale bar = 100 μm. n = 5 mice per genotype.
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Figure 4.6. Loss of Trpv4 alters IVD degeneration adjacent to sites of injury at 6.5months-of-age.
Representative mid-sagittal sections of caudal IVDs from wild-type and Trpv4 KO mice
harvested 6 weeks following needle puncture injury at 6.5-months-of-age (site of puncture
indicated by *). Caudal IVDs Co5/Co6 and Co10/11 served as controls, while IVDs
immediately adjacent to punctured IVDs were assessed as sites experiencing aberrant load
(Co6/Co7 and Co9/Co10). Sections were stained with safranin-o/fast green. IVDs from
both wild-type and Trpv4 KO mice showed signs of advanced degeneration following
puncture. In the caudal IVDs experiencing aberrant load (Co6/Co7 and Co9/Co10), WT
mice showed a trend towards higher degeneration scores compared to Trpv4 KO mice.
Data presented as mean ± SD analyzed by Mann-Whitney test. Scale bar = 100 μm. n= 3
mice per genotype.
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4.6

Discussion

Given that IVDs serves as the major load bearing structures for the spine,
mechanotransduction pathways in its resident cells are likely key regulators of IVD
homeostasis. In this study, we used a conditional knockout mouse model to evaluate the
role of the TRPV4 ion channel as a mechanoreceptor regulating IVD health and
degeneration. Using Col2-Cre to target cells of the NP and the majority of the AF, the
effect of Trpv4 deletion was investigated in the IVDs at different spinal regions: lumbar
spines were used to assess vertebral bone length and IVD tissue morphology, while caudal
spines were used to assess the response of IVD tissues to acute injury. Although loss of
Trpv4 in cartilaginous cells did not affect the vertebral bone length, a significant decrease
in proteoglycan staining was detected in the AF of Trpv4 KO mice compared to WT. In
the caudal AF puncture model, loss of Trpv4 significantly decreased the severity of
degeneration in IVDs adjacent to the site of injury, but did not alter injury-induced IVD
degeneration. These findings support the overall importance of mechanical load as a key
factor regulating IVD degeneration and the specific role of TRPV4 in facilitating the
response of IVD tissues to aberrant mechanical load.
Tissue or cell-type specific knockout mouse models enable targeted gene deletion to
understand the role of specific genes in development, cell function, and disease. Several
Cre strains have been reported to target specific cell types of the IVD. Cre strains such as
Noto-Cre56, Shh-Cre66, and Hif1a-Cre67, are commonly used notochord-Cre mouse to
target the NP, while Gdf5-Cre68 and Col1a2-CreERT69 strains have been used to target the
AF. Previous studies have used different Col2a1-Cre strains to target both NP and AF for
gene deletion70–73. Critical to our experiments was the verification of Cre activity in the
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IVD, to ensure that our genetic strategy would appropriately target Trpv4-expressing cells
of the IVD. To achieve this, we bred Col2-Cre mice with ROSAmTmG/mTmG double reporter
mice and demonstrated Cre activity in the entire NP and most of the AF (excluding outer
1-3 lamellar layers of AF), in mice at post-natal day 1 and 2.5 months-of-age. This pattern
of transgene activity coincides with our previous characterization of Trpv4 expression
(Chapter 3), which localized Trpv4 expression to cells of the NP and inner AF. Previous
studies reported the Cre activity of Col2-Cre62 and Col2-CreER mice using tdTomato as
the reporter59. Similar to our findings, Col2Cre;Rosa26TdTomato mice showed Cre
activity in the entire NP and AF at 6 weeks-of-age, in both lumbar and caudal IVDs.
Interestingly, in Col2CreERT;Rosa26TdTomato mice following tamoxifen-induction at
postnatal day 7, Cre activity was limited to the inner regions of the AF at 6 weeks-of-age.
In contrast, studies using Col1a2-Cre(ER)T;ROSAmTmG mice showed that 100 days
following tamoxifen-induction at 3 weeks-of-age, Cre activity was detected in cells of the
outer AF, but not in the inner AF or the NP. Use of these Cre strains in future studies would
allow for a more detailed examination of the role of Trpv4 in specific cell types of the IVD.
TRPV4 has been shown to be essential in maintaining musculoskeletal tissue health and
function, serving as a regulator of matrix synthesis. In porcine chondrocytes, TRPV4mediated mechanotransduction regulates the cellular response to dynamic loading; TRPV4
antagonism blocked mechanically-induced regulation of TGF-β3 and ADAMTS5 gene
expression as well as the loading-induced enhancement of matrix accumulation42. In the
context of mesenchymal stem cells (MSC) osteogenesis, TRPV4 antagonism inhibited
loading-induced early osteogenic gene expression while prolonged pharmacological
activation promoted osteogenic differentiation, as evidenced by increased collagen and
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mineral deposition74. Similarly, previous work by our group demonstrated that TRPV4
mediates loading-induced increase in type I collagen, aggrecan, and lubricin gene
expression in the primary AF cells (Chapter 3). These findings suggest that TRPV4
contributes to the regulation of matrix synthesis in AF cells, findings further strengthened
by the current study demonstrating that loss of Trpv4 led to decreased proteoglycan staining
in the AF.
Growing evidence suggests that TRPV4 is crucial for joint and bone health. Studies using
pan-Trpv4 knockout and cartilage-specific inducible Trpv4 knockout mouse models
showed distinct alterations in the progression of osteoarthritis: pan-Trpv4 knockout mice
show accelerated age-associated osteoarthritis, while cartilage-specific deletion of Trpv4
at 10 weeks-of-age reduces the severity of age-associated osteoarthritis48,50. The observed
discrepancy in disease progression in these models may be related to Trpv4 deletion in
multiple joint tissues in the pan-Trpv4 knockout mice. TRPV4 expression was detected in
the human fibroblast-like synoviocyte line MH7A, as well as primary synovial cells
derived from rheumatoid arthritis (RA) patients and control patients75. In human
synoviocytes, activation of TRPV4 increased intracellular Ca2+, which was inhibited by
TRPV antagonist. Interestingly, the pro-inflammatory cytokine interleukin-1 alpha (IL-1α)
activated the production of IL-8, a response that was suppressed in the presence of TRPV4
agonist in synoviocytes from RA patients but not from control patients. Furthermore, panTrpv4 knockout mice fed a high-fat diet (41.9% kcal from fat) for 3 months had reduced
weight gain and increased expression of genes related to energy metabolism (i.e.
peroxisome proliferator-activated receptor α, phosphoenolpyruvate carboxykinase, and
lipoprotein lipase) in oxidative skeletal muscle compared to wild-type mice fed the same
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diet76. Additionally, although pan-Trpv4 knockout mice did not show altered longitudinal
bone growth45, these mice showed increased subchondral bone volume, bone mass and
decreased trabecular bone volume, potentially due to insensitivity to mechanical loading
and decreased osteoblast/osteoclast activity48,49.
The roles of TRPV4 in numerous musculoskeletal tissues provided a clear rationale to
examine the role of TRPV4 in multiple spinal tissues. We, therefore, investigated the
effects of Trpv4 deletion on vertebral bone length in our Col2-Cre driven Trpv4 KO model.
No differences in vertebral bone length were detected in Trpv4 KO mice within the lumbar
spine, confirming that changes detected in our model are not due to gross alterations in
vertebral bone. Interestingly, TRPV4 gain-of-function mutation, clinically associated with
skeletal dysplasia, have been shown to increase osteoclast number and activity, leading to
bone loss and decreased bone mass49,78. For example, TRPV4 gain-of-function mutation
has been shown to be associated with brachyolmia, a form of skeletal dysplasia of unknown
etiology that primarily affect the spine. Type 1 brachyolmia, one of three identified types,
is characterized by scoliosis, elongated vertebral bodies, overfaced pedicles, and narrow
IVD spaces79. These studies suggest increased TRPV4 activity is associated with vertebral
bone development.
Using a percutaneous IVD puncture model, we investigated the effect of Trpv4 deletion on
the IVD tissue response to injury. Consistent with previous studies27,28, we showed
advanced degeneration of caudal IVDs marked by decreased cellularity and fibrotic
changes in the NP as well as disruption of the AF lamellar structure 4 weeks after puncture.
Conditional deletion of Trpv4 did not alter IVD degeneration at the site of AF puncture. It
is important to note that AF puncture associated with NP depressurization more accurately
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models IVD herniation resulting in more severe IVD degeneration than models of
progressive age-related or mechanically induced IVD degeneration. Since AF puncture
induces a severe injury with drastic degenerative changes, the modulation of a single
mechanoreceptor may not affect the degenerative process due to injury. Interestingly, loss
of Trpv4 protected from degeneration in IVDs adjacent to sites of injury. Following
puncture, the biomechanical properties of the injured IVD are immediately compromised,
which in turn introduces abnormal levels of mechanical load to the adjacent IVDs. A
similar scenario occurs in the clinical setting in adjacent segment disease, characterized by
degenerative changes occurring in the IVD at a spinal level adjacent to sites of surgical
intervention in the spine80. Previous studies reported increased intradiscal pressure at
adjacent IVDs after single level spinal fusion81. The protective effect of Trpv4 deletion
may be explained by the magnitude-dependent nature of TRPV4 activation. In
chondrocytes, repetitive cyclical mechanical load evoked increased intracellular calcium
response in a strain magnitude-dependent manner82. Furthermore, increased basal calcium
influx through genetic alterations or pharmacological activation of TRPV4 has been shown
to cause cell toxicity and cell death in different cell types83–86. In the context of our injury
model, increased mechanical load experienced by the adjacent IVDs may increase TRPV4mediated intracellular calcium influx, leading to degenerative changes. Together, these
studies demonstrate that while Trpv4 deletion did not alter degenerative changes at the site
of injury, in a less severe more progressive model (i.e. adjacent discs with aberrant loading)
or in a model where mechanical loading is the driver of degeneration, TRPV4 plays an
important role.
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It is important to acknowledge limitations associated with the current study. First, murine
caudal IVDs are different in geometry, biomechanical properties, and surrounding tissue
environment compared to lumbar IVDs of both human and mice87–89. Mouse tails are more
circular in geometry, contain less musculature surrounding the IVD, and experience greater
motion compared to lumbar IVDs. Future studies should adopt the needle puncture
procedure developed to target lumbar IVDs24,25. Furthermore, other parameters of the AF
puncture, such as needle size and depth of puncture can be adjusted to modulate the severity
of injury. An injury model with less severe injury may be appropriate to better study the
role of TRPV4 during injury induced IVD degeneration.
Another limitation of our study is the use of in vivo models. While transgenic mouse models
allow for studies on a protein of interest within the native IVD environment, the small size
of the murine IVD and heterogeneity in IVD cell types within limit our ability to interrogate
mechanistic questions. Future in vitro studies using primary AF cells derived from WT and
Trpv4 KO mice could be conducted using mechanically dynamic bioreactor systems (i.e.
cell stimulators or organ culture) to examine the cellular pathways modulated by loss of
TRPV4. Furthermore, by implementing multi-omics approaches, unbiased studies may be
conducted to examine the effects of Trpv4 deletion in IVD tissues. Lastly, the current study
did not assess sex as biological variable. In the pan-Trpv4 knockout mouse model, male
mice exhibited more severe osteoarthritis and bone abnormalities than female mice.
Consideration of sex-related differences should therefore be incorporated in future studies,
including investigation of the effect of Trpv4 deletion in age-associated IVD degeneration.
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4.7

Conclusions

In the present study, we conditionally knocked out Trpv4 gene in the IVD tissues to
investigate the role of TRPV4 in IVD health and degeneration. Loss of Trpv4 was found
to decrease proteoglycan staining in the AF, suggesting the involvement of TRPV4mediated signalling in proteoglycan synthesis. Using percutaneous AF puncture model, we
demonstrated that Trpv4 deletion did not alter injury-induced degeneration, but protected
from loading-induced degeneration in adjacent IVDs. Taken together, our findings suggest
regulatory roles of TRPV4 in both tissue homeostasis and injury, mediating matrix
production and mechanically-induced IVD degeneration. Understanding the role of
TRPV4 in IVD mechanobiology may contribute to the development of disease modifying
treatments for IVD degeneration.
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Chapter 5

5

Conclusions and General Discussion

5.1

Thesis Summary
“How do annulus fibrosus cells respond/adapt to mechanical load?”

The research presented in this thesis was designed to address this question and aimed to
characterize the mechanotransduction pathways mediating the response of annulus fibrosus
(AF) cells. Specifically, these studies investigated the effects of cyclic tensile strain (CTS)
on AF cells (Chapter 2), the spatiotemporal expression pattern of the candidate
mechanoreceptor, transient receptor potential vanilloid 4 (TRPV4) in spine development
and aging (Chapter 3), the function of TRPV4 in AF cell mechanotransduction (Chapter
3), and the role of TRPV4 in regulating intervertebral disc (IVD) health and injury-induced
degeneration (Chapter 4). Using a mechanically dynamic bioreactor system, we
demonstrated that in vitro exposure of CTS to AF cells led to cytoskeletal remodelling,
MAPK pathway activation, and gene expression changes in a frequency-dependent
manner. Among the panels of genes assessed, we showed that expression of
mechanoreceptors, including Trpv4, was mechanically regulated, suggesting a potential
role of TRPV4 in IVD mechanobiology. Next, using the novel Trpv4-reporter mouse
(Trpv4LacZ/WT), we showed that Trpv4 is expressed during early stages of spine development
and its expression is maintained in mature IVD tissues. Using pharmacological modulation
of TRPV4, we then demonstrated that TRPV4 signalling mediates cytoskeletal remodelling
and CTS- induced changes in extracellular matrix (ECM) genes. Lastly, using Col2Cre;Trpv4fl/fl conditional knock-out mouse we investigated the role of TRPV4 in regulating
IVD health and degeneration. These studies demonstrated that TRPV4 regulates matrix
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homeostasis and tissue response to aberrant load. The specific objectives and findings of
each data chapter are summarized below.

5.1.1 Chapter 2: Quantify the Effects of Mechanical Loading on Annulus
Fibrosus Cells
Objective 1: Validate mechanically-dynamic culture using the MechanoCulture B1
bioreactor
Objective 2: Quantify the effects of acute exposure to CTS on AF cells
Objective 3: Identify mechanosensitive pathway(s) in AF cells following acute exposure
to CTS
Summary of Findings
1. Validation of our culture system involved two steps. First, motion tracking
analysis was used to ensure that strain profiles on the silicone membrane were
uniform during mechanical stretch. Second, genetic labeling using the
NotoCre;ROSAmTmG/mTmG conditional reporter mouse and gene expression analysis
demonstrated that primary murine AF cells maintained an AF-like phenotype in
culture on the bioreactor.
2. AF cells exposed to CTS showed increased stress fibre formation with increasing
loading frequency.
3. Exposure of AF cells to CTS at 2.0 Hz induced a transient phosphorylation of
extracellular signal-regulated kinase1/2 (ERK1/2), but not p38.
4. Acute exposure of AF cells to CTS induced frequency-dependent changes in gene
expression (Table 5.1).
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Table 5.1. Synopsis of gene expression changes induced by CTS protocols in AF cells.
Acan: aggrecan; Col1a1: type I collagen; Cox2: cytochrome c oxidase subunit 2; Fos: FOS
proto-oncogene AP-1 transcription factor subunit; Mmp3: matrix metallopeptidase 3; Myc:
MYC proto-oncogene; P2rx7: purinoreceptor x subtype 7; Prg4: lubricin; Itga5: integrin
subunit alpha 5; Itgb1: integrin subunit beta 1; Tnfα: tumor necrosis factor alpha; Trpv4:
transient receptor protein vanilloid 4. N.S. = No significant differences detected.
CTS Protocol

6% Strain
0.1 Hz
Gene Group
30 min
Col1a1
Extracellular
Acan
Matrix Genes
Prg4
Matrix Remodelling Mmp3
Genes
Inflammatory
N.S.
Cytokine Genes
Candidate
N.S.
Mechano-sensitive
Genes
Not quantified
Cell Surface
Receptor Genes

6% Strain
1.0 Hz
30 min
Acan

6% Strain
2.0 Hz
30 min
Acan
Prg4

N.S.

N.S.

Tnfα

Tnfα

Myc

Cox2
Myc
Fos
Itga5
Itgb1
Trpv4
P2rx7

Not quantified
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5.1.2 Chapter 3: Characterize the Expression Pattern and Function of
Transient Receptor Potential Vanilloid 4 in the Murine
Intervertebral Disc
Objective1: Determine the spatiotemporal expression profile of Trpv4 in the murine spine
Objective 2: Determine the function of TRPV in AF cell mechano-response
Summary of Findings
1. Trpv4 expression was detected in the elongated notochord and condensed regions
of mesenchyme at embryonic day (E)12.5, and subsequently in the NP, AF, and
prevertebral structure at E 17.5 and postnatal day 1.
2. At 2.5 months-of-age, Trpv4 expression was detected in the NP and inner AF.
Expression varied between anatomical regions (thoracic, lumbar, caudal IVDs)
and decreased with age.
3. Pharmacological agonism confirmed the functional activity of TRPV4, and
demonstrated heterogeneous calcium responses in primary AF cells.
4. Activation of TRPV4 in AF cells promoted cytoskeletal remodelling and
increased stress fibre formation, inhibited by Rho-associated protein kinase
(ROCK) inhibition.
5. Pharmacological inhibition of TRPV4 in AF cells prevented CTS-induced
increases in ECM gene expression (Col1a1, Acan, Prg4).
6. In static culture, pharmacological activation of TRPV4 in AF cells induced Acan
and Prg4 gene expression.
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5.1.3 Chapter 4: Determine the Role of Transient Receptor Potential
Vanilloid 4 in Intervertebral Disc Health and Injury
Objective 1: Determine the effects of Trpv4 deletion on lumbar IVD health and vertebral
bone growth
Objective 2: Determine the role of Trpv4 in an injury-induced model of IVD degeneration
Summary of Findings
1. Using a transgenic reporter mouse, Col2-Cre activity was localized to the NP and
most of the AF, identifying the cells targeted in Col2-Cre;Trpv4fl/fl (Trpv4 KO)
mice.
2. Trpv4 KO mice did not show alterations in vertebral bone length or
histopathological signs of lumbar IVD degeneration compared to age-matched
wild-type mice at 4 or 8 months-of-age; however, Trpv4 KO mice showed
decreased proteoglycan staining in the inner AF compared to IVDs of agematched WT mice.
3. In the AF puncture model, loss of Trpv4 did not alter degenerative changes at the
site of injury but prevented mechanically-induced degeneration in IVDs adjacent
to sites of injury.

5.2

Relevance and Contributions to the Field

Mechanotransduction is the cellular mechanism by which physical forces are translated
into biochemical impulses and signals1,2. These biochemical signals include changes to
intracellular concentrations of molecules and elements (i.e. intracellular calcium transient)
as well as the activation of intracellular signalling pathways, each of which may regulate
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changes to cellular and extracellular structures. The idea of applying mechanics to biology
was first postulated by Wilhelm Roux, who proposed that proper embryogenesis occurs as
a result of “formative forces3.” Roux’s contribution to the mechanobiology field was the
concept of “form follows function3,4.” This concept is relevant in IVD mechanobiology, as
the tissue architecture of the NP, AF, and cartilage endplate (CEP) tissues that form the
IVD enable them to work interdependently to function as a load bearing joint. Although
mechanical loading has been established as a key regulators of tissue homeostasis, it is
paradoxically also established as an initiator of IVD degeneration. As such, studies
investigating the effects of both physiological and pathological parameters of mechanical
loading on IVD cells report mechano-regulation of ECM synthesis and/or degradation5–12.
Nevertheless, information on the cell type-specific response to mechanical loading and
mechanisms mediating this response in the IVD is limited. The contributions and
interpretations of the findings presented in this thesis are discussed below in the context to
three general principles of mechanotransduction.

5.2.1 Mechanoreception
Recent studies have reported the expression of different mechanoreceptors, including
integrins13, toll-like receptors5,14, purinoreceptors15, proteinase activated receptors16, and
transient receptor potential ion channels17,18 in the IVDs of different species including
human, porcine, and rat. Among these, previous studies investigating mechano-sensitive
pathway activation in the IVD have been limited to characterization of the α5β1 integrin
receptor6. This knowledge gap highlights the need for in-depth characterization of the
expression pattern and function of the mechanically sensitive “receptorome” of the IVD.
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The data presented in Chapter 3 demonstrate that Trpv4 is expressed during spine
development, detected as early as E12.5 in the notochord and condensed regions of
mesenchymal cells, and maintained in the NP and inner AF of skeletally mature mice.
Given that both embryonic development and homeostasis of the IVD are regulated by
dynamic mechanical cues, it is tempting to speculate that TRPV4 may act as a mediator of
physiologic mechanical signals in both contexts (Figure 5.1). Moreover, Trpv4 expression
in the IVD differed based on anatomical region in the spine and age. The differences in
Trpv4 expression based on anatomical region may be related to differences in mechanical
load experienced in each spinal region. Consistent with this notion, in Chapter 2 we
demonstrate that Trpv4 expression is mechanically regulated. Previous studies comparing
IVD mechanical properties in mice reported that lumbar IVDs were more stiff than caudal
IVDs by nearly two fold; lumbar IVDs compressed by 64% of their original height
compared to tail IVDs which compressed by 98% after static creep compression19. The
authors of this study proposed that these differences were due to the increased motion
experienced by the tail compared to the lumbar spine. Furthermore, we found that Trpv4
expression in both lumbar and caudal IVDs decreased with age. The age-associated
decrease in Trpv4 gene expression may be part of normal IVD aging, potentially
contributing to age-induced changes in biochemical and biomechanical properties of IVD.
Our studies characterizing the spatiotemporal expression of Trpv4 in the IVD suggest that
TRPV4 may play a role in IVD development, homeostasis, and aging.

5.2.2 Mechano-transmission
Mechano-transmitters are molecules that mediate specific intracellular biochemical
signalling cascade upon receptor activation. In Chapters 2 & 3, we showed activation and
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Figure 5.1. Proposed model of TRPV4 signalling in AF cells.
A) Trpv4 expression is detected as early as embryonic day (E) 12.5 and is maintained in
the NP and inner AF of mature IVDs (blue gradient = Trpv4 expression). B) Proposed
mechanism of TRPV4 function in AF cell mechantransduction. In normal loading, TRPV4
and Rho/ROCK signalling are involved in stress fibre formation and regulation of
extracellular matrix (ECM) gene expression. Mechanical load also activates the ERK1/2
pathway. In response to aberrant loading, increased TRPV4 receptor expression leads to
increased TRPV4 function, facilitating degenerative changes and inducing IVD
degeneration. Solid arrows = observed; Dotted arrows = proposed. NP = nucleus pulposus.
AF = annulus fibrosus. CEP = cartilage endplate.
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involvement of different signalling pathways downstream of mechanical load or TRPV4
activation. Specifically, we showed that exposure of AF cells to CTS at 2.0 Hz to AF cells
produced a transient increase in ERK1/2 phosphorylation. One of the upstream signalling
events that can influence ERK activation is a rise in free intracellular calcium
concentrations. Calcium is a versatile second messenger that affects signalling processes,
thereby regulating numerous cellular processes. In Chapter 3, pharmacological activation
of TRPV4 induced both sustained and oscillating calcium signalling in AF cells.
Interestingly, in rat fibroblasts, elevated calcium concentrations activate ERK signalling
cascade by altering ERK2 binding affinity. In cells treated with high concentration of
calcium (1 mM), more proteins were bound to ERK2 compared to untreated cells20.
Moreover, ERK2 nuclear translocation was delayed with increased calcium, suggesting
that intracellular calcium regulates signalling specificity and spatiotemporal regulation of
ERK2 localization20,21. Although speculative, we postulate that the increase in ERK1/2
phosphorylation induced by tensile stretch is regulated by TRPV4-mediated calcium
transients, similar to those we characterized using pharmacological receptor agonists
(Figure 5.1).
Another mechano-transmitter we identified was Rho/ROCK and its role in regulating loadinduced stress fibre formation in AF cells. In many cell types, one of the earliest adaptations
to mechanical stimulation is stress fibre formation20,21. In chondrocytes, TRPV4-mediated
calcium signalling has been shown to regulate cytoskeletal rearrangement22. Our data in
Chapter 3 demonstrates that pharmacological activation of TRPV4 in AF cells led to
increased stress fibre formation, which was inhibited when cells were pre-treated with the
ROCK inhibitor. Although not studied in musculoskeletal cell types, the cross-talk between
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TRPV4 and Rho/ROCK signalling has been demonstrated in endothelial cells23–25. In
healthy endothelial cells, mechanically-induced TRPV4 activates Rho/ROCK signalling to
regulate cell migration, stress fibre formation, and contraction26. However, in pathological
state, Rho/ROCK-mediated cell stiffening caused a decrease in TRPV4 expression, and
pharmacological activation of TRPV4 suppressed Rho/ROCK signalling27. These studies
suggest that Rho/ROCK signalling can act as both an effector and target of TRPV4. In
keeping with these findings, our data suggests that both TRPV4-mediated and Rho/ROCK
signalling pathways are involved in stress fibre formation in AF cells in response to
mechanical load (Figure 5.1).

5.2.3 Mechano-response
The current thesis used both in vitro and in vivo models to study the IVD mechano-response
under physiological and pathological conditions. In Chapter 2, we showed that the cellular
response of AF cells to CTS is frequency-dependent. It is important to note that all CTS
loading protocols used in this study had constant tensile strain (6%) and duration (30 min)
with frequencies falling within the range that was considered physiologically relevant (0.1
Hz, 1.0 Hz, 2.0 Hz). Interestingly, even within the physiological range, changes in
cytoskeleton remodelling, pathway activation, and gene expression were different for each
of the loading protocols. In keeping with previous studies6,28,29, mechanical loading
increased ECM gene expression, which we subsequently showed to be mediated by TRPV4
signalling (Chapter 3). This was further supported by data presented in Chapter 4 where
conditional deletion of Trpv4 was associated with decreased proteoglycan staining in AF
(compared to WT controls). These data suggest that mechanically-induced TRPV4
signalling is involved in proteoglycan synthesis in AF cells.
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Interestingly, among the ECM genes assessed, lubricin (Prg4), which was recently
identified as an AF-enriched gene by our group30, showed frequency-dependent changes
in gene expression, significantly upregulated in AF cells exposed to CTS at 0.1 Hz and 2.0
Hz. Lubricin is a surface-active mucinous glycoprotein found in the synovial joint that
functions to lubricate the cartilage surface and reduce joint friction31,32. A recent study
examining the distribution of lubricin in the IVD showed that in AF, lubricin is present in
the interlamellar space of the annular lamellae33. In the IVD, the lamellar structure of the
AF lengthens and shortens upon loading and unloading, respectively. Accordingly, there is
a relative motion between the lamellae during dynamic load, and lubricin may be one of
the mechanically regulated proteins that contribute to this internal tissue tribology.
Nevertheless, the precise function of lubricin within the IVD and its role in AF
mechanotransduction are unknown.
Notably, other than Trpv4, AF cells exposed to CTS at 2.0 Hz showed increased expression
of Itga5 and Itgb1, suggesting that mechanically stimulated AF cells increase
mechanoreceptor gene expression, thereby potentially perpetuating the activation of
mechanotransduction signalling pathways.
Next, we investigated the role of TRPV4 in regulating the tissue response to IVD injury
(Chapter 4). Using a percutaneous AF puncture model, we demonstrated that deletion of
Trpv4 did not protect from degeneration induced at the site of IVD injury. However, loss
of Trpv4 prevented degeneration due to aberrant load in IVDs adjacent to sites of injury.
These data suggest that although modulation of TRPV4 function does not alter
degeneration following severe acute IVD injury (resulting in complete NP
depressurization), TRPV4-mediated signalling is upstream of the degenerative changes
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induced by aberrant mechanical load in the IVD (Figure 5.1). One possible mechanism for
this may be increased mechanical loading upregulating Trpv4 expression, leading to
increased TRPV4 activity within the IVD cells, contributing to degenerative changes.
In summary, our findings demonstrate that TRPV4 is a mechanoreceptor in AF cells and
regulates ECM synthesis during physiological loading as well as the tissue response to
aberrant mechanical load (Figure 5.1). The current work reinforces the theory suggesting
the existence of a “window” of loading parameters that promote IVD health.

5.3

Limitations and Future Directions

Although specific limitations are addressed within each chapter, it is important to address
important limitations that apply to our overall study design. First, while in vitro bioreactor
systems enable the design of controlled experiments, they do not recapitulate the innate
mechanical loading environment experienced by AF cells in vivo. The IVD represents a
complex loading environment diverse in the type, direction, magnitude, and frequency of
mechanical load experienced. To model the radial strain that is predominantly experienced
by cells of the AF, we chose a bioreactor system that delivered bi-axial multi-directional
CTS. In addition, given the limited number of cells that can be isolated from each of the
murine IVD, primary AF cell cultures were established by pooling AF tissues from all
spinal levels. As such, we acknowledge that our reported findings correspond to a mixed
AF cell population, with variability in cell phenotype introduced by the presence of both
inner and outer AF cells with additional differences related to the anatomical region of the
spine from which the tissue was isolated.
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To address these limitations, future studies could capitalize on the validated bioreactor
system to further characterize the effects of varying tensile strain and loading duration of
CTS on cellular mechano-response to better understand AF mechanobiology.
Mechanistically, CTS experiments could be conducted with pharmacological modulators
of TRPV4 to investigate if TRPV4 mediates mechanical-induction of genes associated with
matrix remodelling, mechano-sensitive genes, or inflammatory cytokine genes.
Furthermore, ex vivo organ culture models allow for reproducible cost-effective studies to
investigate IVD mechanobiology and degeneration in an innate tissue structure. IVD organ
culture systems can help develop treatment strategies, as they have the potential to bridge
the gap between in vitro and in vivo systems.
Recent studies have used ex vivo organ culture bioreactors to deliver diurnal loading cycle
to more accurately model daily activity34–37. Adopting such protocols coupled with cyclic
strain may help recapitulate mechanical environment in vivo. Building upon our findings,
future studies using these model systems should investigate the mechano-response of IVD
tissues under physiological and pathological loading conditions. Given the established
discrepancy between gene expression and protein expression38,39, changes in both gene and
protein expression should be quantified in tissue as well as assessing levels of secreted
proteins in conditioned media. For assessment of changes in IVD tissues, omics
technologies can be used to gain a global understanding of the tissue response to normal
and aberrant load. Notably, using IVDs from large animals (i.e. bovine, porcine) in these
studies may be useful in characterizing the mechano-response of AF cells residing in the
inner and outer regions of AF tissue. Although not yet fully characterized, the two regions
of AF differ in cell morphology and matrix composition. Determining the differential
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responses of inner and outer AF cells to mechanical load may contribute to understanding
IVD tissue anatomy, function, and degeneration.
A second limitation is the use of mouse models. Although mouse models are invaluable to
study genes of interest within the native environment through genetic manipulation, there
are certain differences between mouse and human IVDs that must be acknowledged. One
of the main differences is the cellular composition in the central NP tissue. In mice,
notochordal cells persist in the NP throughout life, while in humans, notochordal cells are
present at birth, but typically disappear by 10 years-of-age40. Notochordal cells are large
vacuolated cells that persists from the notochord structure during development, responsible
for sulphated glycosaminoglycan production in the NP41, and their disappearance is
thought to precede IVD degeneration in humans42. In addition, given the differences in
musculature and increased degree of motion of tails, mouse caudal IVDs have different
mechanical properties compared to both murine and human lumbar IVDs19,43,44. Despite
such differences, both humans and mice have similar lumbar IVD geometry, tissue
architecture, matrix compositions, and biomechanical properties43–45.
An important limitation specific to the mouse models reported in this thesis is the Credriver used to target Trpv4. Using Col2a1Cre;ROSAmTmG/mTmG reporter mice, we showed
that Col2-Cre targets the whole NP and most of the AF (inner 2/3). However, it is important
to note that Col2-Cre is not specific for the IVD, but also targets other tissues, including
chondrocytes, osteoblasts, synovial fibroblasts, and suture mesenchymal cells in the
calvaria46. The loss of TRPV4 in these numerous musculoskeletal cell types could
contribute to alterations in joint function that may impact the phenotype of the knockout
mouse generated. Alterations in other joints tissues in the Trpv4 KO mouse may influence
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the mechanical behaviours of mice (i.e. sedentary or altered gait), thereby impairing our
ability draw conclusions about the precise role of TRPV4 in IVD mechanobiology.
Accordingly, future studies should utilize additional complementary Cre strains to target
Trpv4 deletion in specific tissues of the IVD. For example, previous studies reported that
tamoxifen induction of Col2CreERT (at PN7) and Col1a2-Cre(ER)T (at 3 weeks-of-age)
showed Cre activity in the inner AF and outer AF, respectively. Furthermore, Noto-Cre
mice can be used to target cells of notochordal origin (i.e. NP).
In addition, to further investigate the expression and function of TRPV4 in murine IVD,
mice at advanced ages should be included in future studies. Previous studies reported that
in C57BL/6 mice, both histomorphological and radiological signs of age-induced IVD
degeneration were detected starting at 14 months-of-age, progressing to a moderate to
severe degeneration by 22 months-of-age47. Accordingly, both the Trpv4-reporter
(Trpv4LacZ/WT) and Trpv4 KO mice should be examined at later time points up to 2 years of
age to characterize expression profile and function of Trpv4 during age-associated IVD
degeneration.
Lastly, another limitation to the work presented in Chapter 4 is the use of tail injury model.
Although the percutaneous AF needle puncture model used is less invasive and highly
reproducible compared to surgical AF puncture, the loading environment of caudal IVDs,
and perhaps the phenotype of cells within the IVD are different from those of lumbar IVDs.
The caudal spine generally has little musculature, and has a greater range of motion
compared to the lumbar spine due to the absence of dorsal bony structures and facet
joints43–45. Furthermore, caudal IVDs have different geometry than lumbar IVDs, which
may influence the loading environment and biomechanical properties19,43,44. As such, the
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tail injury model does not accurately model NP herniation in the clinical context in humans.
Future studies could carry out a detailed investigation of the role of Trpv4 using an IVD
injury model as reported by recent studies, which involves needle AF puncture to lumbar
IVDs in mice48,49.
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Appendices
Appendix A. Animal Protocol Notice of Approval

2017-154:9:
AUP Number: 2017-154
AUP Title: Mouse Models to Characterize Intervertebral Disc
Development and Disc Disease
Yearly Renewal Date: 11/01/2020
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2017-154
has been approved by the Animal Care Committee (ACC),
and will be approved through to the above review date.
Please at this time review your AUP with your research team to ensure
full understanding by everyone listed within this AUP.
As per your declaration within this approved AUP, you are obligated to
ensure that:
1) Animals used in this research project will be cared for in alignment
with:
a) Western's Senate MAPPs 7.12, 7.10, and 7.15
http://www.uwo.ca/univsec/policies_procedures/research.html
b) University Council on Animal Care Policies and related Animal
Care Committee procedures
http://uwo.ca/research/services/animalethics/animal_care_and_use_p
olicies.html
2) As per UCAC's Animal Use Protocols Policy,
a) this AUP accurately represents intended animal use;
b) external approvals associated with this AUP, including permits
and scientific/departmental peer approvals, are complete and accurate;
c) any divergence from this AUP will not be undertaken until the
related Protocol Modification is approved by the ACC; and
d) AUP form submissions - Annual Protocol Renewals and Full
AUP Renewals - will be submitted and attended to within timeframes
outlined by the ACC.
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http://uwo.ca/research/services/animalethics/animal_use_protocols.ht
ml
3) As per MAPP 7.10 all individuals listed within this AUP as having any
hands-on animal contact will
a) be made familiar with and have direct access to this AUP;
b)
complete
all
required
CCAC
mandatory
training
([training@uwo.ca] training@uwo.ca); and
c) be overseen by me to ensure appropriate care and use of
animals.
4) As per MAPP 7.15,
a) Practice will align with approved AUP elements;
b) Unrestricted access to all animal areas will be given to ACVS
Veterinarians and ACC Leaders;
c) UCAC policies and related ACC procedures will be followed,
including but not limited to:
i) Research Animal Procurement
ii) Animal Care and Use Records
iii) Sick Animal Response
iv) Continuing Care Visits
5) As per institutional OH&S policies, all individuals listed within this AUP
who will be using or potentially exposed to hazardous materials will have
completed in advance the appropriate institutional OH&S training,
facility-level training, and reviewed related (M)SDS Sheets,
http://www.uwo.ca/hr/learning/required/index.html
Submitted by: Copeman, Laura
on behalf of the Animal Care Committee
University Council on Animal Care

The University of Western Ontario
Animal Care Committee / University Council on Animal Care
London, Ontario Canada N6A 5C1
519-661-2111 x 88792
Fax 519-661-2028
[auspc@uwo.ca]auspc@uwo.caï¿½
http://www.uwo.ca/research/services/animalethics/index.html
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fibrosus cells to cyclic tensile strain is frequency-dependent. Journal of Orthopedic
Research Spine. Accepted July, 2020.

2)

Kerr, G. J., Veras, M. A., Kim, M. M., Séguin, C. A. (2016) Decoding the
intervertebral disc: Unravelling the complexities of cell phenotypes and pathways
associated with degeneration and mechanotransduction. Seminars in Cell and
Developmental Biology.

3)

Kim, M. M., Ramachandran, R., Séguin, C. A. (2020) Spatiotemporal and
functional characterization of TRPV4 in the murine intervertebral disc. In
preparation.

VI. Conferences & Internship Presentations
Presentation type underlined
1)

Kim, M. M., Ramachandran, R., Séguin, C. A. (November 2019) Spatiotemporal
and functional characterization of TRPV4 in the murine intervertebral disc. 2019
Orthopaedic Research Society Philadelphia Spine Research Symposium Skytop,
Pennsylvania. Poster Presentation.
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2)

Kim, M. M., Ramachandran, R., Séguin, C. A. (April 2019) Spatiotemporal and
functional characterization of TRPV4 in the murine intervertebral disc. 2019
London Health Research Day, London, Ontario. Poster Presentation.

3)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (May 2018) Characterizing
mechanotransduction in annulus fibrosus cells. 2018 NSERC CREATE Annual
General Meeting, Kingston, Ontario. Podium Presentation.

4)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (November 2018)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2018 Physiology and Pharmacology Research Day, London, Ontario. Poster
Presentation. (recipient of poster award)

5)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (November 2018)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. CellScale, Waterloo, Ontario. Scientific Internship Presentation.

6)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (May 2018) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2018
NSERC CREATE Annual General Meeting, Kingston, Ontario. Podium
Presentation.

7)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (May 2018) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2018
Canadian Bone and Joint Conference, London, Ontario. Poster Presentation.

8)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (November 2017)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2017 Physiology and Pharmacology Research Day, London, Ontario. Poster
Presentation.

9)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (May 2017) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2017
NSERC CREATE Annual General Meeting, Toronto, Ontario. Podium
Presentation.

10)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (April 2017) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2017
Gordon Research Seminar – Cartilage Biology and Pathology, Tuscany, Italy.
Podium Presentation.

11)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (April 2017) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2017
Gordon Research Conference – Cartilage Biology and Pathology, Tuscany, Italy.
Poster Presentation.

12)

Kim, M. M., Burns, M., Serjeant, M., Séguin, C. A. (January 2017)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. CellScale, Waterloo, Ontario. Scientific Internship Presentation.
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13)

Kim, M. M., Serjeant, M., Cadieux, C., Tenn N. A., Séguin, C. A. (November
2016) Characterization of the cellular response of annulus fibrosus cells to cyclic
tensile strain. 2016 Physiology and Pharmacology Research Day, London, Ontario.
Poster Presentation.

14)

Kim, M. M., Serjeant, M., Cadieux, C., Tenn N. A., Séguin, C. A. (June 2016)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2016 Canadian Connective Tissue Conference, Hamilton, Ontario. Poster
Presentation.

15)

Kim, M. M., Serjeant, M., Cadieux, C., Tenn N. A., Séguin, C. A. (April 2016)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2016 Canadian Bone and Joint Conference, London, Ontario. Poster
Presentation.

16)

Kim, M. M., Serjeant, M., Cadieux, C., Tenn N. A., Séguin, C. A. (March 2016)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2016 London Health Research Day, London, Ontario. Poster Presentation.

17)

Kim, M. M., Cadieux, C., Tenn N. A., Séguin, C. A. (November 2015)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. ORS 3rd International Philadelphia Spine Research Symposium,
Philadelphia, USA. Poster Presentation.

18)

Kim, M. M., Cadieux, C., Tenn N. A., Séguin, C. A. (November 2015)
Characterization of the cellular response of annulus fibrosus cells to cyclic tensile
strain. 2015 Physiology and Pharmacology Research Day, London, Ontario. Poster
Presentation.

19)

Kim, M. M., Cadieux, C., Tenn N. A., Séguin, C. A. (May 2015) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2015 Bone
and Joint Retreat, London, Ontario. Panel Presentation.

20)

Kim, M. M., Cadieux, C., Tenn N. A., Séguin, C. A. (May 2015) Characterization
of the cellular response of annulus fibrosus cells to cyclic tensile strain. 2015
Canadian Connective Tissue Conference, Québec City, Québec. Poster
Presentation. (recipient of travel award)

